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Abstract 
Renewable and compostable bioplastics can be produced from biopolymers such 
as proteins. Animal blood is a by-product from meat processing and is rich in 
protein. It is dried into low value bloodmeal and is used as animal feed or 
fertiliser. Previous work has shown that bloodmeal can be converted into a 
thermoplastic using water, urea, sodium dodecyl sulphate (SDS), sodium sulphite 
and triethylene glycol (TEG). This material is currently being commercialised as 
Novatein Thermoplastic Protein (NTP) and studies are working on improving its 
properties through production of composites and blends. In addition further 
studies are working on understanding its molecular structure before and after 
thermoplastic processing by utilising various analytical techniques. 
A specific area identified for improvement is its colour and smell. NTP is black in 
colour and has an offensive odour which means its current potential applications 
are limited to agriculture and waste disposal. Approximately 30 to 40% of plastics 
are used in short life span applications such as packaging and using bioplastics in 
these applications would be advantageous because of their compostability. To 
increase NTP’s possible range of applications to common applications such as 
packaging and increase its acceptance from consumers, its colour and odour must 
be removed without compromising its mechanical properties. 
Oxidative treatment methods for removing colour and odour from red blood cell 
concentrate (RBCC), modified red blood cell concentrate (mRBCC) and 
bloodmeal were investigated using hydrogen peroxide, peracetic acid (PAA), 
sodium hypochlorite, sodium chlorite, sodium chlorate and chlorine dioxide.  
Treatment effect on protein molecular weight, crystallinity, thermal stability, 
solubility, product colour and smell were investigated.  Treating RBCC and 
mRBCC required multiple processing steps, had high water contents  (67% and 
93% respectively), foamed during treatment with peroxides and the protein was 
prone to hydrolysis.  Bloodmeal contained 95% solids and was less sensitive to 
hydrolysis.   
The best decolouring and deodorising results were obtained by treating bloodmeal 
with 5% PAA.  Using this novel treatment method, decolouring was completed 
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within five minutes and produced a powder which was 67% white based on the 
RGB colour scale.  Protein molecular weight was unaffected by PAA 
concentration, with a number average molecular weight ranging between 190-223 
kDa for 1-5% PAA treated bloodmeal. However, its crystallinity decreased from 
35% to 31-27% when treated with 1-5% PAA. Treating bloodmeal with 1-5% 
PAA also reduced the protein’s thermal stability, glass transition temperature 
(225°C down to 50°C) and increased its solubility from 11% to 85% in 1% SDS 
solution at 100°C. 
3-5% PAA treated bloodmeal powder was extruded using different combinations 
of water, TEG, glycerol, SDS, sodium sulphite, urea, borax, salt and sodium 
silicate at concentrations up to 60 parts per hundred parts bloodmeal (pphBM).  
Partially consolidated extrudates and fully consolidated injection moulded 
samples were obtained using a combination of water, TEG and SDS. 4% PAA 
treated bloodmeal produced the best extruded and injection moulded samples and 
was chosen for investigating the effects of water, TEG and SDS concentration on 
consolidation and specific mechanical energy input (SME) as well as product 
colour and mechanical properties.   
Analysis of variance (ANOVA) showed SDS was the most important factor 
influencing ability to be extruded because it detangled protein chains and allowed 
them to form new stabilising interactions required for consolidation. The best 
extruded sample, which was 98% consolidated and 49% white, contained 40 
pphBM water, 10 pphBM TEG and 6 pphBM SDS.   
TEG had the greatest effect on the product’s mechanical properties and colour 
after injection moulding because of its plasticisation effect. ANOVA showed TEG 
contributed 30.5% to changes in Young’s modulus, 66.9% to strain, 39.7% to 
toughness, 0.1% to UTS and 38.1% to colour. However, SDS also contributed 
8.1% to changes in Young’s modulus, 13.7% to strain, 15.2% to toughness, 12.5% 
to UTS, 0.5% to colour. Initial water content contributed 19.7% to Young’s 
modulus, 1.0% to strain, 0.6% to toughness, 30.0% to UTS and 29.9% to colour. 
The best injection moulded sample was produced using 50 pphBM water, 20 pphBM 
TEG and 3 pphBM SDS.  This produced a material which was 39% white, which 
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had an almost transparent yellow/orange colour with a tensile strength of 4.62 
MPa, Young’s modulus 85.48 MPa, toughness 1.75 MPa and 82.62% strain.  
The mechanical properties of the product manufactured in this study were 
comparable to those of NTP, but the product was mostly decoloured, allowing it 
to be easily pigmented and without an offensive odour. 
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1.1 Renewed Interest in Bioplastics 
Traditional petroleum based plastics are versatile and durable materials used in 
many applications. Because of their durability they can persist in the environment 
for thousands of years after being discarded. This has led to increasing plastic 
pollution problems around the world. Approximately 200 million tonnes of plastic 
is consumed worldwide per year of which 30-45% is used as short life span 
products [1-4]. In New Zealand 252 thousand tonnes of plastic waste is disposed 
to landfills each year [5]. Plastic waste, pollution, increasing cost of petroleum 
products and limitations with recycling resulted in increased demand for plastic 
products which are both compostable and sustainable [4]. 
Proteins are naturally occurring biopolymers made from amino acids and have 
been used to produce compostable bioplastics using film casting and 
thermoplastic processing techniques. These products can be used in short life span 
applications where their biodegradability is an advantage [1, 2].  
For bioplastics to become economically viable they must be processed using 
common plastics processing methods such as extrusion. When processing 
biopolymers using extrusion, there are a wide range of variables that can influence 
processability. These include biopolymer-biopolymer interactions, biopolymer-
additive interactions, temperature and shear. A balance between reducing 
interactions allowing melt/flow and the formation of new interactions which 
stabilise the product must also be achieved. Therefore successful extrusion is 
influenced by many factors which mean that successful processing is a difficult 
task to achieve and only possible within a small window of processing conditions 
[6-9]. 
Food crops (e.g. corn) are commonly used in the bioplastics industry and there is 
increasing pressure on food crop supplies due to competition between the food, 
biofuel and bioplastics industries. This has led to increased interest in second 
generation bioplastics (SGB) produced from waste or by-products and do not 
compete with human food or biofuel production [10]. 
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1.2 Meat Processing Industry By-Products 
New Zealand has a large meat processing industry, processing approximately 7 
hundred thousand pigs, 4 million cattle and 27 million sheep and lamb each year 
[11]. A large amount of by-products (52-68% live weight) are produced from this 
industry and efficient utilisation is necessary to reduce the costs of treating plant 
effluents, reduce impact on the environment and increase income generated [11-
13]. One of these products is bloodmeal. Bloodmeal is inedible grade dried blood 
which has usually been unhygenically collected. Approximately 80,000 tonnes of 
blood is collected in New Zealand each year [7]. Bloodmeal is low value 
(approximately $1.3 per kg) and only used as a fertiliser or as a pet food additive 
in low quantities [14]. Its high protein content means it has potential to be used in 
higher value applications. 
Bloodmeal’s smell is caused by the formation of odour compounds during the 
storage of blood before drying. Its colour is caused by the internal bond 
configuration of the haem porphyrin contained in haemoglobin. To modify its 
colour the internal bond configuration must be modified [15, 16]. 
At Waikato University bloodmeal has been used to produce a second generation 
bioplastic using extrusion with the additives urea, sodium sulphite, sodium 
dodecyl sulphite, water and triethylene glycol [7, 9, 17]. The material has a tensile 
strength of 5.7 MPa, Young’s modulus 49.4 MPa, 81% strain and degrades in 12 
weeks when composted [18, 19]. The material is black in colour and has an 
offensive odour. To improve its range of applications and increase its acceptance 
by consumers its aesthetic qualities must be improved. More specifically the 
bloodmeal’s smell and black colour must be removed or modified. The protein’s 
molecular weight must not be significantly reduced so that its ability to be 
extruded and its mechanical properties are not reduced. 
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1.3 Project Goal 
The purpose of this work is to successfully produce a deodorised and decolourised 
bioplastic from bloodmeal and understand the relationship between its molecular 
structure, processing and mechanical characteristics. 
The main research questions were: 
1. How can the colour and smell be removed efficiently from animal blood 
products (e.g. red blood cell concentrate, bloodmeal) without damaging 
the protein excessively? 
2. How are protein properties modified after treatment and how does this 
affect material processability and characteristics? 
3. Can the decoloured bloodmeal be processed into a bioplastic? 
4. What are the mechanical properties of the new bioplastic? 
Based on the questions identified in the problem statement, the objectives of this 
thesis were: 
1. Investigate methods available for removing the colour and smell from 
bloodmeal while still maintaining its ability to be processed into a 
bioplastic. 
2. Identify changes in molecular structure and molecular interactions caused 
by the smell and colour removal. 
3. Process the decoloured bloodmeal into a bioplastic using extrusion and 
injection moulding. 
4. Characterise the properties of the new decoloured bloodmeal based 
bioplastic. 
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2.1 Introduction 
New Zealand has a large meat processing industry processing approximately 7 
hundred thousand pigs, 4 million cattle and 27 million sheep and lamb each year 
[11]. By-products (also known as co-products) of the meat processing industry 
include fractions such as offal, paunch contents, bone, skin, fat, and blood. 
Increasing environmental awareness and a desire to improve animal processing 
plant economics has led to developing strategies for exploiting by-products. This 
reduces the costs of treating plant effluents while also reducing the impact on the 
environment caused by disposal and increasing income generated by the 
processing plant [20]. This chapter covers the use of animal by-products, more 
specifically how blood is collected and processed as well as its properties and 
applications. 
2.2 Animal Processing, By-Products and Uses 
By-products represent 52%-68% (depending on type of animal) of an animal’s 
live weight [12]. They are classified as either edible or inedible for humans. 
Edible by-products include organs such as livers, kidneys tongues and intestines. 
These are called variety meats and are good sources of nutrients [12, 21]. Bones 
and skin can be heated to extract gelatine which is used in a variety of 
applications including ice cream and lollies. Fats can be used to produce edible 
tallow. Hygienically collected blood can be used in specialty foods such as blood 
pudding as well as in laboratory applications. By-products are usually highly 
perishable and must be processed efficiently otherwise they degrade and become 
classified as inedible by-products [21]. 
Over 50% of by-products are not suitable for consumption [12]. Inedible by-
products can include hides, bones, meat scraps, fats and blood. Hides are 
converted into leather, bones into bone meal, meat scraps into meat meal and fats 
into tallow for lubricants [21]. 
Approximately 80,000 tonnes of blood is collected from animal processing plants 
each year in New Zealand [7]. Blood contributes greatly to the total pollution 
from a slaughter house [22, 23]. Because of the cost and difficulty in collecting 
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blood hygienically it is often processed into products not suitable for human 
consumption such as bloodmeal. This provides a small amount of income (in New 
Zealand approximately $1.3 per kg) but is usually done to reduce treatment cost of 
plant effluents [14, 23]. 
2.2.1 Blood Collection 
When an animal is killed, approximately 50% of its blood is released, typically to 
the slaughter room floor. It is collected through drains but can be contaminated 
with vomit, urine and excrement.  The remainder of the blood is retained in the 
muscles, organs and capillary system [13, 21, 24]. As blood released during the 
slaughtering process is the largest contributor to liquid waste in the animal 
processing industry it is usually collected, steam coagulated and dried into 
bloodmeal [25]. Bloodmeal is used as fertiliser or animal feed, contains about 
90% protein, but has a dark red colour and unpleasant smell.   
If animal blood is used for human consumption, it must be hygienically collected. 
This can be done by inserting a hollow “thief” knife into the animal’s jugular 
while the animal is still alive and allowing the blood to drain into a collection 
vessel [13, 26]. Some processing factories in New Zealand use the Halal kill 
method, which involves cutting the animals throat after the animal has been 
stunned, and letting the blood drain onto the floor.  In this case, the blood can be 
collected by someone standing next to the animal with a bucket (Figure 1). Yields 
for collected blood from slaughtered cows and bulls range between 10-18 litres 
per animal [12, 13, 22, 26, 27].  
The volume of blood collected depends on animal weight, bleeding time and 
collection method [27, 28]. Larger animals will yield more blood as will longer 
bleeding times, however longer bleeding times will also increase processing time. 
Special precautions must be taken to collect blood hygienically for edible 
products [29, 30]. Released blood will clot within 10 minutes by the conversion of 
soluble fibrinogen into insoluble fibrin [13]. After or during blood collection 
anticoagulants can be mixed with blood to prevent formation of clots [13, 23, 31-
34]. Sodium citrate is the most commonly used anticoagulant. Mechanical 
stirring, ammonium oxalate, sodium chloride, sodium fluoride and proteolytic 
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enzymes such as papain have also been used to prevent coagulation [22, 35]. The 
type of anticoagulant used must be suitable for the final application the blood will 
be used for.  
If collected blood is destined to be used for human consumption it is stored in 
stainless steel tanks to prevent contamination [26]. When the animal it was 
collected from has passed veterinary inspection the blood can be processed [13, 
26].  
 
Figure 1: Blood collection during slaughter. 
2.2.2 Blood Components 
Blood accounts for 2-8% of an animal’s live weight [13, 22, 23, 27, 36]. Its main 
roles are to carry nutrients, transport oxygen, remove waste products, equalise 
body temperature and help defend against pathogens. Blood contains high levels 
of protein and its composition varies slightly between species and individual 
animals. Bovine blood contains approximately 80% water and 17% protein. The 
remaining 3% is fat, carbohydrates and minerals [31]. 
Blood can be separated into two components by centrifugation (Figure 2). 
Centrifuging 100 kg of blood will yield approximately 66 kg plasma as the 
supernatant and 33 kg red blood cells in the heavy fraction, which are also known 
as erythrocytes, corpuscles and red blood cell concentrate (RBCC) (Table 1). 
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Figure 2: Blood being centrifuged into plasma (orange) and RBCC (red). 
Plasma is 90-91% water and 8-9% protein [12]. The main proteins in plasma are 
albumins, immunoglobins, α and β globulins and fibrinogen [13, 31]. The 
majority of hygienically collected blood is used to produce plasma because of its 
desirable colour [12, 26, 34, 37]. Light yellow plasma has good functional 
properties such as emulsification, gel formation and solubility [26, 32]. Plasma 
can be sterilised by microfiltration and is used in various applications including 
food products and lab and medical applications [12, 38, 39]. 
The RBCC is about 33% solids (mainly haemoglobin) and contains 75% of the 
total protein in blood [26, 40]. However, RBCC has limited use in food because of 
its black colour, unpleasant metallic taste and smell when dried [30, 41-43]. It is 
currently only used in low-value applications such as fertiliser or as a minor 
additive in animal feed, but it has potential for bioplastics.  To add value and 
increase its potential use as a bioplastic, the colour and smell must be removed. 
The iron containing haem group can be separated from haemoglobin. This form of 
iron has high bioavailability and can be used as an iron supplement. It can also be 
used in foods where colour and taste are not limiting factors such as blood 
sausages [12, 13, 31]. The uses of blood products are summarised in Figure 3. 
Table 1: Percentage composition of whole blood, plasma and RBCC [13, 31]. 
 Whole Blood Plasma RBCC 
Water 80 90-91 60-65 
Protein 17 8-9 30-35 
Other (salts, fats, cell debris) 3 1 5 
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Blood Released During Slaughter 
 Approximately 18% protein, 80% water 
 
Hygienic Collection Unhygienic Collection 
No anticoagulant Anticoagulant 
Serum  Clot 
Plasma 
8-9% protein 
90-91% water 
 
Red Blood Cells 
30-35% protein 
65-75% water 
Pit Blood 
10-15% solids 
85-90% water 
 
Food Additive 
-specialty foods 
-e.g. black pudding 
Decolourisation 
Disposal 
Haem 
-iron supplement 
 
Globin 
-food additive 
-pet food 
 
 
Blood Meal 
75-85% protein 
5% moisture 
Lab and Medical 
-culture media 
 
Food Additive 
-gel former 
-emulsifier 
Foaming agent 
Industrial 
-dyes 
-concrete 
-film former 
 
 
Figure 3: Uses of animal blood collected from the meat processing industry. 
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2.2.3 Haemoglobin 
Haemoglobin is a globular protein that binds and transports oxygen in blood [44, 
45]. Its molecular weight is approximately 65 kDa. It has two α and two β 
polypeptide chains held together by non-covalent interactions [46]. Each α chain 
contains 141 amino acid residues and each β chain 146 amino acid residues. Each 
polypeptide chain has a bound haem group which contains iron. The iron is held 
in the centre of the haem group by four nitrogen atoms (Figure 4). The haem 
group is bound to the polypeptide chain between the iron molecule and the 
proximal histidine on the polypeptide chain. The iron is also responsible for 
binding oxygen. All vertebrate haemoglobins are similar in structure and 
composition [44]. 
 
Figure 4: Structure of haemoglobin. Reprinted by permission from Macmillan Publishers Ltd: Nature 
Reviews Drug Discovery [47], copyright (2004). 
2.2.3.1 What Causes the Colour of Haemoglobin? 
The haem group is a chromophore (part of molecule responsible for colour) and is 
responsible for haemoglobins dark red colour. Chromophores consist of 
conjugated bonds or ring systems (e.g. aromatic) which absorb light at certain 
wavelengths due to energy differences between orbitals. When light of a certain 
wavelength is absorbed by an object the objects colour will be the complementary 
colour of the absorbed wavelength (Table 2) [15]. Haem absorbs light between 
500-550 nm (blue/green) which means its observed colour will be red [16]. To 
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change the colour of a molecule, the chromophore must be removed or modified 
by altering the bonds/structure of the chromophore. 
Table 2: Colour of absorbed wavelength and observed/complementary colour [15, 48]. 
Wavelength (nm) Colour Observed/Complementary Colour 
400-435 Violet Green-yellow 
435-480 Blue Yellow 
480-490 Green-Blue Orange 
490-500 Blue-Green Red 
500-560 Green Purple 
560-580 Yellow-Green Violet 
580-595 Yellow Blue 
595-605 Orange Green-Blue 
605-750 Red Blue-Green 
 
It has been shown using X-ray crystallography, that porphyrins such as haem 
(Figure 5) are planar and that the red highlighted pathway in Figure 6 is the 
preferred system for π-electron delocalisation because it provides the level of 
highest bond equalisation (the outer bonds 1-2, 3-4, 5-6 and 7-8 can be treated as 
normal double bonds). It has been shown that the reduction of one, two, three or 
four of the outer double bonds has little effect on the porphyrins absorption 
spectrum despite a reduction in conjugation. This showed that the highlighted 
centre is responsible for the colour of the porphyrin [16]. Therefore, to change the 
colour of haemoglobin the bonds or structure of the red highlighted centre of the 
haem porphyrin (Figure 6) must be altered. 
 
Figure 5: Structure of Haem porphyrin group [49]. 
 
Figure 6: Preferred π-electron delocalisation 
pathway (highlighted in red) [16, 49]. 
 13 
 
An example where bond configuration affects colour can be seen during enzyme 
haem degradation into bile products. Breaking the tetrapyrrole ring into a linear 
molecule produces green biliverdin and removing a double bond from biliverdin 
produces yellow bilirubin (Figure 7). 
 
Figure 7: Enzymatic haem degradation into bilirubin [50]. 
2.3 Bloodmeal and Its Production 
Blood not hygienically collected during slaughter is washed into an effluent 
holding pit below the slaughter floor and is known as “pit blood” [36]. Pit blood 
contains urine, hair and vomit from slaughtered animals. The blood will also be 
diluted with wash water and can reach dry solid concentrations as low as 10% [23, 
36]. Pit blood can be combined with untreated red blood cells and dried to 
produce blood meal [26, 36].  
Blood meal is a dark brown powder with low moisture (5-10%) and high protein 
content (75-85%) [13, 23, 36]. The remaining percentage contains extraneous 
compounds such as ash and fibres [23]. Despite the high protein content it is only 
used in low value products such as fertiliser and as an additive in animal feed. 
Because of its unpalatable taste it is usually limited to below 5% in animal feeds 
[51, 52]. 
Bloodmeal has a high percentage of hydrophobic amino acids such as valine, 
leucine, isoleucine, phenylalanine and methionine. This combined with heat 
induced disulphide and non-disulphide cross-links (e.g. lysinoalanine) means 
bloodmeal has poor solubility [7, 53, 54]. 
  
Haem (red) Bilirubin (yellow)Biliverdin (green)
double bond removal
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In many countries blood meal must be produced at high temperatures to ensure 
sterilisation. Covalent cross-link and hydrophobic interaction formation during 
heating reduces bloodmeal solubility. Blood meal production can be divided into 
two categories: 
1. Drying whole blood: Indirect heat from a steam jacketed shell is applied to 
whole blood in a batch cooker to boil off water. Some processes use 
stirrers to increase heat transfer. Blood is dried until it reaches 2-10% 
moisture. Temperatures can reach up to 138°C and drying times up to 10 
hours. This method is very energy inefficient and produces proteins with 
very low solubility due to high temperatures and long residence times. 
This method is usually used at plants with old equipment [23, 27, 55]. 
 
2. Solids coagulation followed by drying: Blood is first coagulated by steam 
injection. The optimum coagulation temperature is 90°C. Up to 92% of the 
solids can be coagulated using heat [28]. It is difficult to achieve uniform 
coagulation in large tanks because of poor steam distribution. The 
coagulated blood solids are separated from liquids by centrifugation. Up to 
half of the water can be removed before drying using coagulation and 
centrifugation.  
The solids can be dried using a variety of drying methods e.g. rotary drum, ring 
and batch drying. This method requires less energy but still produces a denatured 
protein. Protein properties will vary depending on the type of dryer used. This 
method has become most commonly used. Continuous processes and different 
drying methods (e.g. spray dryer, spouted bed dryer) have been used to improve 
energy efficiency, reduce labour requirements and improve protein solubility [23, 
27, 55]. 
Protein properties and amino acid content of blood meal will vary with processing 
conditions and supplier. High processing temperatures reduce the solubility of 
blood meal. The amino acid composition of different commercially available 
bloodmeals is shown in Table 3. 
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Table 3: Amino acid composition of commercially available bloodmeals. 
 Bloodmeal 1 
[55] 
Bloodmeal 2 
[56] 
Spray Dried RBCC 
[31] 
Lysine 10.23 7.85 10.37 
Histidine 6.13 6.53 6.38 
Arginine 4.23 4.18 2.07 
Aspartic acid 10.42 7.17 11.03 
Threonine 4.47 3.49 5.11 
Serine 4.03 4.08 5.47 
Glutamic acid 9.08 8.79 8.09 
Proline 4.12 4.62 3.24 
Glycine 4.06 4.46 4.51 
Alanine 7.94 7.69 9.47 
Cysteine 1.08 1.24 - 
Valine 9.32 7.08 8.5 
Methionine 1.01 1.10 0.36 
Isoleucine 0.91 0.91 - 
Leucine 12.97 11.42 13.92 
Tyrosine 2.80 2.34 2.39 
Phenylalanine 7.34 6.20 8.19 
Tryptophan - 1.22 - 
 
Poor protein recovery during coagulation can be caused by wash water diluting 
the blood during collection [23, 27]. Excess water will also increase energy 
requirements and processing times [28]. Coagulation can be improved by aging 
the collected blood before processing. This is usually done by leaving the blood in 
storage tanks overnight or for several days [23, 27, 28]. 
Aged blood can be coagulated at lower temperatures than fresh blood. However 
aging blood also causes protein decomposition and odours to develop [27, 28]. 1% 
calcium chloride can be added to fresh blood with continuous stirring for two 
hours to improve coagulation without overnight aging [28]. If aging is preferred, 
chemical or biological methods can be used to preserve blood during aging and 
help prevent odour generation. 
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2.3.1 Blood Preservation Techniques 
Blood provides an excellent environment for the growth of microorganisms and is 
highly susceptible to microbial spoilage [22, 57]. Unhygienic collected blood will 
contain large numbers of bacteria from wash water, hides and animal waste 
released from the intestines and stomach (e.g. vomit) [58]. Staphylococcus aureus, 
Escherichia coli and Pseudomonas fluorescens are often found in contaminated 
blood [59]. Blood should be processed as soon as possible to prevent degradation 
and odour generation [27, 51]. However blood is usually aged at room 
temperature to improve solids yield during coagulation. Extended storage at high 
temperatures allows the growth of contaminating blood degrading 
microorganisms. Blood can be preserved using refrigeration, chemical additives 
or bio-preservation. 
2.3.1.1 Bio-preservation 
Bio-preservation utilises lactic acid bacteria and their metabolic products to 
control the growth and replication of unwanted microorganisms [59-61]. LAB are 
also naturally present in blood and on vegetables and are considered food grade 
organisms [60]. They preserve blood by competing for nutrients and producing 
inhibitory metabolites such as lactic acid and bacteriocins [60, 61]. Inulin can be 
added with lactic acid bacteria to increase contaminant inhibition [62]. 
Enterococcus raffinosus is commonly used to preserve hygienically collected 
blood [59, 62, 63]. Bio-preservation has only been used for food grade products. It 
may be too expensive for inedible applications. It has yet to be tested with highly 
contaminated blood sources such as pit blood. 
2.3.1.2 Chemical Preservation 
Chemical preservation can only be used for blood if it is not intended for human 
consumption [13]. It is a cheap option and several different chemicals have been 
recommended at different strengths (Table 4). 
  
 17 
 
Table 4: Chemical additives to preserve blood. 
Chemical Additive Concentration 
Hydrochloric acid [13, 23, 64] 0.25 mol/L 
Phosphoric acid [13, 23] 0.25 mol/L 
Formic acid [13, 23] 0.25 mol/L 
Sulphuric acid [13, 23, 65] 0.25-0.30 mol/L 
Ammonia [13, 22, 23] 0.10-0.50% 
Sodium chloride [22] 3.0% 
Sodium metabisulphite [27, 28] 0.03-0.3% 
Calcium Oxide [13, 66, 67] 0.125-1.5% 
 
2.3.2 Bloodmeal and Smell 
Bloodmeal is usually left to age in tanks before drying. This combined with the 
high probability of bacterial contamination and the high protein content means 
that the blood is susceptible to the formation of odour causing compounds through 
bacterial degradation and putrefaction (decomposition of proteins by anaerobic 
bacteria) leading to spoilage [68, 69]. Other odour causing compounds can also be 
formed during the drying process due to the degradation of thermally unstable 
amino acids and the oxidation of lipids. 
The main compounds responsible for agricultural waste odours are ammonia, 
amines, sulphur containing compounds, volatile fatty acids, mercaptans, indoles, 
skatole, phenols, alcohols and carbonyls [70, 71]. A previous study has identified 
the odorous compounds in bloodmeal using gas chromatography [18]. The 
majority of the odour causing compounds have ring or conjugated structures 
which make them susceptible to oxidation (Table 5). 
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Table 5: Odour causing compounds identified in bloodmeal using gas chromatography [18, 72-75]. 
Compound Odour Structure/Formula Also Found In 
Common Compounds 
dimethyl disulfide Decaying 
vegetables  
[76]
 
Meat rendering 
Meat meal 
Swine farms 
hexanal Grassy, sour, 
pungent 
 
[77]
 
Meat rendering 
Swine farms 
2-pentyl furan Earthy, Bitter 
 
[78]
 
Meat meal 
Swine farms 
Compounds formed from thermal degradation 
2-heptanone Dairy, cheese, 
mushroom  
[77]
 
Meat rendering 
Swine farms 
6-methyl-2-heptanone Leaves 
 
[77]
 
- 
2-nonanone Fruity 
 
[77]
 
- 
nonanal Waxy, fatty 
 
[77]
 
- 
2-decanone Floral 
 
[77]
 
- 
Compound formed from bacterial or thermal degradation 
3-methyl butanoic acid Body odour, sour 
 
[77]
 
Putrefaction 
Swine farms 
Compounds formed from lipid oxidation 
heptanal Fatty 
 
[77]
 
Meat rendering 
Swine farms 
benzaldehyde Almond 
[77]
 
Swine farms 
Compounds from putrefaction 
phenol Phenolic 
[77] 
Swine farms 
4-methyl phenol Phenolic 
 
[79]
 
Swine farms 
indole Faecal 
 [77] 
Putrefaction 
Swine farms 
methyl indole Faecal 
 [77] 
Putrefaction 
Swine farms 
Unclassified compound 
1-octen-3-ol Earthy, fungal 
 
[79]
 
Mushrooms, 
pesticides 
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The study concluded that the odour compounds are caused by the storage of blood 
before drying. The putrefaction products 3-methyl butanoic acid, phenol, 4-methyl 
phenol, indole and methyl indole were found in bloodmeal. The study also 
suggests that other putrefaction products such as putrescine, cadaverine and 
methyl mercaptan could also be present, although they could not be detected due 
to equipment limitations. Lipid peroxidation products such as aldehydes, ketones 
and furans were also identified. However it was concluded that these did not 
impact the overall odour profile of bloodmeal significantly [18]. 
2.4 Proteins and Amino Acids 
Proteins participate in almost every process (catalytic, contractile, structural, 
transport and defence) that takes place in a cell and are the most abundant 
biopolymer [80, 81]. Biopolymers are polymers that occur in biological systems. 
They are different from non-biological polymers (e.g. polyethylene) because they 
usually consist of a large variety of repeat units which leads to complex 
interactions and properties allowing them to fill different biological roles [81]. 
Biopolymers can be divided into nucleic acids, lipids, polysaccharides and 
proteins. Proteins consist of amino acid residues covalently linked in linear 
sequence. Proteins can be made from hundreds of amino acids (oligopeptide) or 
thousands/millions of amino acids (polypeptide) [82]. 
2.4.1 Amino Acids 
Amino acids contain three parts (Figure 8): 
1. Basic amino group (NH2) 
2. Acidic carboxyl group (COOH) 
3. Carbon atom centre with hydrogen atom and R side group. The central 
carbon atom is referred to as alpha carbon. The R group can have 20 
different chemical compositions (Table 6). 
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Figure 8: General amino acid structure. 
R groups vary in structure, size and charge and define the type of amino acid. 
Different R groups interact differently with the environment such as aqueous 
surroundings, other parts of the protein and other substances. Physical properties 
such as solubility of a given protein are determined by the sequence of R groups 
i.e. amino acid sequence. There are two possible stereoisomers of each amino acid 
(left-L and right-D), however only the left configurations are found in proteins 
[80, 83]. Amino acids can be grouped based on the structure and properties of 
their R groups (Table 6). 
Aliphatic amino acid side chains are hydrophobic and usually found clustered 
within the interior of the protein, therefore stabilising the structure. Longer side 
chains cause the amino acid to become more hydrophobic. The different sizes and 
shapes of the side chains allow them to pack together tightly [46, 82]. 
Phenylalanine, tyrosine and tryptophan are amino acids with aromatic side chains. 
These can all participate in hydrophobic interactions. These proteins absorb 
ultraviolet light (maximum at 280 nm) and can be used to characterise proteins. 
The aromatic ring of tyrosine contains a hydroxyl group making it slightly less 
hydrophobic. It is an important functional group in some enzymes and proteins 
because of its ability to form hydrogen bonds. Phenylalanine and tryptophan are 
highly hydrophobic and are usually contained within the core of proteins [46, 82]. 
Serine and threonine have hydroxyl groups on their side chains making them 
hydrophilic. Amino acids with either positively or negatively charged side groups 
are the most hydrophilic [46]. Lysine has a second amino group on its side group. 
Arginine has a positively charged guanidinium group and histidine has an 
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aromatic imidazole group. The side chain of histidine can be positively charged or 
uncharged at pH 7 and facilitates many enzyme catalysed reactions by acting as a 
proton donor/acceptor. Aspartate and glutamate contain side chains that are 
usually negatively charged at pH 7. The uncharged versions are called asparagine 
and glutamine which have an amine group in place of the carboxylate group [46, 
82]. 
Cysteine and methionine both contain hydrophobic side chains. Cysteine can be 
oxidised to form a covalently linked dimeric amino acid called cystine. Cystine is 
formed when two cysteine molecules are bound by a disulphide bond. The 
disulphide bonds are important in many proteins as they form covalent links 
between parts of a polypeptide or between two different polypeptide chains [46, 
82]. 
Unlike the other amino acids, proline has a cyclic structure. The side chain is 
attached to the amino acid at both the alpha carbon and amino group. The side 
chain provides similar properties to other aliphatic amino acids (hydrophobic, 
found in the interior of proteins) but has added rigidness due to the cyclic 
structure. Proline is usually found in locations where proteins bend [46, 82, 83]. 
Table 6: Structure and grouping of common amino acids [46, 82-84]. 
Aliphatic (non-aromatic/open chain) amino acids 
Glycine 
(Gly, G) 
Alanine 
(Ala, A) 
Valine 
(Val, V) 
Leucine 
(Leu, L) 
Isoleucine 
(Ile, I) 
     
 
Amino acids with aromatic rings 
Phenylalanine (Phe, F) Tyrosine (Tyr, Y) Tryptophan (Trp, W) 
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Amino acids with hydroxyl side chains 
Serine (Ser, S) Threonine (Thr, T) 
  
 
Positively charged amino acids 
Lysine (Lys, K) Arginine (Arg, R) Histidine (His, H) 
   
 
Amino acids with amido and carboxylate groups 
Aspartate 
(Asp, D) 
Glutamate 
(Glu, E) 
Asparagine 
(Asn, N) 
Glutamine 
(Gln, Q) 
    
 
Amino acids containing sulphur 
Cysteine (Cys, C) Methionine (Met, M) 
  
 
Amino acid with cyclic structure 
Proline (Pro, P) 
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Amino acids are joined together and peptide chains/proteins produced by 
condensation reactions [81, 82]. This involves removing hydrogen and oxygen 
atoms from both amino acids producing a bond between the two amino acids and 
water as a by-product (Figure 9). The double bond between oxygen and the 
carboxyl carbon is shared between the carboxyl carbon and adjacent nitrogen 
atom due to a resonance effect [81]. This link between amino acid residues is 
known as the amide link or peptide bond. Polypeptides with N number of amino 
acid residues will have N-1 amide links [81, 82]. 
 
Figure 9: Peptide bond formation between amino acids. 
pH is important for protein properties as it determines an amino acids state of 
ionisation. At low pH (high [H
+
]) the amino terminal will usually acquire an extra 
hydrogen atom and will terminate with NH3
+
 (Figure 10). At high pH (low [H+]) 
the carboxyl end will usually lose a hydrogen atom and will be COO
-
 (Figure 11). 
At physiological pH (pH ≈ 7) both ends are modified as described i.e. NH3
+
 and 
COO
-
 (Figure 12). This state is known as zwitterionic (two opposing charges 
within the same molecule) and does not promote polymerisation because the 
amino end has an extra hydrogen whereas condensation requires the loss of 
hydrogen. At the carboxyl end the O-H bond is broken instead of the C-O bond 
required for condensation. This mechanism prevents spontaneous polymerisation 
which could have negative effects on the proteins structure and activity. 
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Figure 10: Amino acid at acidic 
pH 
 
Figure 11: Amino acid at basic pH 
 
Figure 12: Amino acid at 
physiological pH (pH≈7) 
2.4.2 Protein Structure 
A protein’s final three dimensional structure will be that which minimises its total 
free energy [81]. Protein structure is influenced by hydrogen bonding, 
hydrophobic interactions, electrostatic interactions and van der Waals interactions. 
Protein structure can be described at four different levels which are primary, 
secondary, tertiary and quaternary structure. 
Hydrogen bonding can occur between charged and uncharged molecules. It 
involves sharing a hydrogen atom between two other atoms. The atom that the 
hydrogen is more closely associated is the hydrogen donor (usually oxygen or 
nitrogen covalently bonded to hydrogen) and the other atom is the hydrogen 
acceptor (usually oxygen or nitrogen). The acceptor has a partial negative charge 
which attracts the hydrogen atom [46]. Hydrogen bonding can occur between 
polypeptide backbone components and also between water and amino acid side 
chains on the proteins surface [44].  
Hydrophobic interactions form because nonpolar side chains tend to cluster in a 
nonpolar environment rather than interact with a polar solvent like water [44]. 
This happens because water bonds strongly to itself and forces the nonpolar 
molecules together [46]. The forming of hydrophobic cores or clusters on the 
interior of a protein is favourable because it reduces interactions between nonpolar 
residues and water. The interior core of proteins are usually hydrophobic and 
contains nonpolar side chains whereas the surface of the protein can contain both 
polar and nonpolar side chains (Figure 13) [44]. 
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Figure 13: Hydrophobic and hydrophilic amino acid locations on proteins. 
Electrostatic interactions occur between charged groups and can also be called an 
ionic bond, salt linkage, salt bridge or ion pair. Electrostatic interactions are 
weakest in water because of water’s high dielectric constant [46].  
Van der Waals forces are weaker than hydrogen bonding and electrostatic 
interactions. They are caused because at any given time the electronic charge 
around an atom is not distributed symmetrically. This causes the charge around 
neighbouring atoms to behave in a similar way. As the atoms get closer the 
attraction increases until they reach the van der Waals contact distance. At this 
distance outer electron clouds overlap and repulsive forces become more 
dominant causing a decrease in attractive forces [46]. 
The primary structure of a protein is the linear sequence of amino acid residues 
held together by covalent bonds. Because the backbones of all amino acid 
residues are the same the primary structure can be defined by the sequence of side 
groups i.e. R1, R2,...Rn [81]. The primary structure is formed by the condensation 
reaction described previously. 
The secondary structure of a protein is the arrangement of amino acid residues 
that are adjacent or in close proximity to each other [46, 82]. The secondary 
structure is stabilised by the formation of hydrogen bonds from carboxyl group 
oxygens and amine hydrogens between residues of the polypeptide chain [85]. 
The polypeptide chain aligns so that the maximum number of hydrogen bonds are 
formed [80]. The most common forms of secondary structure are alpha-helices 
and beta-sheets. Other secondary structures include 310 helices, random coils and 
beta-turns. The specific organisation caused by hydrogen bonds is often called the 
intermolecular crystallization [80]. 
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The alpha-helix is where the polypeptide is coiled into a helical structure where 
the side chains extend outwards and there is a turn every 3.6 residues [44, 46, 81]. 
Alpha helices are stabilised by the formation of hydrogen bonds between the NH 
and CO groups of the nth and the n-4 residue on the polypeptide chain [46, 81]. 
Each residue occupies 0.15 nm resulting in a turn every 0.54 nm. The diameter is 
approximately 0.6 nm if side groups are ignored [44, 81, 85]. Helix turns can be 
both clockwise (right handed) or anti-clockwise (left handed), but only clockwise 
helices are found in proteins [46]. Alpha helices are most commonly found in 
globular proteins such as haemoglobin [46, 85]. 
Beta sheets (also known as pleated sheets) are produced when hydrogen bonds are 
formed between carboxyl and amine groups of adjacent polypeptide chains [46, 
85]. Parallel sheets form when the adjacent polypeptide chains run in the same 
direction (N to C or C to N) whereas antiparallel sheets are formed when the 
adjacent polypeptide chains run in opposite directions [44, 85]. Beta sheets can be 
found in both fibrous and globular proteins [85]. 
Beta-turns (also known as a reverse turn, hairpin, tight turn or beta-bend) are 
formed by the formation of a hydrogen bond between the CO and NH group three 
residues apart. The beta-turn allows a polypeptide chain to reverse its direction 
[46]. Proline has a cyclic structure and usually promotes the formation of a beta-
turn. Beta-turns often cause the formation of anti-parallel beta-sheets [44]. 
The tertiary structure of a protein is the arrangement of amino acid residues that 
are far apart or the folding of a polypeptide chain [44, 46, 82]. Common tertiary 
structures are fibrous and globular proteins.  
Fibrous proteins are formed when polypeptide chains are organized into fibres or 
sheets around a single axis [44]. These proteins are usually strong and resistant to 
solubilisation in water. Examples of fibrous proteins include alpha-Keratin (hair, 
nails, horns), beta-Keratin (feathers), Fibroin (silk) and collagen (tendons, skin) 
[44, 82]. 
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Globular proteins are formed when different segments of a polypeptide chain 
folds back on itself, the structure is stabilised mostly by hydrogen bonds with 
some ionic interactions [82]. Globular are more common than fibrous proteins and 
the folding provides the diversity which allows them to carry out a wide variety of 
functions such as acting as catalysts, transportation and regulation [44, 46]. 
Globular proteins are usually folded so that hydrophobic side chains are contained 
within a hydrophobic core and the hydrophilic or polar side groups are on the 
surface [82]. 
The quaternary structure of a protein is the assembly of two or more polypeptide 
subunits. The subunits can be identical or varied. The quaternary structure is 
stabilised by weak forces such as hydrogen bonds, ionic interactions, hydrophobic 
interactions and van der Waals forces. In some cases disulphide bonds can also be 
involved [44]. Protein primary, secondary, tertiary and quaternary structure is 
summarised in Figure 14. 
 
Figure 14: Primary, secondary, tertiary and quaternary structure of proteins [86]. 
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2.5 Conclusion 
New Zealand has a large meat processing industry which produces a lot of by-
products. To increase income generated per animal, reduce waste and waste 
disposal costs by-products are used in a variety of applications. Blood is one of 
the major by-products but has limited edible applications because it is difficult to 
collect hygienically and also because of its colour, taste and smell. As a result it is 
usually dried into bloodmeal. 
Blood colour is caused by the haem group contained in haemoglobin. The colour 
is caused when the bounds absorb light in the blue/green wavelength resulting in 
the observation of their complementary colour (red). To change the colour of 
haemoglobin the bonds or structure of the red highlighted centre of the haem 
porphyrin (Figure 6) must be altered. 
Bloodmeal has an unpleasant odour which is caused by putrefaction of proteins 
during aging. The main odour causing compounds in bloodmeal are 3-methyl 
butanoic acid, phenol, 4-methyl phenol, indole and methyl indole which are 
formed by putrefaction during storage of blood before drying. Other putrefaction 
products putrescine, cadaverine and methyl mercaptan could also be present. 
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Chapter 3 Methods for Decolouring Blood 
Products 
Chapter 3  
Methods for Decolouring Blood Products 
 
Red blood cell concentrate treated with different sanitising and bleaching 
chemicals. 
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3.1 Introduction 
Current blood based bioplastics are black and have an offensive odour. To 
increase their acceptance by consumers the colour and smell must be removed or 
modified by removing or degrading the haem and odour causing compounds [26]. 
The objective of this chapter was to find methods available for removing colour 
and smell from blood products so they could be used as a feedstock to produce 
bioplastics. This chapter investigated existing methods for decolouring red blood 
cell concentrate (RBCC). It also investigated potential alternative bleaching and 
sanitising methods for removing the colour and smell from RBCC and bloodmeal 
so that they could be used to produce a decoloured bioplastic. 
3.2 RBCC Decolouring Methods 
The majority of methods have been developed to remove the colour from blood or 
RBCC for food applications (Table 7). Extraction methods using organic solvents 
such as methanol and acidified acetone have been used to produce a decolourised 
precipitated protein with high molecular weight and good foaming and 
emulsification properties [87, 88]. Carboxymethyl cellulose and activated carbon 
has been used to extract haem at low pH with protein yields between 60-100% 
[31, 89, 90]. However the removal of the haem group reduced the stability of the 
protein and makes it more susceptible to denaturants [13]. 
The enzymes pepsin, papain and alcalase have also been used to hydrolyse RBCC 
and produced decolourised peptides. These peptides were not completely 
colourless and required further filtration, bleaching or treatment with extraction 
methods [39, 40, 91-94]. Current decolourisation methods have had limited large 
scale success because they are expensive. 
A cheaper alternative to remove colour was to degrade the haem group using an 
oxidant. Debuyser (1999) and Izumi et al. (1991) used hydrogen peroxide at pH 9-
12.5, whereas Wismer-Pederson and Frohlich (1992) added hydrogen peroxide to 
RBCC at pH 2-3 [38, 42, 43]. Treatment temperatures ranged from 20°C to 
140°C. The haem group was very sensitive to degradation by even small 
concentrations of hydrogen peroxide.  Haem degradation using oxidation involved 
cleaving the porphyrin ring to produce yellow degradation products [95].  
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Table 7: Blood and RBCC decolourisation methods. 
Date Author Material Treatment 
1975 Tybor, Dill & 
Landmann [88] 
RBCC Acidified acetone extraction 
1980 Ranken [32] RBCC Chloroform and acidified acetone 
1981 Hald-Christensen, 
Adler-Nissen, Olsen 
RBCC Alcalase and activated carbon 
1981 Sato, Hayakawa & 
Hayakawa [89] 
RBCC SP-sephadex, Amberlite CG-120, 
Dowex 50W-x4, Amberlite CG-50, 
Carboxymethyl Cellulose 
exchangers 
1982 Luijerink [96] RBCC Solid state treatment with 
Methanol/Ethanol solution 
1982 Swan [40] RBCC Alcalase and activated carbon 
1983 Sato & Hayakawa [97] RBCC Carboxymethyl Cellulose column 
1984 Luijerink [87] RBCC Acid splitting + acidified organic 
solvent extraction (Methanol, 
Ethanol, Acetone) 
1985 Tayot & Veron [90] RBCC Acidified methanol/ethanol and 
activated carbon 
1986 Piot, Guillochon & 
Thomas [39] 
RBCC Pepsin hydrolysis and alumina 
column 
1987 Wismer-Pedersen [98] RBCC Hydrogen peroxide oxidation 
1990 Lee, Wang, & Nakai 
[99] 
RBCC Sodium alginate 
1991 Izumi, Nonaka & 
Hayashi [43] 
RBCC Hydrogen peroxide oxidation 
1992 Wismer-Pedersen [38] RBCC Hydrogen peroxide oxidation 
1995 Aubes-Dufau, Seris, & 
Combes [91] 
RBCC Pepsin + various separation 
processes (UF, chromatography, 
organic solvents) 
1995 Synowiecki, Jagielka & 
Shahidi [94] 
RBCC Alcalase hydrolysis and charcoal 
extraction 
1996 Holm-Jensen [100] Whole 
Blood/RBCC 
High temperature/pressure 
hydrolysis 
1996 Yang and Lin [101] RBCC Comparison between sodium 
carboxymethyl cellulose, 
propylene glycol alginate and 
sodium alginate viscosity 
enhancers 
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Date Author Material Treatment 
1998 Yang & Lin [34] RBCC Comparison between sodium 
carboxymethyl cellulose, acidified 
acetone, hydrogen peroxide 
oxidation and alcalase hydrolysis 
1999 De Buyser [42] Whole 
Blood/RBCC 
Hydrogen peroxide oxidation 
1999 Gomez-Juarez, 
Castellanos, Ponce-
Noyola, Calderon & 
Figueroa [92] 
RBCC Papain hydrolysis, ultrafiltration 
and sodium hypochlorite 
bleaching 
1999 Duarte, Simoes, & 
Sgarbieri [31] 
RBCC Carboxymethyl cellulose 
extraction 
2003 Silva & Silvestre [35] RBCC Comparison between acidified 
acetone and CMC extraction 
2007 Guo, Zhao, Wang & 
Cui [102] 
RBCC Protease hydrolysis 
 
3.2.1 Globin Precipitation using Organic Solvents 
Low pH (pH 2-5) causes the haem group to dissociate from globin. Dissociated 
haem could be separated from the globin by using organic solvents to precipitate 
the globin. Cold acidified acetone is the most efficient and most often used, but 
methylethyketone (MEK), methanol and ethanol have also been used [26, 87]. 
Tybor et al (1973) decoloured haemoglobin by adjusting to pH 4 using ascorbic 
acid prior to treatment with acidified acetone. This method required large volumes 
of acetone (4 L acetone for 1 L protein solution) [88]. This method has not been 
used on a large scale because acetone is toxic and it is difficult to remove residues 
from the final product [26]. In addition, acetone is a highly volatile and flammable 
therefore processing facilities need to be designed to contain its vapours. 
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3.2.2 Haem Extraction using Solid Media 
Adsorption media such as activated carbon or carboxymethyl cellulose (CMC) 
have been used as an alternative to organic solvents to remove the haem from 
acidified haemoglobin solutions [26]. Sato et al (1981) used CMC 
chromatography to obtain a high quality product. However this method required 
low protein loading rates (1 g CMC to produce 70 mg globin) [89]. 
Tayot et al (1985) absorbed haem using activated carbon in the presence of 
alcohol, at pH 3 and below 20°C. Under these conditions activated carbon did not 
absorb globin and close to 100% protein was recovered. However a long 
residence time (up to 15 hours) was required for this method [90]. 
Lee et al (1990) developed an alternative to CMC adsorption using sodium 
alginate to bind haem under various conditions. They found the best conditions 
were pH 2.25, 0.348% sodium chloride and 0.107% sodium alginate. These 
conditions gave 64.9% protein yield [99]. 
3.2.3 Enzyme Hydrolysis 
Protein hydrolysis is the process of breaking a protein down into its constituent 
amino acid chains. Common methods include enzyme, acidic and alkaline 
hydrolysis. Proteolytic enzymes have been used to degrade haemoglobin and 
release the haem. The released haem aggregates into micro droplets because of its 
hydrophobic nature [26]. The amino acids and peptides from the hydrolysed 
protein can then be separated from the haem by ultrafiltration or centrifugation 
[26]. 
Pepsin, alcalase and proteinase have been used to hydrolyse haemoglobin [39, 40, 
94]. The degree of hydrolysis will effect yield and properties of the peptides [26, 
94]. Peptide yields reported in literature range from 65-85%. Strategies such as 
using exopeptidases for controlling the extent of reaction have been included to 
increase yield and reduce bitterness that can result from hydrolysis [103]. The 
hydrolysates are not completely colourless and further treatment to remove haem 
using activated carbon, ultrafiltration and bentonite clay is often required. 
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3.2.4 Oxidative Destruction of Haem 
Hydrogen peroxide (H2O2) has been used to destroy haem. Methods described in 
literature vary. De Buyser (1999) and Izumi et al. (1991) suggest adding hydrogen 
peroxide to haemoglobin under alkaline conditions (pH 9-12.5) [42, 43]. Wismer-
Pederson and Frohlich (1992) suggest treating the haemoglobin at pH 2-2.5 [38]. 
Red blood cells were usually modified by diluting to approximately 7% protein 
concentration. The amount of hydrogen peroxide used ranged from 0.3-10% (by 
protein solution weight). Residence times reached up to 25 hours and 
temperatures ranged from 20-90°C [38, 42, 43, 98]. Care must be taken when 
treating haemoglobin with hydrogen peroxide because excessive hydrogen 
peroxide can result in the oxidation of sulphur-containing amino acids in the 
protein and also cause a decrease in functional properties [38]. Other oxidising 
agents that can be used include sodium peroxide, calcium peroxide and nitrates 
[42]. 
Hydrogen peroxide is often produced as a by-product of oxygen dependent 
metabolism. Catalase, a naturally occurring enzyme, prevents hydrogen peroxide 
damage in cells.  It is present in blood and rapidly breaks down hydrogen 
peroxide into water and oxygen. If catalase is present during hydrogen peroxide 
mediated decolouring, much of the hydrogen peroxide will be consumed by the 
enzyme-catalysed decomposition.  Successful hydrogen peroxide treatment 
requires catalase to be deactivated, which can be achieved by heating to above 
70°C [26]. However, heat treatment will coagulate proteins making them 
insoluble [26, 43]. An alternative method is to adjust the pH to 2 [26]. 
Hydrogen peroxide treatment has the disadvantage that long times are required for 
decolourisation (up to 24 hours). Other potential problems with using hydrogen 
peroxide include modifying side groups, crosslinking, backbone fragmentation 
and forming protein peroxides [104, 105]. Hydrogen peroxide is also used as a 
cleaning agent and to bleach pulp and paper. In the wastewater treatment industry 
hydrogen peroxide treatment has been used to reduce smell, chemical oxygen 
demand and biological oxygen demand. It has also been used to treat rendering 
gas emissions [106]. Cysteine, methionine, histidine, glycine and lysine are all 
susceptible to oxidation by hydrogen peroxide [107]. 
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3.2.5 Other Methods 
Gomez-Juarez et al (1999) hydrolysed haemoglobin using papain at pH 2.5 for 2 
hours. The peptides were then ultrafiltered and decolourised using sodium 
hypochlorite at room temperature. Low levels of sodium hypochlorite are 
permitted as food bleach. The decolourised protein had good emulsifying and 
foaming properties [93]. 
Piot et al (1986) hydrolysed haemoglobin using pepsin at pH 2 for three hours. 
The peptides were then passed through alumina columns which absorbed haem 
containing peptides. When attempted on a large scale they had a protein yield of 
25%. A white powder was obtained and consisted of peptide chains ranging from 
5-13 amino acids long [39]. 
3.3 Alternative Chemicals for Colour and 
Smell Removal from Blood Products 
The previously described methods for colour removal were developed for food 
applications where fresh blood or RBCC were used and no degradation odour 
compounds were formed. Therefore they may not be able to remove the odour 
compounds present in bloodmeal. Possible strategies to remove the smell are 
extraction or oxidation of the smell causing compounds. Treating bloodmeal with 
steam and activated carbon to extract smell compounds has been used with limited 
success [18]. Therefore they were not considered during this investigation. 
Chemical oxidation has been used to remove smell causing compounds from 
sewage treatment plants, rendering plants and swine and poultry farms. The 
oxidising agents used are also commonly used to bleach or remove colour from 
textiles, fabrics and animal by-products by oxidising the bonds of the colour 
causing components. This means that the colour and smell from bloodmeal could 
potentially be removed using one processing step using chemical oxidation. 
Potential oxidising chemicals include sodium hypochlorite, sodium chlorite, 
sodium chlorate, chlorine dioxide, hydrogen peroxide and peracetic acid. 
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3.3.1 Sodium Hypochlorite, Sodium Chlorite, 
Sodium Chlorate and Chlorine Dioxide 
Sodium hypochlorite (NaClO) is a common household bleach and disinfectant, 
usually available in a 3-6% solution. It is used commercially for cleaning in the 
beer, wine and food industries, in water treatment facilities and as bleach for 
textiles and blood [93, 108, 109]. Sodium hypochlorite has been used to treat 
rendering gas emissions and was found to be effective against a wide range of 
odorous compounds [106]. Sodium hypochlorite solutions are able to modify 
proteins through amino acid side chain modification, backbone fragmentation, 
crosslink formation, unfolding and chloroamine formation [108, 110]. 
Methionine, cysteine, histidine, tryptophan, lysine, tyrosine and the alpha amino 
group are most susceptible to modification by sodium hypochlorite [109-112].  
Sodium hypochlorite is able to form trihalomethanes (atoms replaced by halogen 
atoms e.g. chlorine) and other chlorinated organic compounds which are 
pollutants and carcinogenic [113]. As a result alternatives chemicals to sodium 
hypochlorite have been used for textile bleaching and water treatment. 
Sodium chlorite (NaClO2) and sodium chlorate (NaClO3) are chemicals used for 
pulp and paper bleaching [114]. Sodium chlorite is also used for disinfection, 
sterilisation and to oxidise odour compounds [115]. Sodium chlorite and sodium 
chlorate can also be used to produce chlorine dioxide (ClO2) by acidification. 
Chlorine dioxide has been used to bleach pulp and paper as well as to disinfect 
water and foods. The main advantage is that it produces less chlorinated by-
products compared to sodium hypochlorite [116]. It can be used in solution or as a 
gas. Chlorine dioxide has been shown to oxidise SH groups into disulphide bonds 
[117, 118]. Oxidation of proteins with tryptophan, histidine and tyrosine with 
chlorine dioxide led to carbon bond breakages and low molecular mass 
compounds [116] 
  
 37 
 
3.3.2 Peracetic Acid 
Peracetic acid (PAA, CH3COOOH) also known as peroxyacetic acid, is a clear 
liquid with a strong vinegar smell and low pH (less than pH 2) [119]. It is 
produced commercially by reacting acetic acid with hydrogen peroxide in the 
presence of a catalyst and sold as an equilibrium mixture containing peracetic 
acid, acetic acid, hydrogen peroxide and water. Non-equilibrium mixtures can be 
produced using distillation to remove acetic acid, hydrogen peroxide and water 
although this is more expensive. 
Due to its effectiveness and growing concerns over the environmental impact of 
chlorine use, PAA has been suggested as an alternative for use in waste water 
treatment and pulp and textile bleaching [119]. When used to bleach linen PAA 
gave better brightness and less fibre damage [120]. PAA has also been used as a 
food and surface sanitizer as well as to remove odours from wastewater sludges 
[119]. PAA is a protein denaturant and is known to react quickly with proteins 
[109, 121]. It does not produce any harmful disinfection by-products and if 
discharged into the environment PAA decomposes and bioaccumulation is 
unlikely to occur [113, 122]. 
Previous studies involving PAA and proteins had variable results in terms of its 
reaction with amino acids. In one study PAA was used to oxidise wool and it was 
shown PAA exclusively oxidised disulphide bonds and tryptophan side chains 
while no significant oxidation of tyrosine occurred [123]. A separate study 
showed that PAA readily oxidised cysteine, methionine, histidine, glycine and 
lysine but not tryptophan [107]. While a third study involving PAA and dairy 
proteins suggested tryptophan and methionine were most vulnerable and lysine 
was not affected [109]. The variable results could be due to the different reaction 
conditions, proteins used and PAA mixture compositions. 
No articles were identified which focused on using PAA to decolourise blood or 
blood products for use in bioplastics. One of the disadvantages with PAA is its 
relatively high cost. However as demand and global production increases its cost 
may decrease [119].  
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A patent search revealed one relevant patent where a peracid was used to treat 
meat industry by-products [124]. McAninch and Holzhauer (2002) developed a 
method for bleaching tripe using a mixture of peracids, hydrogen peroxide and 
water [124]. It was suggested that the peracid mixture worked better than the 
existing method (35% hydrogen peroxide) because hydrogen peroxide did not 
work well as a cleaner and the existing processes had multiple stages and was not 
efficient. However this method was primarily focused on mixtures involving 
tartaric and malic acid with the final bleached product aimed at the food industry. 
The common uses for the oxidising chemicals discussed and their potential effects 
on bloodmeal protein are summarised in Table 8. 
Table 8: Possible side effects on protein when blood products are treated with various oxidising chemicals 
[107, 109, 110, 123]. 
Chemical Uses Potential Effects on Bloodmeal Protein 
Sodium 
hypochlorite 
Disinfectant, 
cleaning agent for 
food and wine 
industry, water 
treatment, bleach 
for pulp and paper 
Side chain modification, backbone fragmentation, 
deamination of lysine, cross linking of cysteine and 
methionine, tryptophan susceptible to damage, 
tyrosine also susceptible to forming chlorotyrosine,  
formation of unstable chloramines on alpha amino 
group and lysine side chain. 
Sodium 
Chlorite 
Disinfectant, bleach 
for pulp and paper, 
chlorine dioxide 
generation 
Side chain modification, backbone fragmentation, 
cross link formation and chlorination of amino acids. 
Sodium 
Chlorate 
bleach for pulp and 
paper, chlorine 
dioxide generation 
Side chain modification, backbone fragmentation, 
cross link formation and chlorination of amino acids. 
Chlorine 
dioxide 
Disinfectant, water 
treatment, bleach 
for pulp and paper 
Denaturation by modification of tryptophan and 
tyrosine residues, degradation of amino acids into 
small molecular weight products. 
Hydrogen 
Peroxide 
Disinfectant, bleach 
for hair, pulp and 
paper, effluent 
treatment 
Side chain modification, backbone fragmentation, 
cross link formation. 
Peracetic 
Acid 
Disinfectant, water 
and sludge 
treatment, tripe 
bleach 
Backbone fragmentation if hydroxyl radicals formed 
during breakdown of peracetic acid, crosslink and 
double bond breakage, denaturation. 
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3.4 Protein Oxidation 
Proteins and other biological molecules can be damaged or modified by oxidants. 
Protein oxidation can lead to side chain modification, back bone cleavage and 
cross link formation [125, 126]. The amount and type of damage varies depending 
on the type, strength and concentration of the oxidant as well as secondary 
reactions (e.g. repair mechanisms and antioxidants) [127]. In natural systems 
small amounts of some oxidants (e.g. superoxide, hydrogen peroxide, hydroxyl 
radical) are produced through metabolism. As a result there are antioxidant 
defences such as enzymes (e.g. superoxide dismutase, catalase) which can 
scavenge radicals and help reduce damage to biomolecules [110, 125, 127]. 
The strength of oxidants, stability of newly formed or intermediate oxidants, 
number of C-H bonds and accessibility are factors which influence where 
oxidation will occur. Highly reactive radicals such as the hydroxyl radical (•OH) 
are the least selective and cause the most damage. OH• oxidises most side chains 
and can also react with the polypeptide backbone causing both fragmentation and 
side chain modification [127, 128]. 
Backbone oxidation involving •OH and oxygen happens through hydrogen atom 
abstraction from the alpha carbon forming a carbon centred radical and can lead to 
fragmentation. The type of products formed by fragmentation depends on the 
pathway by which fragmentation occurs (Figure 15). 
 
Figure 15: Peptide bond cleavage via alternative pathways. (a) diamide pathway and (b) α-amidation 
pathway [126]. 
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Cysteine and methionine are the most susceptible amino acids to oxidation. 
Oxidation of cysteine results in the formation of disulphides and thiyl radicals. 
Methionine oxidation results in the formation of methionine sulfoxide. Because 
they are easily oxidised by a range of oxidants, repair systems exist for these two 
amino acids and enzymes are able to convert them back to their unmodified 
forms. These are the only systems known that are able to repair oxidative 
modification to amino acids [125, 126, 129, 130]. However these repair 
mechanisms are not expected to be active in RBCC or bloodmeal. 
Common products from side chain oxidation are peroxides, alcohols and 
carbonyls. Carbonyls have been used to monitor amino oxidation using western 
blotting and high performance chromatography [130]. Other products used to 
monitor oxidative modifications include disulphides, thiyl radicals and cross-
linked aggregates. Possible modifications are summarised in Table 9 and methods 
used for their detection in Table 10. 
Table 9: Most susceptible amino acids to oxidation and their possible oxidation products [125, 126, 129]. 
Amino Acid Possible modifications 
Cysteine Disulfides, glutathiolation, cysteic acid 
Methionine Methionine sulfoxide, methionine sulfone 
Histidine Oxo-histidine, asparagines, aspartic acid 
Tyrosine Dityrosine, chlorotyrosine, nitrotyrosine 
Lysine Chloramines, deamination 
Arginine Glutamic semialdehyde 
Valine, Leucine, Tyrosine, Tryptophan Hydroperoxide and hydroxide derivatives 
Several Cross links, aggregates, fragments 
All Carbonyls 
Protein peroxides can also be formed which are able to damage other proteins. 
The amount and structure depends on the location, type of radical, oxygen 
concentration and the presence of other reactants [127, 131]. Transfer of the 
radical from the side chain to the backbone is favourable due to the stability of the 
alpha carbon radical, reduced steric crowding and the stability of carbonyl 
products formed [127]. 
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Table 10: Methods used for detecting some oxidation products [125]. 
Oxidative 
modification 
Common methods used for detection 
Disulfides SDS gel electrophoresis 
Thiyl radicals Electron spin resonance spectroscopy 
Methionine sulfoxide Amino acid analysis 
Carbonyls Western blot, high performance liquid chromatography 
Crosslinks/aggregates SDS gel electrophoresis, high performance liquid 
chromatography 
Fragments SDS gel electrophoresis, high performance liquid 
chromatography 
Protein oxidation can have negative effects on the properties and processing 
characteristics of bioplastics (Figure 16). Side chains participate in hydrogen 
bonding and hydrophobic interactions which stabilise the bioplastic. If side chains 
are modified they may not be able to contribute to stabilising interactions which 
will lead to a decrease in mechanical properties such as strength, stiffness and 
elongation. Backbone fragmentation can also lead to reduced mechanical 
properties as well as poor consolidation because the smaller chains would have 
reduced entanglements and fewer stabilising interactions. If disulphide cross-
linking between proteins occurred then processing would also be inhibited 
because the cross-links would prevent the protein chains from flowing past each 
other. This can result in processing equipment blocking or high shear rates which 
can lead to protein degradation. 
 
Figure 16: How protein oxidation can affect properties and processing of bioplastics.  
Possible Outcomes  of Protein Oxidation
Side Chain Modification Cross-linkingBack Bone Fragmentation
Possible Effects on Bioplastic
Reduced Mechanical Properties
Modified side chains may 
contribute less to hydrophobic 
interactions and hydrogen bonding.
Reduced Mechanical Properties
The smaller peptides would not 
entangle as much leading to 
reduced strength and elongation.
Not Able to be Processed
Processing equipment may block 
because cross-links prevent flow and 
restrict movement of protein chains.
Not Able to be Processed
May not be able to form a 
consolidated product because the 
small peptides would not be able to 
entangle and interact sufficiently.
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3.5 Conclusion 
Several existing methods were identified to decolour blood or RBCC with the 
main purpose of using them as an additive in foods. However these methods were 
expensive or produced peptides which were not suitable for bioplastics. In 
addition these methods would not be effective at removing odour compounds 
from bloodmeal. 
From the existing methods available for decolouring RBCC for food applications, 
hydrogen peroxide decolourisation was identified as having the most potential for 
applying the decoloured RBCC powder to bioplastics. Therefore this method was 
selected to be investigated further in Chapter Four. 
Chemical oxidation could potentially be used to remove the colour and smell from 
bloodmeal, but treating proteins with oxidants can cause damage to the protein. 
The amount and type of damage depends on the oxidant, protein and defence 
mechanisms. Back bone fragmentation, side chain modification and cross link 
formation can occur when treating proteins with oxidants. This can prevent the 
powder being processed or reduce mechanical properties of the bioplastic. 
Potential chemicals identified were sodium hypochlorite, sodium chlorite, sodium 
chlorate, chlorine dioxide, hydrogen peroxide and PAA. The effect of these on 
RBCC and bloodmeal were investigated in Chapter Five. 
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Chapter 4 Red Blood Cell Concentrate 
Decolourisation using Hydrogen Peroxide 
Chapter 4  
Red Blood Cell Concentrate Decolourisation 
using Hydrogen Peroxide 
 
RBCC (left) and hydrogen peroxide treated RBCC (right). 
 
 
 
 
 
Work from this chapter was published in the journal paper: Decolouring Haemoglobin as a Feedstock for Second-
Generation Bioplastics [132].  
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4.1 Chapter Overview 
Previous studies have focused on colour removal from RBCC for food 
applications. Hydrogen peroxide treatment was one of these methods and was 
identified as having the most potential for removing the colour from RBCC for 
use in bioplastic applications. 
RBCC concentration, pH and reaction temperature were the most important 
factors influencing the decolourising process. They were investigated with the aim 
of developing a method which could be scaled to commercial level for producing 
a bioplastic feedstock. Initial trials showed pH was an important factor for 
decolourisation and solids lost due to foaming. At pH 14 there was a 96% 
reduction in solution colour but 8.4% solids were lost due to foaming. There was a 
76% reduction in solution colour at pH 2 and only 2.6% solids were lost due to 
foaming. The optimal conditions identified for the potential large scale production 
of decolourised protein from RBCC were: centrifuging 9% w/w RBCC aqueous 
solution at pH 2, then reacting with 7.5 g (30% w/w) hydrogen peroxide at 30°C. 
These conditions achieved a 93% reduction in solution colour after three hours 
and the molecular weight of the decoloured protein was not significantly reduced. 
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4.2 Experimental 
4.2.1 Aim 
The overall aim of this section was to identify optimal conditions for decolouring 
RBCC with hydrogen peroxide so it could be scaled to commercial production. 
More specifically, the objective was to investigate the effect of pH, RBCC 
concentration and reaction temperature on colour reduction as well as the 
effectiveness of the process, which was characterised by decoloured protein yield. 
4.2.2 Methods and Materials 
Frozen RBCC (33% solids) centrifuged from hygienically-collected bovine blood 
was supplied by a local meat processing facility.  All other chemicals were 
supplied by Ajax Finechem. 
The effect of pH, RBCC concentration, hydrogen peroxide concentration, reaction 
temperature and centrifugation on decolouring and foaming was explored. All 
trials were repeated at least two times. 
10 g RBCC (33% solids by mass) was mixed with 100 g distilled water in 1 L 
glass beakers.  Mass was used as RBCC was too viscous to accurately measure 
volumetrically.  Solution pH was adjusted to 2, 5, 8, 11, 13 and 14 by adding 1 
mol/L HCl or 2 mol/L NaOH.  After slowly adding 15 g (30% w/w) hydrogen 
peroxide while mixing, the solution was left to react for three hours.  
To determine the effect of RBCC concentration on decolouring and foaming, 10-
30 g RBCC was added to distilled water and the total mass made up to 110 g with 
distilled water.  Resulting solutions were adjusted to pH 2 and 15 g (30% w/w) 
hydrogen peroxide was added and left to react for three hours. For both pH and 
RBCC concentration trials, mass loss due to foaming was determined by 
collecting foam produced during reaction in a pre-weighed container and oven 
drying overnight at 60°C.  Percentage mass lost due to foaming was calculated by 
dividing dry mass of foam by initial dry solids of the solution. 
Solution colour before, during and after treatment was determined by measuring 
UV/Vis absorbance at 540 nm. Reduction in solution colour was reported as 
percentage change in absorbance from the initial absorbance. 
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To investigate the effect of temperature and hydrogen peroxide concentration on 
decolouring, 7.5, 15 or 22 g (30% w/w) hydrogen peroxide was added to 9% w/w 
RBCC aqueous solutions at pH 2. Solutions were kept in a preheated water bath 
with an oscillating platform at 20, 30 or 40°C. The absorbance of each solution at 
540 nm was measured every 20-30 minutes for three hours and the percentage 
change calculated. Hydrogen peroxide remaining after three hours was determined 
by titrating liberated iodine from acidified potassium iodide solution using 0.1 M 
sodium thiosulfate (standardised using potassium iodate) and ammonium 
molybdate catalyst [133]. 
To investigate the effect of centrifugation, two 9% w/w RBCC aqueous solutions 
at pH 2 were centrifuged separately at 4000 rpm for five minutes to remove haem 
precipitate. Supernatants were decanted and treated with 7.5 g or 15 g hydrogen 
peroxide. After three hours, the final colour content was measured and percentage 
change calculated. 
Decoloured RBCC was produced by centrifuging 9% w/w RBCC aqueous 
solution at pH 2, then reacting with 7.5 g (30% w/w) hydrogen peroxide at 30°C. 
The decoloured solution was freeze dried and ground into a powder. Protein 
solubility at various concentrations were tested at pH 4, 7 and 9.5 by adding 20 ml 
phosphate buffer to pre-weighed amounts of decolourised protein in test tubes. 
After one hour, solubility was investigated by visual examination. 
4.2.2.1 Molecular Weight Analysis 
Molecular weight was investigated by dissolving 8-9 mg decoloured powder in 
0.02 M phosphate buffer at pH 7 containing 2% sodium dodecyl sulphate, 0.5% 
sodium sulphite and 0.1 M sodium chloride, heated to 100°C for 5 minutes. After 
centrifuging the solution at 11,000 rpm for three minutes to remove any remaining 
solid particles, a 0.5 ml aliquot was applied to a Superdex 200 gel filtration 
column (GE Healthcare) connected to an Akta Explorer 100 (GE Healthcare). The 
column was calibrated with a low molecular weight size exclusion calibration kit 
(GE Healthcare). Two column volumes of 0.02 M phosphate running buffer at  
pH 7 containing 0.1% sodium dodecyl sulphate and 0.1 M sodium chloride was 
applied at a flow rate of 0.5 ml/min. Protein concentration was measured at      
215 nm using an inline detector. 
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4.3 Results and Discussion 
4.3.1 Effect of pH on Decolouring and Foaming 
The greatest change in colour occurred at pH 2 (76% reduction) and pH 14 (96% 
reduction). The change in colour decreased as pH approached pH 8, where there 
was only a 3% reduction in colour (Figure 17). At both pH 9 and pH 12, solution 
colour was reduced by 27%. Deybuyser (1999) suggested decolouring 
haemoglobin at pH 9-12 at 50°C. The brown protein they produced required 
further oxidative treatment for 1 second at high temperature (150°C) or 48 hours 
at low temperature (50°C). Decolouring appeared to depend on catalase activity, 
which was highest at pH 8.  Where catalase activity was high, decolouring extent 
was low. 
 
Figure 17: Reduction in solution colour at different pH. 
 
Figure 18: Solids lost in foam at different pH. 
In general as pH increased, percentage solids lost increased except for pH 8 where 
only 3.3% solids were lost in the foam (Figure 18). The pH was clearly important 
for decolourisation and for controlling the amount of solids lost in the foam. 
Foaming was a combination of catalase action, protein denaturation and 
spontaneous hydrogen peroxide decomposition.  As pH deviated from neutral, 
more protein may have been denatured and trapped in the foam. At pH 8 very 
little protein was denatured and foaming was mainly due to catalase action which 
may explain why pH 8 did not follow the general trend. At pH 14, large amounts 
of protein may have been denatured. Hydrogen peroxide also decomposes and 
readily produces oxygen in alkaline conditions. The combined effect of large 
amounts of oxygen and denatured protein resulted in high mass lost in the foam. 
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At pH 2, catalase action was reduced and hydrogen peroxide was stabilised. 
Therefore, there was less oxygen from hydrogen peroxide decomposition and less 
chance for protein to be trapped in this foam which minimised protein losses at 
pH 2. 
Decolourisation was most effective at pH 2 and pH 14. However, pH 14 was not 
suitable for large scale production due to the high loss of solids in the foam. At 
pH 2, catalase action was reduced and hydrogen peroxide was able to degrade the 
haem. Haem also dissociated from the globin at this pH and formed an aggregate 
because of its hydrophobic nature [7]. Therefore, pH 2 was the best pH for 
decolourisation, which was consistent with previous work done by Wismer-
Pedersen and Frohlich (1992). 
4.3.2 Effect of Dilution on Foaming 
It is desirable to minimise foam in a large scale process. This could be achieved 
by having low RBCC concentrations. At pH 2, the solids lost in foam increased 
linearly with RBCC concentration (Figure 19). The best concentration was found 
to be 9% w/w RBCC because at this concentration the least solids were lost due to 
foaming. Antifoam could be used as an alternative approach to reduce foaming. 
However this was not investigated and should be investigated in future studies. 
 
Figure 19: Percentage solids lost as foam at different RBCC concentrations. 
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4.3.3 Decolourisation Rate at Different Temperatures and 
Hydrogen Peroxide Concentrations 
Rate of decolourisation increased as temperature and hydrogen peroxide added 
increased (Figure 20, Figure 21, Figure 22). Comparing the 20°C curve for all 
three hydrogen peroxide amounts shows that when the amount of hydrogen 
peroxide added increased from 7.5-22 g the rate of decolourisation increased. This 
was also consistent for 30°C and 40°C. 
However, increasing the amount of hydrogen peroxide had little effect on final 
percentage decolourisation. Thus, regardless of how much hydrogen peroxide was 
used, a maximum of approximately 90% decolourisation was obtained. It would 
be favourable to use as little hydrogen peroxide as possible to reduce operating 
costs. 
The reactions expected to occur during decolouring, based on the mechanism 
described by Nagababu and Rifkind (2000) are: Hydrogen peroxide reacts with 
haemoglobin to form a reactive intermediate called ferrylhaemoglobin. 
Ferrylhaemoglobin is a strong oxidising agent and reacts with another molecule of 
hydrogen peroxide to produce the superoxide free radical and water. This can 
occur either in the haemoglobin molecule with the haem porphyrin still attached 
or outside the globin if the haem has floated free due to the acidic pH.  Hydrogen 
peroxide may also react with methaemoglobin (HbFe
3+
) and produce oxygen 
instead of superoxide. This does not lead to haem degradation. The haemoglobin 
intermediates are also involved in side reactions which consume hydrogen 
peroxide. The overall reaction mechanism described by Nagababu and Rifkind 
(2000) is: 
 
 
 
 
Superoxide (SO) can either react with the tetrapyrrole rings, diffuse out of the 
haem molecule and be removed by superoxide dismutase (an enzyme present in 
natural systems which degrades superoxide produced as a by-product during 
Other reactions 
HbFe(II) + H2O2 → HbFe(IV)=O + H2O2 → HbFe(III) + O2˙ˉ → Haem degradation                        (1) 
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metabolism), or react with the globin. It is not known how many superoxides react 
with a haem molecule, or are consumed by reacting with superoxide dismutase or 
globin.  
Haem concentration was directly related to absorbance at 540 nm and reaction 
rates were obtained by fitting the following equations for haem degradation (2), 
hydrogen peroxide consumption (3), and superoxide production and consumption 
(4).  The equations assumed two hydrogen peroxides (HP) were consumed to 
produce a superoxide (SO), N moles of SO were consumed to degrade a haem 
molecule, and M moles of SO reacted with a globin or superoxide dismutase 
(which will be proportional to the globin concentration). Concentration was 
measured in mol.g
-1
. 
SOHaem
Haem CCk
t
C
1


 (2) 
 
HPHaem
HP CCk
t
C
2


 (3) 
 
SOGlobinSOHaemHPHaem
SO MCCkNCCkCCk
t
C
3122 


 (4) 
The parameters k1, k2, k3 (g.mol
-1
.s
-1
), N and M (Table 11) were obtained by fitting 
the model to experimental data. k1, k2 and k3 varied with temperature and an 
Arrhenius equation: 
 





 
 RT
EA
Aek  (5) 
 
was used to estimate the Arrhenius constants (Table 12).  A is the frequency 
factor, EA is activation energy, R is the ideal gas constant and T is temperature in 
Kelvin.  Goodness of fit was determined by summing the error squared between 
model and experimental data and by regression analysis (coefficient of 
determination) (Table 13). 
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Figure 20: Change in solution colour, 10 g RBCC, 100 g distilled water, pH2, 7.5 g hydrogen peroxide at 20, 
30 and 40°C. 
 
Figure 21: Change in solution colour, 10 g RBCC, 100 g distilled water, pH2, 15 g hydrogen peroxide at 20, 
30 and 40°C. 
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Figure 22: Change in solution colour, 10 g RBCC, 100 g distilled water, pH2, 22 g hydrogen peroxide at 20, 
30 and 40 °C. 
Table 11: Fitted model parameters. 
Parameter 
Fitted Constants 
20°C 30°C 40°C 
k1 (g.mol
-1
.s
-1
) 80000 100000 140000 
k2 (g.mol
-1
.s
-1
) 20000 25000 40000 
k3 (g.mol
-1
.s
-1
) 10000 10000 10000 
N (mol) 10 10 10 
M (mol) 500 500 500 
 
Table 12: Activation energy and frequency factor for model parameters. 
 k1 k2 k3 
A (g.mol
-1
.s
-1
) 3.28 x 10
8
 9.52 x 10
8
 6.00 x 10
5
 
EA (J.mol
-1
) 20240 26000 10330 
 
Table 13: Goodness of fit values for fitted models. 
H2O2 (g) 7.5 15 22 
Temp (°C) 20 30 40 20 30 40 20 30 40 
R
2
 0.87 0.98 0.99 0.83 0.98 0.97 0.92 0.97 0.95 
SSE 520.26 139.78 22.72 742.02 205.73 162.56 476.81 244.81 319.36 
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The model showed a good fit with experimental data for 30 and 40°C (Table 13) 
but was not as good a fit at 20°C, probably due to diffusion effects that were not 
accounted for in the model.  At the higher temperatures, diffusion was likely to be 
sufficiently rapid so the reaction rates were the rate limiting steps.  The model was 
particularly sensitive to the rate of SO production (k2), indicating that this was a 
limiting step.  Reducing k2 reduced overall percentage decolouring.  Rate of SO 
reaction with superoxide dismutase and globin (k3) appeared to be independent of 
temperature, but was significant because of the large M factor required to fit the 
data. 
Hydrogen peroxide concentrations showed little change both experimentally 
(Table 14) and theoretically, showing that while initial peroxide concentration is 
important for reaction rates, very little is consumed. If the decoloured globin can 
be recovered from solution, for example by ultrafiltration, the solution could 
potentially be recycled to minimise hydrogen peroxide use. Alternatively, the 
hydrogen peroxide could be degraded by adding catalase to prevent excessive 
oxidation of the protein. 
Table 14: Change in hydrogen peroxide concentration after three hours. 
H2O2 (g) 7.5 15 22 
Temp (°C) 20 30 40 20 30 40 20 30 40 
Initial concentration (mol/L) 0.56 0.56 0.56 1.06 1.06 1.06 1.47 1.47 1.47 
Final concentration (mol/L) 0.40 0.34 0.32 0.80 0.77 0.72 1.17 1.13 1.08 
Percent consumed 29 39 43 25 27 32 20 23 27 
When producing decoloured protein on a large scale, it would be advantageous to 
reduce the time taken for decolourisation. The data (Figure 20 to Figure 22) 
indicated there were two options: add large amounts (22 g) of hydrogen peroxide 
at low temperature (20°C) or add smaller amounts (7.5 g) of hydrogen peroxide 
and heat to between 30 and 40°C 
Adding large amounts of hydrogen peroxide is not recommended because it can 
oxidize amino acids in the protein or cause peptide fragmentation. Large amounts 
of hydrogen peroxide would also increase production costs. 
If the decoloured protein is destined to be used in food applications excessive 
heating is not recommended as it can denature proteins causing a loss in 
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functional properties such as foaming, solubility and emulsification. However for 
bioplastics loss of functional properties is not as important, therefore a higher 
heating temperature could be used. The body temperature of cattle is 
approximately 38°C. Therefore, heating to 30°C is only a mild heat treatment and 
is unlikely to cause excessive damage to the protein. Adding 7.5 g (30% w/w) 
hydrogen peroxide and heating to 30°C was selected as the preferred method for a 
potential large scale process. 
4.3.4 Centrifuging Before Hydrogen Peroxide Addition 
When RBCC solution was reduced to pH 2, a proportion of haem dissociated from 
the globin and formed an aggregate, which could be removed by centrifugation. 
When RBCC solution was centrifuged before adding hydrogen peroxide, 
decolourisation was more efficient (Table 15). For example, adding 7.5 g (30% 
w/w) of hydrogen peroxide with no centrifugation reduced colour by 62%. If the 
same amount of hydrogen peroxide was added after centrifugation, there was a 
92% reduction in colour. Less foam was also observed when hydrogen peroxide 
was added after centrifugation. 
Removing the haem precipitate by centrifugation reduced the haem in solution 
and therefore reduced the hydrogen peroxide required for decolourisation. The 
haem removed by centrifugation was most probably unmodified and has the 
potential to be used in iron supplement products. Reducing the amount of 
hydrogen peroxide used was desirable so production cost would be minimised and 
protein molecular mass maintained. 
Table 15: Percentage reduction in solution colour when different amounts of hydrogen peroxide are added 
without centrifuging and with centrifuging. 
Conditions No Centrifugation With Centrifuging 
RBCC 0.00% 5.52% 
Control (pH 2, No H2O2) 0.00% 66.55% 
7.5 g H2O2 62.70% 92.83% 
15 g H2O2 84.68% 96.00% 
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4.3.5 Decoloured Powder Solubility 
The decoloured protein showed good solubility at pH 4. When the pH was 
increased to 7 solubility decreased. The decolourised protein was sparingly 
soluble at pH 9.5 (Table 16). Good solubility at pH 4 and pH 7 indicated the 
protein was not substantially modified or damaged by lowering the pH, adding 
hydrogen peroxide or heat treatment.  
Wismer-Pedersen and Frohlich (1992) suggested that pH of the RBCC solution be 
readjusted to between pH 4-5 before adding hydrogen peroxide, to protect the 
protein and prevent loss of functional properties. However, when this was 
attempted, large volumes of foam formed. Most catalases have an optimal activity 
between pH 7-8. Catalase activity was reduced at pH 2 but activity was restored 
when pH was raised causing foaming. 
Table 16: Decolourised protein solubility at pH 4, pH 7 and pH 9.5. 
Conc. (mg/ml) pH 4 pH 7 pH 9.5 
0.25 Dissolved Dissolved Dissolved 
0.5 Dissolved Dissolved Dissolved 
1.0 Dissolved Dissolved Not Dissolved 
2.0 Dissolved Dissolved Not Dissolved 
3.0 Dissolved Dissolved Not Dissolved 
4.0 Dissolved Dissolved Not Dissolved 
5.0 Dissolved Dissolved Not Dissolved 
6.0 Dissolved Dissolved Not Dissolved 
7.0 Dissolved Not Dissolved Not Dissolved 
8.0 Dissolved Not Dissolved Not Dissolved 
9.0 Dissolved Not Dissolved Not Dissolved 
10.0 Dissolved Not Dissolved Not Dissolved 
4.3.6 Decoloured Powder Molecular Mass 
The RBCC and decoloured RBCC have similar gel filtration elution profiles 
(Figure 23), indicating the molecular weight of the protein was not altered 
significantly. This suggested that the mechanism for haem degradation described 
by Nagababu and Rifkind (2000) was suitable for this process [104]. Molecular 
mass was maintained because the iron contained within the haem group is unable 
to act as a Fenton reagent with hydrogen peroxide and produce the more reactive 
hydroxyl radical which could lead to backbone fragmentation [26, 31]. 
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Because the molecular mass of the decoloured protein was not reduced it could be 
possible to process it into a bioplastic. However disulphide cross-links could also 
be forming during hydrogen peroxide treatment. The dissolving buffer contained 
sodium sulphite which removed disulphide cross-links. Therefore these would not 
have been detected and if present would restrict processing. This was investigated 
further using thermal analysis in Chapter Five. 
 
Figure 23: Elution profile for hydrogen peroxide decoloured RBCC. 
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4.4 Conclusion 
Utilisation of the protein in RBCC in human food is limited and it could be a 
potential feedstock for second generation bioplastics. Published decolourisation 
methods utilising hydrogen peroxide have problems such as excessive foaming, 
long processing times and the potential for amino acid oxidation when large 
amounts of hydrogen peroxide are used. 
The effects of RBCC concentration, pH and reaction temperature were the most 
important factors influencing the decolourising process. They were investigated 
with the aim of developing a method which could be scaled to commercial level 
for producing a bioplastic feedstock.  
Initial trials showed pH was a very important factor and affected foaming and 
decolourisation. A 96% reduction in solution colour was achieved at pH 14, but 
8.4% solids were lost due to foaming. At pH 8, solution colour was only reduced 
by 3% and 3.3% solids were lost. Solids lost in foam were thought to depend on a 
combination of catalase action, protein denaturation and spontaneous hydrogen 
peroxide decomposition. The best pH was found to be pH 2, where solution 
colour was reduced 76% and only 3% solids were lost in foam. 
The amount of hydrogen peroxide required for decolourisation was reduced by 
centrifuging to remove aggregated haem after pH adjustment. The research 
showed that the best conditions for the potential large scale production of 
decolourised protein from RBCC were: centrifuging 9% w/w RBCC aqueous 
solution at pH 2, then reacting with 7.5 g (30% w/w) hydrogen peroxide at 30°C. 
These conditions achieved a 93% reduction in solution colour after three hours 
and the molecular weight of the decoloured protein was not significantly reduced. 
This section successfully produced decolourised protein from RBCC with a high 
yield. However, further investigations into removal of haem by increasing 
centrifugation time or speed could further reduce the treatment time and hydrogen 
peroxide required. Strategies for recycling or removing remaining hydrogen 
peroxide should also be investigated.  
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Although this method produced a decoloured protein from RBCC while 
maintaining its molecular mass, it may not be suitable for use with bioplastics 
because it requires large volumes of water and long residence times which can 
increase processing costs. Therefore it is recommended that alternative methods 
for decolouring RBCC and bloodmeal be investigated before selecting the most 
preferred method. 
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Chapter 5 Investigating Red Blood Cell Concentrate and Bloodmeal 
Decolourisation 
Chapter 5  
Investigating Red Blood Cell Concentrate and 
Bloodmeal Decolourisation 
 
Bloodmeal powder. 
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5.1 Chapter Overview 
In Chapter Four, the colour from RBCC was successfully modified by diluting 
with water, reducing to pH 2, centrifuging and then treating with hydrogen 
peroxide. However, this method had several disadvantages such as long 
processing times, multiple processing steps and high water requirements. The 
objective of this chapter was to explore different methods for efficiently 
producing decoloured blood protein for use in bioplastics. More specifically a 
method was required which was simple, environmentally friendly and efficiently 
removed colour and odour while also avoiding significant reduction in the 
proteins molecular mass. 
The colour is caused by the haem porphyrin and the smell by degradation odour 
compounds. These are susceptible to oxidation due to their conjugated or ring 
structures. In this chapter the oxidising chemicals sodium hypochlorite, sodium 
chlorite, sodium chlorate, chlorine dioxide, hydrogen peroxide and PAA were 
applied to RBCC, modified RBCC (mRBCC) and bloodmeal at high 
concentrations. Their effect on colour, smell and molecular weight were 
investigated. In addition crystallinity and thermal stability was investigated for the 
most effective methods. 
When sodium hypochlorite, sodium chlorate and chlorine dioxide was used to 
treat RBCC, mRBCC and bloodmeal they produced treated powders which were 
22-61% white. Molecular mass was not significantly reduced but they were not 
effective at removing the odour from bloodmeal. Therefore these methods were 
not suitable for producing a bioplastic feedstock.  
Sodium chlorite, hydrogen peroxide and PAA treatment of RBCC and mRBCC 
produced treated powders which were 55-93% white. However these methods 
were not suitable for use with bioplastics because they significantly reduced the 
molecular mass of the protein, required long residence times or for the case of 
sodium chlorite had environmental concerns such as chlorination of the protein. 
Treating bloodmeal with hydrogen peroxide, sodium chlorite and PAA produced 
powders which were 31-76% white and also improved the odour. PAA treatment 
had the greatest effect on bloodmeal colour and smell and also does not have the 
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same environmental problems as sodium chlorite treatments. Decolouring was 
completed with five minutes. Bloodmeal molecular weight was not significantly 
reduced which indicated it could still be possible to process it into a bioplastic and 
the mechanical properties may not be reduced. Therefore it was concluded that 
treating bloodmeal with PAA had the most potential for producing a decoloured 
protein for use in bioplastics.  
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5.2 Experimental 
5.2.1 Aim 
The aim of this section was to investigate the decolouring and deodorising effect 
of the different readily available oxidising chemicals identified in Chapter Three 
on RBCC, mRBCC and bloodmeal. These were used at high concentrations to 
reduce the time required for colour and odour removal. 
5.2.2 Methods and Materials 
5.2.2.1 Bloodmeal, RBCC and mRBCC Treatment Trials 
Three different blood products were used in this chapter, these were bloodmeal, 
RBCC and mRBCC. Bloodmeal is a dried blood protein powder, RBCC is a 
viscous liquid produced by centrifuging whole blood and mRBCC is diluted 
RBCC which has been adjusted to pH 2 and centrifuged. Their properties are 
summarised in (Table 17). 
Table 17: Summary of blood products used to produce a decoloured protein for use in bioplastics. 
Material Supplier Grade Solids (%) pH 
Bloodmeal Wallace Corporation Inedible 95 - 
RBCC Local meat processing factory Hygienically collected 33 7 
mRBCC Produced by author from hygienically collected RBCC 6.6 2 
Bloodmeal decolourisation and deodorisation was investigated by treating 5 g of 
bloodmeal with 20 g of decolouring solutions of varying strengths (Table 18). The 
contents were stirred for one hour then filtered and washed with distilled water 
using a Buchner funnel and Whatman grade one (11 µm cut off) filter paper. 
RBCC decolourisation and deodorisation was investigated by treating 5 g of 
RBCC with 20 g of decolouring solutions and stirring for one hour. 
mRBCC was produced by diluting 5 g of RBCC with 20 g of distilled water and 
lowering to pH 2 using 1 mol/L HCl. At this pH the protein becomes denatured 
and the haem dissociates and forms a precipitate. Solutions were centrifuged at 
4000 RPM for five minutes using a Sigma 6-15 centrifuge. Supernatant was 
decanted and treated with 20 g of decolouring solutions. The contents were stirred 
for one hour. If a precipitate formed it was filtered and washed with distilled 
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water using a Buchner funnel and Whatman grade one (11 µm cut off) filter 
paper. 
When decolouring mRBCC with hydrogen peroxide, the existing method from 
Chapter Four was used where 5 g RBCC were diluted with 50 g of distilled water, 
adjusted to pH 2, centrifuged and the supernatant and treated with 3.75 g of 
hydrogen peroxide (30%) at 30°C for three hours. 
All treated samples were frozen then freeze dried overnight using a Labconco 
Freezone 2.5 freeze dryer to between 5-10% moisture. Improvement of smell was 
analysed subjectively by the author based on previous experience with blood 
products. 
Table 18: Chemicals used for decolouring RBCC and bloodmeal. 
Material Supplier Grade 
Sodium hypochlorite (15, 10, 5 wt%) Ajax Finechem Analytical 
Sodium chlorite (5 wt%) Ajax Finechem Analytical 
Sodium chlorate (5 wt%) Ajax Finechem Analytical 
Chlorine dioxide (2 wt%) Prepared from acidified sodium chlorite - 
Hydrogen peroxide (30, 15, 5 wt%) Ajax Finechem Analytical 
Peracetic acid (5 wt% peracetic acid, 7.5 
wt% Acetic acid, 25 wt% Hydrogen 
peroxide) 
Solvay Industrial 
Peracetic acid (15 wt% Peracetic acid, 
17.5 wt% Acetic acid, 21 wt% Hydrogen 
peroxide) 
Degussa Industrial 
Copper sulphate (5 wt%) Allied Signal Analytical 
Note: Hydrogen peroxide and sodium hypochlorite diluted to required percentage using distilled water. Sodium chlorite, 
sodium chlorate and copper sulphate solutions prepared by dissolving required amount of solids in distilled water. 
The blood products used and amount of decolouring chemicals used in this 
chapter are summarised in Figure 24. 
 
Figure 24: Summary of decolouring chemicals used on RBCC, mRBCC and bloodmeal.  
* Hydrogen peroxide method from Chapter Four. 
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The applied concentrations and decolouring chemical to solids ratio varied 
between RBCC, mRBCC and bloodmeal because of their different solids contents. 
The applied concentrations and decolouring chemical to solids ratio are presented 
in Table 19. Applied concentration for RBCC and mRBCC was calculated by 
taking into account the moisture contents of RBCC and mRBCC. Because 
bloodmeal had low moisture content, the applied concentration of the oxidising 
chemicals applied to bloodmeal was assumed to be equal to the original 
concentration. Chemical to solids ratio (w/w) was calculated by dividing the mass 
of dry solids for bloodmeal, RBCC and mRBCC by the mass of the oxidising 
chemical (after correcting for dilution) applied to them. 
Table 19: Applied concentration and chemical to solids ratio when different decolouring solutions are used 
on bloodmeal, RBCC and mRBCC. 
 Bloodmeal RBCC mRBCC 
Chemical Original 
Conc. 
(%) 
Applied 
Conc. 
(%) 
Chemical 
to solids 
ratio (w/w) 
Applied 
Conc. 
(%) 
Chemical 
to solids 
ratio (w/w) 
Applied 
Conc. 
(%) 
Chemical 
to solids 
ratio (w/w) 
Hydrogen Peroxide 30 30 1.20 24.00 3.64 0.02* 0.70* 
  15 15 0.60 
Not Applied   5 5 0.20 
Peracetic acid 15 15 0.60 
  5 5 0.20 4.00 0.61 2.22 0.62 
Sodium Hypochlorite 15 15 0.60 12.00 1.82 6.67 1.86 
  10 10 0.40 8.00 1.21 4.44 1.24 
  5 5 0.20 4.00 0.61 2.22 0.62 
Sodium Chlorite 5 5 0.20 4.00 0.61 2.22 0.62 
Sodium Chlorate 5 5 0.20 4.00 0.61 2.22 0.62 
Chlorine Dioxide 2 2 0.08 1.60 0.24 0.89 0.25 
Copper Sulphate 5 5 0.20 4.00 0.61 2.22 0.62 
*Hydrogen peroxide method from Chapter Four. 
The processability and mechanical properties of bioplastics produced from 
proteins can be influenced by properties such as molecular mass, crystallinity and 
molecular stabilising interactions such as hydrogen bonding, cross-linking and 
hydrophobic interactions. Therefore these properties were investigated using gel 
filtration chromatography, X-ray diffraction and thermal gravimetric analysis. 
5.2.2.2 Molecular Mass Analysis of Decoloured Powders 
Reduced molecular mass can lead to a reduction in a bioplastics mechanical 
properties and processability due to reduced chain entanglements. Molecular mass 
of freeze dried and ground treated powders were analysed using gel filtration 
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chromatography as previously described in Chapter Four. In addition the number 
average molecular weight (MN), weight average molecular weight (MW) and 
polydispersity index (PI) was calculated using equations 6, 7 and 8 where Ni is 
equal to the number of molecules with molecular weight Mi [134]. 
   
∑       
∑     
 (6) 
   
∑        
∑       
 (7) 
   
  
  
 (8) 
5.2.2.3 X-Ray Diffraction Analysis 
Crystallinity can affect mechanical properties because hydrogen bonds which 
stabilise the regular structure of the protein can also contribute to the bioplastics 
strength. Processing can also be affected by crystallinity because additives may be 
required to disrupt hydrogen bonding to allow chains to re-entangle during 
processing. X-ray diffraction was used to investigate the crystallinity of treated 
powders which could also give an indication of changes in hydrogen bonding and 
how different treatments could be affecting the amino acids involved with it.  
The X-ray diffraction pattern of selected decoloured powders was measured using 
low angle powder X-ray diffraction (XRD). XRD was carried out using a Philips 
X-ray diffractometer at a low angle configuration of 2Ѳ=2° to 60°, with a 
scanning rate of 2Ѳ=2°min-1, operating at a current of 40 mA and a voltage of 40 
kV using CuKα1 radiation. 
5.2.2.4 Thermogravimetric Analysis 
Thermal stability was used as an indirect method to investigate changes in 
stabilising interactions such as cross-linking, hydrogen bonding and hydrophobic 
interactions. A reduction in thermal stability would indicate that the amount of 
stabilising interactions had been reduced and could suggest that the amino acids 
involved in these had been altered. In addition thermal stability was used as a 
secondary method to validate changes in molecular mass investigated using gel 
chromatography. If molecular mass had been significantly reduced a significant 
loss in thermal stability would be expected. 
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Thermal stability of selected decoloured powders was investigated using a thermal 
gravimetric analyser (SDT 2960, TA Instruments). Approximately 10 mg of 
sample was used. The mass loss was recorded while the sample was heated from 
room temperature to 800°C at a rate of 10°C per minute. The data was normalised 
at 150°C to account for water loss and the percentage change in mass calculated. 
The first derivative of percentage mass change versus temperature was also 
calculated to investigate temperature regions where mass loss was occurring. 
5.2.2.5 Powder Colour Analysis 
Dried samples were ground to a fine powder using mortar and pestle. The powder 
colour was analysed using a Minolta Chroma Meter CR-200b set in L*a*b* (CIE 
1976) mode using D (6504K) illuminant conditions as these settings represent 
what is seen by the human eye the closest. The L*a*b* values were converted to 
RGB and percent whiteness calculated using the equation: 
                 
     
   
     (9) 
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5.3 Results and Discussion 
Chemicals were used at different concentrations for the different feedstocks 
because the feedstocks had different moisture contents (Table 19). Bloodmeal was 
treated at the highest applied concentration because of its low moisture content, 
but it also the lowest decolouring chemical to solids ratio because of its high 
solids content.  
RBCC was treated at a slightly reduced applied concentration because it had 
higher moisture content than bloodmeal. However, because RBCC had low solids 
content it had a high decolouring chemical to solids ratio. mRBCC was treated at 
a significantly lower applied concentration which was caused by the 20 g of water 
used to dilute the RBCC prior to pH adjustment. The chemical to solids ratio was 
calculated based on previously calculated 2% solids loss after centrifugation 
which most probably consisted of dissociated haem and the cell membrane. The 
loss in solids resulted in a slightly higher decolouring chemical to solids ratio 
when compared to RBCC. For hydrogen peroxide treated mRBCC the applied 
concentration is greatly reduced because 50 g of water is used for dilution and 
only 3.75 g of hydrogen peroxide (30%) was used. 
5.3.1 Red Blood Cell Concentrate and Modified Red 
Blood Cell Concentrate Treatment Analysis 
5.3.1.1 Colour and Smell of Treated RBCC and mRBCC 
Treating RBCC with different chemicals produced powders ranging from 26% 
whiteness to 91% whiteness. PAA, hydrogen peroxide and sodium chlorite 
treatment produced 91%, 71% and 61% white powders respectively. They also 
removed offensive odours (Table 20). Sodium hypochlorite (5-15% 
concentration) produced 55-61% white powders (Figure 26) but did not remove 
odour. Sodium chlorate, chlorine dioxide and copper sulphate did not alter the 
original colour of RBCC significantly (Figure 25) so would not be useful for 
producing a bioplastic feedstock. 
The decolouring solutions were oxidising agents (excluding copper sulphate) and 
would have been altering the bond configuration of the haem porphyrin. They 
could also be oxidising the odour compounds. PAA, hydrogen peroxide and 
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sodium chlorite were the strongest oxidising agents (reduction potentials of 1.81, 
1.76 and 0.681 V respectively) used which could explain why they were the most 
effective at removing colour and odour [18]. 
Because of the high concentrations, colour removal occurred very quickly. 
Sodium chlorite colour removal occurred within five minutes. In the case of PAA 
and hydrogen peroxide, colour removal was almost instantaneous. 
Treating RBCC with hydrogen peroxide resulted in large volumes of foam being 
produced from catalase action. However, colour was still able to be removed, 
probably because catalase was overcome by the combination of high 
concentration and high ratio of hydrogen peroxide to protein. A significant 
increase in temperature was also observed because of exothermic decomposition 
of hydrogen peroxide. When RBCC was treated with PAA foaming was reduced. 
This was probably due to the acetic acid deactivating catalase. The foaming that 
did occur was probably due to PAA and hydrogen peroxide spontaneously 
decomposing. 
Table 20: Effect of different chemicals on RBCC colour and smell. 
Rank Material 
Treatment 
Method 
Applied 
Conc. 
(%) 
Chemical 
to solids 
ratio 
L* R G B 
White 
(%) 
Colour 
Smell 
Improved? 
1 RBCC PAA 
(5%) 
4 0.61 95 243 242 208 91 
 
Yes 
2 RBCC H2O2 
(30%) 
24 3.64 77 218 184 139 71 
 
Yes 
3 RBCC NaClO2 
(5%) 
4 0.61 67 188 157 123 61 
 
Yes 
4 RBCC NaClO 
(15%) 
12 1.82 65 165 157 144 61 
 
No 
5 RBCC NaClO 
(10%) 
8 1.21 64 161 155 138 59 
 
No 
6 RBCC NaClO 
(5%) 
4 0.61 58 148 138 132 55 
 
No 
7 RBCC ClO2 
(2%) 
1.6 0.24 35 126 63 62 33 
 
No 
8 RBCC CuSO4 
(5%) 
4 0.61 33 86 76 67 30 
 
No 
9 RBCC Untreated 
 
- - 28 106 57 58 29 
 
No 
10 RBCC NaClO3 
(5%) 
4 0.61 27 86 56 54 26 
 
No 
 
Figure 25: Freeze dried RBCC. 
 
Figure 26: Sodium hypochlorite (15%) treated RBCC. 
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Sodium chlorite, hydrogen peroxide and PAA treatment were also the most 
effective when treating mRBCC. Hydrogen peroxide (Figure 27), PAA and 
sodium chlorite (Figure 28) treatment produced 55, 87 and 93% white powders 
respectively and also removed odour (Table 21). Sodium hypochlorite, sodium 
chlorate, chlorine dioxide and copper sulphate did not effectively remove colour 
or odour, therefore they were not suitable for producing a bioplastic feedstock 
which is the same result obtained when treating RBCC with these chemicals. 
Table 21: Effect of different chemicals on modified RBCC colour and smell. 
Rank Material 
Treatment 
Method 
Applied 
Conc. 
(%) 
Chemical 
to solids 
ratio 
L* R G B 
White 
(%) 
Colour 
Smell 
Improved? 
1 mRBCC NaClO2 
(5%) 
2.22 0.62 95 246 240 225 93 
 
Yes 
2 mRBCC PAA 
(5%) 
2.22 0.62 91 239 229 199 87 
 
Yes 
3* mRBCC H2O2 
(30%) 
0.02 0.70 64 180 147 92 55 
 
Yes 
4 mRBCC NaClO 
(10%) 
4.44 1.24 49 125 115 100 44 
 
No 
5 mRBCC NaClO 
(5%) 
2.22 0.62 47 121 110 102 44 
 
No 
6 mRBCC NaClO 
(15%) 
6.67 1.86 47 129 107 94 43 
 
No 
7 mRBCC CuSO4 
(5%) 
2.22 0.62 29 82 65 52 26 
 
No 
8 mRBCC Untreated - - 28 79 62 54 25 
 
No 
9 mRBCC ClO2 
(2%) 
0.89 0.25 27 79 60 51 25 
 
No 
10 mRBCC NaClO3 
(5%) 
2.22 0.62 23 69 51 46 22 
 
No 
*Hydrogen peroxide method from Chapter Four. 
 
Figure 27: Hydrogen peroxide treated mRBCC. 
 
Figure 28: Sodium chlorite treated mRBCC. 
The percent whiteness of powders for all treatments except sodium chlorite was 
reduced when comparing mRBCC to RBCC. This was likely caused by the 
decolourant being diluted by the additional 20 g of water in mRBCC. However 
excellent decolourisation was still achieved with much lower chemical 
concentrations. This was because at pH 2 the haem group dissociated from the 
globin and formed a precipitate which could be removed, reducing the amount of 
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haem that needed to be degraded. This also made haem more accessible to the 
chemicals so a lower concentration could still be effective at removing the colour. 
Sodium chlorite has been shown to be more effective at acidic pH due to the 
formation of highly reactive side products such as the chlorite ion and chlorous 
acid [135]. mRBCC was at pH 2 whereas RBCC was at pH 7. This could explain 
why sodium chlorite was more effective on mRBCC than RBCC even though its 
concentration was lower. 
When mRBCC was treated with hydrogen peroxide the dramatic decrease in 
colour removed was because of the 50 g diluting water and reduced amount of 
hydrogen peroxide used. This method produced less foam because catalase action 
was reduced at pH 2. There was also less temperature increase because of the 
reduced concentrations. However this method took three hours to achieve colour 
removal. 
5.3.1.2 Molecular Mass of Treated RBCC and mRBCC 
Although treating RBCC with sodium chlorite, hydrogen peroxide and PAA had 
the best colour and odour removal they also produced low molecular mass 
peptides (Figure 29 and Figure 30).  
 
Figure 29: Elution profile for RBCC treated with sodium chlorite, sodium chlorate and chlorine dioxide. 
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Figure 30: Elution profile for RBCC treated with peracetic acid (5%), hydrogen peroxide (30%) and copper 
sulphate. 
Sodium chlorite can cause peptide cleavage and disulphide cross-linking by 
reacting with highly reactive amino acids such as tryptophan and methionine. Gel 
chromatography showed sodium chlorite treatment produced low molecular 
weight peptides because peaks at 6.5 and below 1.13 kDa were identified in 
addition to the original peak at 65 kDa. However, a peak was also observed at 669 
kDa which suggests that high molecular weight aggregates were also formed. This 
indicated that some of the protein remained at its original molecular weight but a 
large majority was also broken into smaller peptides and some large aggregates 
were formed (Figure 29). This resulted in the number average molecular weight 
being increased from 87 kDa for untreated RBCC to 143 kDa for sodium chlorite 
treated RBCC. In addition 39% of sodium chlorite treated RBCC was below 30 
kDa whereas only 9% of untreated RBCC is below this value (Table 22). 
PAA and hydrogen peroxide had the most severe effect on RBCC molecular 
weight. This was expected as they have a higher oxidation potential than sodium 
chlorite. No peaks were identified for both at approximately 65 kDa. Instead two 
new peaks were formed at approximately 6.5 and below 1.13 kDa (Figure 30), 
indicating that they could have oxidised the protein backbone and produced small 
polypeptide chains. If the protein was being cut at random locations then several 
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random peaks would be expected. This was not observed which suggests that the 
protein was being cleaved at specific sites, however these were not determined. 
Hydrogen peroxide and PAA treatment of RBCC reduced the number average 
molecular weight to 19 and 13 kDa respectively. 92% of hydrogen peroxide 
treated RBCC was below 30 kDa whereas 96% of PAA treated RBCC was below 
this value. This would greatly reduce their ability to be processed into a bioplastic 
or if processable the bioplastic would have greatly reduced mechanical properties 
due to poor entanglement. 
Table 22: Number average molecular weight, weight average molecular weight, polydispersity index and 
molecular mass distribution of decoloured RBCC powders. 
    Molecular Mass Distribution (kDa) 
 MN 
(kDa) 
MW 
(kDa) 
PI 1490-560 560-215 215-80 80-30 30-11 11-4 4-1.6 1.6-0.6 
RBCC 87 264 3.0 0.02 0.05 0.11 0.73 0.06 0.01 0.01 0.01 
NaClO2 
(5%) 
143 441 3.1 0.07 0.14 0.18 0.22 0.11 0.09 0.13 0.06 
NaClO3 
(5%) 
171 373 2.2 0.05 0.21 0.28 0.36 0.03 0.04 0.02 0.01 
ClO2 
(2%) 
98 264 2.7 0.02 0.06 0.18 0.65 0.05 0.02 0.01 0.01 
H2O2 
(30%) 
19 372 19.8 0.01 0.01 0.02 0.04 0.12 0.48 0.24 0.08 
PAA 
(5%) 
13 288 21.6 0.01 0.01 0.02 0.02 0.06 0.40 0.33 0.15 
CuSO4 
(5%) 
65 198 13.1 0.01 0.02 0.12 0.60 0.10 0.08 0.05 0.02 
Sodium chlorite treated mRBCC (Figure 31) showed one difference to sodium 
chlorite treated RBCC (Figure 29). This was that no high molecular weight 
aggregates were detected for mRBCC treated with sodium chlorite. The acidic pH 
of mRBCC could be causing a greater amount of sodium chlorite to be converted 
to chlorite ions and chlorous acid which may lead to less disulphide cross-links 
forming. A small amount of these cross-links could be forming but would be 
removed and not detected due to sodium sulphite in the dissolving buffer. Sodium 
chlorite treated mRBCC had a number average molecular weight of 44 kDa and 
55% was below 30 kDa. 
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The elution profile for PAA treated mRBCC (Figure 32) was similar to that for 
RBCC treated with PAA. Both showed that molecular mass was reduced 
significantly. PAA treated mRBCC had a number average molecular mass of 21 
kDa and 91% was below 30 kDa. These values were slightly better than PAA 
treated RBCC. It appears that the diluting effect of the additional 20 g water 
(Table 19) in mRBCC slightly reduces the reduction in molecular mass but not 
enough to prevent excessive damage to the protein. 
Hydrogen peroxide treatment of mRBCC did not reduce the molecular mass 
significantly as shown in Figure 32. It had a number average molecular weight of 
90 kDa. 22% was below 30 kDA compared to 9% for untreated RBCC which 
indicated some smaller molecular mass peptides were formed. However 28% of 
hydrogen peroxide treated mRBCC was above 80 kDa compared to 18% for 
untreated RBCC indicating that some higher molecular weight aggregates were 
also formed which is responsible for the slightly higher number average molecular 
weight. Treating mRBCC with hydrogen peroxide had a significantly lower 
applied concentration and decolouring chemical to solids ratio than that used for 
RBCC because more water was used for dilution and less hydrogen peroxide was 
added. This was probably why molecular mass was not significantly reduced and 
percent whiteness was not as high as when RBCC was treated with hydrogen 
peroxide. 
Literature has shown that sodium hypochlorite can cause high amounts of 
disulphide cross-links to form because it is highly reactive with cysteine [112]. 
Sodium hypochlorite treated RBCC and mRBCC could not be dissolved for 
analysis. This result suggested that sodium hypochlorite treatment caused high 
amounts of disulphide cross-links to form reducing its solubility. However 
because of the poor colour and odour removal by sodium hypochlorite it was 
decided not to investigate further. 
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Figure 31: Elution profile for modified RBCC treated with sodium chlorite, sodium chlorate and chlorine 
dioxide. 
 
Figure 32: Elution profile for modified RBCC treated with peracetic acid (5%), hydrogen peroxide (30%) 
and copper sulphate. 
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Table 23: Number average molecular weight, weight average molecular weight, polydispersity index and 
molecular mass distribution of decoloured mRBCC powders. 
    Molecular Mass Distribution (kDa) 
 MN 
(kDa) 
MW 
(kDa) 
PI 1490-560 560-215 215-80 80-30 30-11 11-4 4-1.6 1.6-0.6 
mRBCC 94 316 3.3 0.03 0.05 0.15 0.64 0.10 0.01 0.02 0.00 
NaClO2 
(5%) 
44 212 4.9 0.01 0.02 0.09 0.33 0.21 0.12 0.16 0.06 
NaClO3 
(5%) 
134 373 2.8 0.05 0.13 0.27 0.37 0.06 0.05 0.05 0.02 
ClO2 
(2%) 
86 204 2.4 0.01 0.05 0.16 0.69 0.04 0.04 0.01 0.00 
H2O2 
(30%) 
90 266 3.0 0.02 0.07 0.19 0.50 0.09 0.04 0.06 0.03 
PAA 
(5%) 
21 489 23.4 0.02 0.01 0.01 0.05 0.08 0.29 0.35 0.19 
CuSO4 
(5%) 
72 180 2.5 0.01 0.03 0.14 0.64 0.06 0.08 0.03 0.01 
Molecular mass analysis revealed that molecular mass was significantly reduced 
for sodium chlorite, hydrogen peroxide and PAA treated RBCC and sodium 
chlorite and PAA treated mRBCC. This indicated that these powders would most 
probably not be suitable for use in a bioplastic. 
5.3.1.3 Thermal Stability of Treated RBCC and mRBCC 
The thermal stability of both hydrogen peroxide and PAA treated RBCC was 
reduced significantly (Figure 33). Hydrogen peroxide and PAA treatment resulted 
in complete loss of thermal stability as shown by its rapid mass loss as 
temperature was increased. This was probably due to the combination of severe 
reduction in molecular mass as previously shown and reduction in other 
stabilising interactions which are investigated later. 
Sodium chlorite treated RBCC and mRBCC (Figure 33 and Figure 34) also 
showed reduced thermal stability initially as would be expected due to its reduced 
molecular mass. However at approximately 350°C their rate of mass loss was 
reduced. This is the region where large molecules become degraded. This 
suggested cross-link formation occurred when RBCC and mRBCC were treated 
with sodium chlorite. Sodium chlorite treated RBCC appears to be more thermally 
stable above 350°C than sodium chlorite treated mRBCC, which suggested a 
greater amount of disulphide cross-linking occurred for sodium chlorite treated 
RBCC. There is strong evidence which supports this because high molecular mass 
aggregates were detected in elution profiles for sodium chlorite treated RBCC but 
not for sodium chlorite treated mRBCC. For sodium chlorite treated mRBCC the 
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cross-linked aggregates may not have been detected with gel chromatography 
because there were less than sodium chlorite treated RBCC and they could have 
been removed by the sodium sulphite in the dissolving buffer. 
When the haem group is removed from the protein by producing modified RBCC 
(diluting RBCC and lowering to pH 2) thermal stability was also reduced slightly 
(Figure 34). This was because the haem group stabilises the haemoglobin 
molecule by filling the hydrophobic core. 
Thermal degradation of untreated RBCC, untreated mRBCC and hydrogen 
peroxide treated mRBCC occurred in three stages. These were 0 to 150°C, 230 to 
400°C and above 400°C. The first stage was attributed to the loss of bound water 
and the second stage to the breaking of S-S, O-N and O-O linkages. Above       
400°C thermal decomposition was occurring through peptide bond reduction [7]. 
Thermal degradation of RBCC treated with sodium chlorite, hydrogen peroxide 
and PAA occurred in four stages. This was also the same for mRBCC treated with 
sodium chlorite and PAA. In addition to the three stages identified previously for 
materials such as untreated RBCC, another region was identified from 150°C to 
230°C. This region can be attributed to low molecular weight compounds or 
oligomers [7, 136]. Gel chromatography identified small molecular weight 
peptides in these materials and their degradation could be responsible for mass 
loss in this region. 
Table 24: Percentage mass loss at 0-150°C, 150-230°C and 230-400°C for decoloured RBCC powders. 
Region RBCC H2O2 treated RBCC NaClO2 treated RBCC PAA treated RBCC 
0-150°C 13 7 11 15 
150-230°C - 12 9 14 
230-400°C 38 33 24 29 
400°C Thermal Decomposition 
 
Table 25: Percentage mass loss at 0-150°C, 150-230°C and 230-400°C for decoloured mRBCC powders. 
Region mRBCC H2O2 treated mRBCC NaClO2 treated mRBCC PAA treated mRBCC 
0-150°C 12 11 9 10 
150-230°C - - 15 11 
230-400°C 41 38 24 35 
400°C Thermal Decomposition 
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Figure 33: Thermal stability of hydrogen peroxide and sodium chlorite treated RBCC. 
 
 
Figure 34: Thermal stability of hydrogen peroxide and sodium chlorite treated modified RBCC. 
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5.3.1.4 XRD Patterning of Treated RBCC and mRBCC 
XRD plots of RBCC showed two peaks at 2Ɵ=9.5 and 2Ɵ=20, which correspond 
to inter-helix packing and the alpha helix backbone [137]. When RBCC was 
treated with hydrogen peroxide and sodium chlorite these peaks were reduced or 
disappeared completely (Figure 35), indicating loss of regular structure. This was 
probably caused by hydrogen peroxide reacting with highly susceptible amino 
acids such as tryptophan, proline and histidine which help stabilise protein 
structure [125, 126, 129]. Exactly what amino acids were modified could be 
investigated with amino acid analysis. 
Chromatography analysis showed that hydrogen peroxide treatment of RBCC 
produced smaller peptides than sodium chlorite treatment. Whereas XRD analysis 
showed that hydrogen peroxide treated RBCC retained more regular structure than 
sodium chlorite treated RBCC. Therefore it was suggested that hydrogen peroxide 
and sodium chlorite acted at different locations on the protein. Hydrogen peroxide 
reacted preferentially with the protein back bone reducing chain size and then 
reduced regular structure of the protein, whereas sodium chlorite preferentially 
acted on the side chains reducing the regular structure of the protein then reacted 
with the protein backbone. 
XRD analysis of mRBCC treated with sodium chlorite and hydrogen peroxide 
showed that regular structure was not significantly affected (Figure 36). The 
method used for treating mRBCC with hydrogen peroxide was much weaker than 
that used for RBCC which can explain why the regular structure of the protein and 
molecular weight was maintained when treating mRBCC but not RBCC with 
hydrogen peroxide. Regular structure was not reduced as significantly when 
mRBCC was treated with sodium chlorite as when RBCC was treated with 
sodium chlorite. Haem was more accessible for mRBCC and whiteness was also 
higher. Therefore in this case the sodium chlorite may have preferentially reacted 
with haem instead of structure stabilising amino acids. 
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Figure  
Figure 35: XRD plots of PAA, hydrogen peroxide and sodium chlorite treated RBCC. 
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Figure 36: XRD plots of peracetic acid, hydrogen peroxide and sodium chlorite treated modified RBCC. 
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5.3.1.5 Suitability of Decoloured RBCC and mRBCC for Bioplastics 
Treating RBCC and mRBCC with hydrogen peroxide, sodium chlorite and PAA 
had the best colour and odour removal. However sodium chlorite, hydrogen 
peroxide and PAA (except for mRBCC treated with hydrogen peroxide) treatment 
reduced the molecular weight of the protein. As a result any material produced 
would be likely to have poor mechanical properties. In addition to this there is a 
high possibility that chlorinated organic compounds were also formed when using 
sodium chlorite. All of these methods also dealt with materials with high moisture 
contents. This meant that high volumes of solutions had to be handled in order to 
produce small amounts of decoloured powders. 
Treating mRBCC with hydrogen peroxide produced a decoloured and deodorised 
powder without significantly reducing molecular weight, molecular interactions or 
thermal stability. Therefore this material could be potentially processed into a 
bioplastic. However this method required long processing times, multiple 
processing steps and large volumes of water which would lead to high production 
costs as previously discussed in Chapter Four. 
These results showed that treating RBCC and mRBCC with different chemicals 
prior to drying may not be an appropriate method for producing a bioplastic 
feedstock. Although the colour and odour could be removed using hydrogen 
peroxide, sodium chlorite and PAA treatment they also had undesired affects such 
as reduced molecular weight. This means that their ability to be processed into a 
bioplastic would be reduced. Even if the decoloured protein could be processed 
into a material its mechanical properties would most likely be significantly 
reduced. 
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5.3.2 Bloodmeal Treatment Analysis 
5.3.2.1 Colour and Smell of Treated Bloodmeal 
Treating bloodmeal with different chemicals produced powders ranging from 18-
76% in whiteness. Hydrogen peroxide, sodium chlorite and PAA improved colour 
and removed odour, whereas sodium hypochlorite, sodium chlorate, chlorine 
dioxide and copper sulphate did not (Table 26). 
Table 26: Effect of different chemicals on bloodmeal colour and smell. 
Rank Material 
Treatment 
Method 
Applied 
Conc. 
(%) 
Chemical 
to solids 
ratio 
L* R G B 
White 
(%) 
Colour 
Smell 
Modified? 
1 BM PAA 
(15%) 
15 0.6 84 227 208 144 76 
 
Yes 
2 BM PAA 
(5%) 
5 0.2 77 215 187 111 67 
 
Yes 
3 BM H202 
(30%) 
30 1.20 67 187 154 109 59  Yes 
4 BM H2O2 
(15%) 
15 0.60 66 183 153 102 57 
 
No 
5 BM H2O2 
(5%) 
5 0.20 52 149 119 79 45 
 
No 
6 BM NaClO2 
(5%) 
5 0.20 35 103 77 56 31 
 
Yes 
7 BM Untreated - - 20 61 45 42 19 
 
No 
8 BM NaClO 
(5%) 
5 0.20 20 64 43 39 19 
 
No 
9 BM NaClO 
(10%) 
10 0.40 20 57 46 40 19 
 
No 
10 BM NaClO3 
(5%) 
5 0.20 19 65 39 38 19 
 
No 
11 BM NaClO 
(15%) 
15 0.6 19 51 45 42 18 
 
No 
12 BM Distilled 
Water 
- - 18 60 39 38 18 
 
No 
13 BM ClO2 
(2%) 
2 0.08 18 60 39 38 18 
 
No 
14 BM CuSO4 
(5%) 
5 0.20 19 51 45 40 18 
 
No 
Hydrogen peroxide (5-30%) treated bloodmeal produced 45-59% white powders. 
Odour was only able to be removed when hydrogen peroxide concentration was 
30%. Sodium chlorite treatment produced a 31% white powder and also removed 
the odour. 5% PAA produced a 67% white powder and 15% PAA produced a 
76% white powder due to its higher concentration. PAA may be more effective on 
colour than sodium chlorite and hydrogen peroxide because it also contained 
hydrogen peroxide and because of its low pH which has been shown to prevent 
catalase action [119]. Both PAA treatment concentrations were effective at 
removing the bloodmeal odour. Sodium chlorite took up to 30 minutes for a 
noticeable colour change whereas hydrogen peroxide and PAA colour removal 
occurred instantaneous and was completed within 5 minutes. These results 
showed a similar trend to those obtained when treating RBCC and mRBCC with 
these chemicals.  
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5.3.2.2 Molecular Mass of Treated Bloodmeal 
Gel chromatography elution profiles for all treatment methods (except sodium 
chlorite) showed a main peak at approximately 65 kDa (Figure 37, Figure 38), 
indicating that the molecular mass had not been significantly reduced. Attempts to 
dissolve sodium chlorite treated bloodmeal were unsuccessful which could 
indicate cross-linking was occurring. 
Sodium hypochlorite treated bloodmeal was able to be dissolved whereas sodium 
hypochlorite treated RBCC and mRBCC was not. This may have been due to the 
highly aggregated bloodmeal reducing the accessibility of reactive sites for 
sodium hypochlorite. RBCC would not be as aggregated and mRBCC would have 
been denatured at the low pH. This means accessibility to reactive amino acids 
would have been easier resulting in higher amounts of cross-link formation and 
poor solubility. 
 
Figure 37: Elution profile for BM treated with sodium hypochlorite, sodium chlorate and chlorine dioxide. 
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Figure 38: Elution profile for BM treated with peracetic acid, hydrogen peroxide and copper sulphate.  
Previous studies suggested that treating proteins with oxidising agents could result 
in chain fragmentation. This was seen when treating RBCC and mRBCC with the 
decolouring agents. However, this did not occur when treating bloodmeal with the 
decolouring agents. 23% of untreated bloodmeal was below 30 kDa (Table 27). 
Treating bloodmeal with hydrogen peroxide (15%) increased the amount of 
peptides below 30 kDa to 35%. This was the only method which significantly 
increased the amount of peptides below 30 kDa. The lack of chain fragmentation 
could be due to the bloodmeal being highly aggregated which will reduce the 
ability of the decolouring chemicals to access the amino acid back bone. 
Previous studies also suggested that treating proteins with oxidising agents could 
result in aggregation due to disulphide cross-linking. All treatment methods 
appeared to produce larger molecular weight aggregates. 39% of protein in 
untreated bloodmeal was larger than 80 kDa and most treatment methods 
increased this to between 40-50%. 48% of the protein of sodium hypochlorite 
(5%) treated bloodmeal had a molecular weight greater than 80 kDa. This 
increased to 55% when the treatment strength was increased to 15% and was most 
likely caused by the higher concentration. 57% of the protein in bloodmeal treated 
with chlorine dioxide (2%) was greater than 80 kDa and this was the highest of all 
the treatment methods. 
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Table 27: Number average molecular weight, weight average molecular weight, polydispersity index and 
molecular mass distribution of decoloured bloodmeal powders. 
    Molecular Mass Distribution (kDa) 
 MN 
(kDa) 
MW 
(kDa) 
PI 1490-560 560-215 215-80 80-30 30-11 11-4 4-1.6 1.6-0.6 
Bloodmeal 139 455 3.3 0.07 0.11 0.21 0.38 0.09 0.06 0.05 0.03 
NaClO 
(5%) 
199 495 2.5 0.12 0.16 0.20 0.31 0.07 0.06 0.05 0.03 
NaClO 
(15%) 
226 556 2.5 0.14 0.18 0.23 0.34 0.04 0.04 0.02 0.01 
NaClO3 
(5%) 
218 544 2.5 0.13 0.18 0.23 0.36 0.04 0.03 0.02 0.01 
ClO2  
(2%) 
228 556 2.4 0.15 0.18 0.24 0.34 0.03 0.03 0.02 0.01 
H2O2 
(15%) 
148 497 3.4 0.08 0.13 0.17 0.27 0.11 0.11 0.08 0.05 
H2O2 
(30%) 
172 496 2.9 0.09 0.16 0.21 0.31 0.09 0.06 0.05 0.03 
PAA 
(5%) 
214 555 2.6 0.13 0.19 0.19 0.26 0.06 0.07 0.06 0.04 
PAA  
(15%) 
162 477 2.9 0.08 0.15 0.19 0.31 0.09 0.06 0.08 0.04 
CuSO4 
(5%) 
172 481 2.8 0.09 0.16 0.21 0.33 0.08 0.07 0.04 0.02 
5.3.2.3 Thermal Stability of Treated Bloodmeal 
Treating bloodmeal with sodium chlorite, hydrogen peroxide and PAA caused a 
decrease in thermal stability (Figure 39). Thermal stability can be reduced by 
reductions in stabilising interactions or molecular mass. Molecular mass analysis 
(Figure 38) showed that molecular mass was not significantly reduced for 
decoloured bloodmeal powders. Whereas XRD patterning (Figure 40) showed 
reduced peak intensities for peaks associated with alpha helices. This was seen for 
all treatment methods and was most significant for PAA treatment. In literature 
PAA has been shown to be highly reactive with the amino acid histidine, the main 
amino acid which stabilises alpha helices. Due to histidines ring structure it is 
probably easily oxidised by sodium chlorite and hydrogen peroxide as well. This 
could explain the reduction in those peak intensities when bloodmeal was treated 
with the decolouring chemicals [107]. This showed that reduction in thermal 
stability of treated bloodmeal powders was most likely caused by reduction of the 
molecular interactions that stabilise the regular structures and not by reduction in 
molecular mass. However other stabilising interactions such as disulphide cross-
linking and hydrophobic interactions were not investigated and could also be 
reduced by the decolouring treatment and cause reduction in thermal stability. 
These can also influence processing requirements and should be investigated later.  
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Thermal stability was most significantly reduced for PAA treatment which also 
showed the greatest reduction in structure. In literature PAA has been shown to 
reduce disulphide cross-links which could also be a contributing factor [138]. The 
low pH of PAA can cause the haem to dissociate from the globin which also leads 
to reduced thermal stability as has previously been shown (Figure 34). These 
additional factors could also be contributing to the reduction in thermal stability 
caused by PAA treatment and are investigated further in Chapter Six. PAA 
contains acetic acid which can cause swelling of proteins [139]. This may increase 
decolouring effectiveness because of improved access to the haem porphyrin. This 
may also help remove odour compounds trapped between chains because it gives 
access to them where as hydrogen peroxide and sodium chlorite could not reach 
them. However this could also improve access to stabilising amino acids which 
could explain why PAA had a significant effect on structure whereas hydrogen 
peroxide and sodium chlorite did not. 
Sodium chlorite treated bloodmeal initially showed a similar degradation profile 
to untreated bloodmeal and hydrogen peroxide treated bloodmeal. However at  
350°C its rate of mass loss decreased. This was also seen for RBCC and mRBCC 
treated with sodium chlorite. This temperature range is usually associated with 
cross link degradation [7]. This confirmed that sodium chlorite treatment resulted 
in the formation of some disulphide cross-links. 
 
Figure 39: Thermal stability of hydrogen peroxide, sodium chlorite and peracetic acid treated bloodmeal. 
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Table 28: Percentage mass loss at 0-150°C and 230-400°C for decoloured bloodmeal powders. 
Region Bloodmeal H2O2 (5%) 
treated 
Bloodmeal 
H2O2 (30%)  
treated  
Bloodmeal 
NaClO2 (5%) 
treated 
Bloodmeal 
PAA (5%) 
treated 
Bloodmeal 
0-150°C 4 11 11 9 5 
230-400°C 40 38 36 37 38 
400°C Thermal Decomposition 
It was interesting that sodium chlorite treated RBCC and mRBCC was still 
soluble whereas sodium chlorite treated bloodmeal was not. All three had similar 
thermal stability profiles which indicated the presence of cross-links. This 
suggested RBCC and mRBCC were soluble probably due to its decreased 
molecular mass. The other decolouring treatments had little effect on bloodmeal 
molecular weight. It is possible that sodium chlorite also did not reduce molecular 
weight but may have formed larger aggregates as shown by TGA, which would 
further reduce the solubility of bloodmeal after being treated with sodium chlorite. 
5.3.2.4 XRD Patterning of Treated Bloodmeal 
XRD analysis showed a slight reduction in the regular structure of hydrogen 
peroxide and sodium chlorite treated bloodmeal. PAA treatment appeared to have 
a more significant effect on structure than hydrogen peroxide and sodium chlorite 
(Figure 40). This was probably because PAA is a stronger oxidant than hydrogen 
peroxide and sodium chlorite. Another factor could be that bloodmeal is highly 
aggregated which could have prevented the sodium chlorite and hydrogen 
peroxide from reaching the amino acids responsible for stabilising structure, 
whereas PAA contains acetic acid which can cause swelling which will have 
increased access to the stabilising amino acids. 
PAA is a strong oxidising agent capable of peptide cleavage as well as side chain 
modification. Chromatography results showed that molecular mass was not 
significantly reduced, whereas XRD analysis indicated a reduction in structure. 
This suggested that PAA was acting on the side groups of the protein, causing it to 
lose its structure but was not cleaving the protein into smaller chains. 
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Figure 40: XRD plots of hydrogen peroxide, sodium chlorite and peracetic acid treated bloodmeal. 
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5.3.2.5 Suitability of Decoloured Bloodmeal for Bioplastics 
Treating bloodmeal with sodium chlorite, hydrogen peroxide and PAA did not 
cause as severe reductions in molecular mass, interactions or thermal stability 
when compared to RBCC and mRBCC. This could be due to RBCC and mRBCC 
not being as cross-linked or aggregated as the dried bloodmeal making them more 
accessible to the decolouring chemicals. Also when mRBCC was lowered to pH 2 
the proteins may be slightly unwound exposing more amino acids making them 
more susceptible to modification or damage. 
Treating bloodmeal with sodium chlorite, hydrogen peroxide and PAA could 
potentially be used to produce a bioplastic feedstock. These methods were quick, 
simple and removed the colour and smell from bloodmeal. 
In a previous study gas chromatography of decoloured bloodmeal powders 
showed that for hydrogen peroxide treated bloodmeal the odour compounds 1-
octen-3-ol, phenol 4-methyl phenol, indole and methyl indole were no longer 
present, which suggests they were oxidised. However when prepared into a pre-
extrusion mixture, 4 methyl phenol, indole, methyl indole returned. It was 
suggested that some of the compounds were oxidised and some were trapped 
between chains and became free when plasticisers were added [18]. 
The study also showed increased quantities of amino acid oxidation products such 
as hexanal, heptanone and heptanal for sodium chlorite treated bloodmeal. It also 
revealed the presence of esters. Ester formation can be initiated by formation of 
alkyl chlorides which may indicate chlorination is occurring during sodium 
chlorite treatment. When pre-extrusion mixtures were produced using sodium 
chlorite treated bloodmeal the smell returned again. This could be similar to 
hydrogen peroxide treated bloodmeal when some of the compounds were oxidised 
and some were trapped between chains and became free when plasticisers were 
added [18]. The study also analysed PAA treated bloodmeal and found that it 
removed 1-octen-3-ol, phenol, 4-methyl phenol, indole and methyl indole. PAA 
treatment was the most effective method at oxidising putrefaction compounds as 
shown by gas chromatography. In addition the bloodmeal smell didn’t return 
when pre-extrusion mixtures were produced, although a vinegar smell was 
observed most probably due to acetic acid or acetylation of the protein [18].  
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PAA may have been more effective at oxidising the odour compounds trapped 
between the chains because it causes swelling of proteins and can act as a 
plasticiser. This would have provided better access to the odour compounds 
trapped within the chains allowing them to be oxidised more efficiently (Figure 
41). 
  
Figure 41: Acetic acid increasing access of colour and odour removing chemical to haem and odour 
compounds (left). Reduced access to haem and odour compounds due to aggregation (right). 
5.3.3 Ranking Methods Based on Powder Properties 
The methods were ranked by combining the results for colour removal, smell 
modification, simplicity, speed and environmental friendliness of process and 
effects on protein molecular weight (Table 29). Although XRD patterning and 
thermal stability was also investigated for some treatment methods as an 
indication of possible molecular interactions, these were not included in the 
ranking system because molecular interactions can potentially be reduced or 
increased during processing with the use of additives as discussed later in Chapter 
Seven. Points were assigned to each component and the methods were ranked 
based on the highest total score. The points were assigned as follows: 
 Colour: Max 100 
o Points assigned were equal to percentage whiteness. 
o E.g. untreated bloodmeal is 19 % white and is assigned 19 points. 
 Smell: Max 100 
o If the smell was improved-100 points. 
o If the smell was not improved-0 points. 
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 Simplicity of process: Max 100 
o If the process was simple i.e. low volumes of feedstocks being 
handled and few processing steps-100 points. 
o If the process required handling high volumes of feedstocks and 
many processing steps (diluting, pH adjustment, centrifuging etc.)-
0 points. 
 Speed: Max 100 
o If colour and odour removal occurred within 5 minutes-100 points. 
o If colour and odour removal took longer than 5 minutes-0 points. 
 Environmental Friendliness: Max 100 
o If there were no environmental concerns-100 points 
o If there were environmental concerns-0points  
 Molecular Weight: Max 100 
o If the molecular mass was not significantly reduced based on gel 
elution profiles and number average molecular weight-100 points. 
o If the molecular mass was significantly reduced based on gel 
elution profiles and number average molecular weight-0 points. 
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Table 29: RBCC and bloodmeal treatment methods ranked based on colour, smell and molecular weight. 
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1 BM PAA (15%) Yes 76 100 100 100 100 100 576 
2 BM PAA (5%) Yes 67 100 100 100 100 100 567 
3 BM H202 (30%) Yes 59 100 100 100 100 100 559 
4 BM H2O2 (15%) No 57 0 100 100 100 100 457 
5 BM H2O2 (5%) No 45 0 100 100 100 100 445 
6 RBCC PAA (5%) Yes 91 100 0 100 100 0 391 
7 mRBCC PAA (5%) Yes 87 100 0 100 100 0 387 
8 RBCC H2O2 (30%) Yes 71 100 0 100 100 0 371 
9 mRBCC H2O2 (30%) Yes 55 100 0 0 100 100 355 
10 BM Untreated No 19 0 100 0 100 100 319 
11 BM Distilled Water No 18 0 100 0 100 100 318 
12 BM NaClO2 (5%) Yes 31 100 100 0 0 N/A 231 
13 RBCC Untreated No 29 0 0 0 100 100 229 
14 mRBCC Untreated No 25 0 0 0 100 100 225 
15 BM ClO2 (2%) No 18 0 100 0 0 100 218 
16 BM CuSO4 (5%) No 18 0 100 0 0 100 218 
17 mRBCC NaClO2 (5%) Yes 93 100 0 0 0 0 193 
18 RBCC NaClO2 (5%) Yes 61 100 0 0 0 0 161 
19 RBCC ClO2 (2%) No 33 0 0 0 0 100 133 
20 RBCC CuSO4 (5%) No 30 0 0 0 0 100 130 
21 mRBCC CuSO4 (5%) No 26 0 0 0 0 100 126 
22 RBCC NaClO3 (5%) No 26 0 0 0 0 100 126 
23 mRBCC ClO2 (2%) No 25 0 0 0 0 100 125 
24 mRBCC NaClO3 (5%) No 22 0 0 0 0 100 122 
25 BM NaClO (5%) No 19 0 100 0 0 N/A 119 
26 BM NaClO (10%) No 19 0 100 0 0 N/A 119 
27 BM NaClO3 (5%) No 19 0 100 0 0 N/A 119 
28 BM NaClO (15%) No 18 0 100 0 0 N/A 118 
29 RBCC NaClO (15%) No 61 0 0 0 0 N/A 61 
30 RBCC NaClO (10%) No 59 0 0 0 0 N/A 59 
31 RBCC NaClO (5%) No 55 0 0 0 0 N/A 55 
32 mRBCC NaClO (10%) No 44 0 0 0 0 N/A 44 
33 mRBCC NaClO (5%) No 44 0 0 0 0 N/A 44 
34 mRBCC NaClO (15%) No 43 0 0 0 0 N/A 43 
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Although sodium chlorite treatment of mRBCC produced a 93% white powder 
this method was not able to be used because the molecular weight of the protein 
had been greatly reduced (Figure 31). Sodium chlorite was also effective for 
treating bloodmeal. However the powder could not be dissolved using sodium 
sulphite SDS, suggesting cross-links had increased as a result of treatment. Also 
when processed into a pre-extrusion mixture the odour returned, this is discussed 
further in Chapter Eight. Using sodium chlorite also had environmental issues 
because there was the potential for chlorinated organic compounds to be 
produced. 
Many of the RBCC, mRBCC and bloodmeal decolourisation methods had 
disadvantages associated with them. Hydrogen peroxide treatment of mRBCC 
required large volumes of water and long processing times. Sodium chlorite 
treatment of mRBCC reduced the proteins molecular weight and also had 
potential to produce chlorinated polymer chains. Treating RBCC and mRBCC 
with PAA resulted in the formation of small molecular weight peptides. This 
meant these methods were not applicable in the bioplastic process because of their 
high costs, reduction in protein molecular weight or formation of harmful by-
products. 
PAA treatment of bloodmeal was found to have the most potential for use in 
producing bioplastics because it removed the colour and smell from bloodmeal 
quickly without significantly reducing its molecular weight. Compared to other 
methods described in literature (organic solvents, enzymes etc.) PAA treatment 
was much faster with decolourisation occurring within minutes and was more 
environmentally friendly. Another advantage of this process was that it was 
relatively simple. Studies which investigated using PAA in wastewater and 
sanitising applications did not identify any harmful disinfection by-products and 
also found that PAA decomposes into water and acetic acid [113, 120].  
When PAA treated bloodmeal was processed into a pre-extrusion mixture the 
odour did not return whereas for sodium chlorite and hydrogen peroxide treated 
bloodmeal it did. However a vinegar odour was observed for PAA treated 
bloodmeal because of the acetic acid. Structure and thermal stability were reduced 
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by PAA treatment and this should be further investigated with relation to its 
ability to be processed. 
Although 15% PAA treatment was ranked first it was not considered for use in 
bioplastic feedstock production. This was because it would be too expensive and 
dangerous to use such as high concentration of PAA. There was also very little 
improvement in colour when compared to 5% PAA treatment. Therefore 1-5% 
PAA treatment was chosen to be investigated further. 
PAA treatment requires cooling for the reaction vessel because heat was produced 
during the decolourisation treatment. The heat was caused by PAA reacting with 
the bloodmeal as well as PAA decomposition. The amount of heat generated 
increased as the amount of bloodmeal being treated increased. Temperatures up to 
100°C were reached, but could be controlled with water or ice without affecting 
the rate of colour removal. Large batches would require sufficient cooling and 
stirring to maintain the temperature at safe working limits and also to protect the 
protein from thermal hydrolysis. On a large scale heat removed by cooling water 
could be cycled around the processing plant for use in other areas. 
The reaction vessel must also be vented to allow the release of gases given off 
during the decolourisation treatment. The main gases produced are oxygen and 
carbon dioxide. These must be vented to prevent over pressurisation of the 
reaction vessel. 
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5.4 Conclusion 
Sodium hypochlorite, sodium chlorate, chlorine dioxide and copper sulphate did 
not remove colour and odour from RBCC, mRBCC or bloodmeal. Whereas 
sodium chlorite, hydrogen peroxide and PAA removed the colour and smell from 
RBCC, mRBCC and bloodmeal. 
Treating RBCC and mRBCC with sodium chlorite, hydrogen peroxide and PAA 
was not suitable for bioplastic production because they reduced molecular weight 
and had potential to form harmful by-products. Treating mRBCC with hydrogen 
peroxide did not reduce molecular weight but required long processing times and 
large volumes of water which would not be desirable for a large scale process. 
Treating bloodmeal with sodium chlorite, hydrogen peroxide and PAA produced 
decoloured and deodorised powders without decreased molecular weights. 
Treating bloodmeal with hydrogen peroxide (30%), PAA (5%) and sodium 
chlorite (5%) produced 59, 67 and 31% white powders respectively and also 
removed the odour. Gas chromatography done in a separate study showed PAA 
removed the most odour causing compounds [18]. It also found that when pre-
extrusion mixtures were produced some of the original odour returned for 
hydrogen peroxide and sodium chlorite treated bloodmeal but not for PAA treated 
bloodmeal. In addition, treating bloodmeal with sodium chlorite could also form 
chlorinated compounds. Therefore, it was concluded that PAA had the most 
potential for use in a bioplastics because it removed colour and odour efficiently 
and was also environmentally friendly. However before this was possible further 
research into how PAA treatment affected bloodmeal properties was required. 
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Peracetic Acid and Bloodmeal 
 
 
Peracetic acid molecule. 
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6.1 Chapter Overview 
In Chapter Five it was found that treating bloodmeal with PAA had the most 
potential for producing a bioplastic feedstock. However PAA treatment could also 
have effects on molecular weight, structure and interactions which could influence 
processing, consolidation and mechanical properties. No previous work has been 
done involving treating bloodmeal with PAA for use in a bioplastic. Therefore 
this chapter investigated how PAA treatment affected the properties of bloodmeal 
using gel chromatography, thermogravimetric analysis, dynamic mechanical 
analysis, X-ray diffraction and solubility tests. The aim of this section was to 
understand how PAA treatment affected bloodmeal molecular weight, structure 
and interactions so that the information could be used later to help identify what 
additives and conditions were required for processing decoloured bloodmeal into 
a bioplastic. 
It was found that PAA oxidised the haem porphyrin and odour compounds 
resulting in colour and odour removal. 1 and 2% PAA treatment produced 47 and 
55% white powders respectively but did not remove odour completely. 3% PAA 
treatment produced a 63% white powder and was the lowest concentration which 
removed the odour from bloodmeal. 4 and 5% PAA treated bloodmeal produced 
64 and 67% white powders respectively. 
Gel chromatography indicated that 23% of the protein in untreated bloodmeal was 
below 30 kDa, whereas 22-25% of the protein in 1-5% PAA treated bloodmeal 
was below 30 kDa. These results showed that PAA treatment did not greatly 
reduce the molecular weight of bloodmeal. However, increasing PAA treatment 
concentration from 1-5% decreased bloodmeal crystallinity from 35-27%. 
Thermal stability and glass transition temperature also decreased and in addition 
solubility in phosphate buffer, 1% SDS and 1% sodium sulphite increased. 
Results indicated that PAA at low concentrations (1-2%) reacted preferentially 
with haem, odour compounds and disulphide cross-links due to its high affinity 
for conjugated compounds. When the concentration of PAA was increased above 
3% the concentration was high enough to increase reactions with amino acid side 
chains causing a reduction in stabilising forces such as hydrogen bonding and 
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hydrophobic interactions which lead to decreased crystallinity, thermal stability 
and glass transition temperatures. 
When PAA treated bloodmeal was compared to Pre-extruded Novatein 
Thermoplastic Protein (PNTP, bloodmeal mixed with urea, SDS, sodium sulphite, 
TEG, water) using XRD, TGA and DMA they had similar results. This showed 
that PAA treatment had a similar effect on bloodmeal structure and interactions as 
urea, SDS and sodium sulphite.  
These results showed that 3-5% PAA treated bloodmeal could potentially be 
processed into a bioplastic. Because many of the stabilising interactions originally 
in bloodmeal were removed by PAA treatment, when processing these powders 
urea, SDS and sodium sulphite may be required at lower amounts or may no 
longer be required at all. 
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6.2 Experimental 
6.2.1 Aim 
The aim of this section was to investigate how different PAA treatment strengths 
affected the molecular and thermal properties of bloodmeal protein so that this 
information could be used to aid processing. More specifically its effect on 
molecular weight, crystallinity, thermal stability, glass transition temperature and 
solubility were investigated (Figure 42). 
 
Figure 42: Experimental summary. Possible effects of PAA treatment and methods used to investigate them. 
6.2.2 Methods and Materials 
6.2.2.1 Peracetic Acid Treatment of Bloodmeal 
Decoloured bloodmeal powders were produced for analysis by treating 100 g 
bloodmeal with 300 g PAA solution (1-5% concentration w/w). After 5 minutes 
of continuous mixing 300 g distilled water was added to form a slurry which was 
then filtered to remove acetic acid and unreacted PAA. Any remaining acetic acid 
was neutralised by submerging the filtered and treated bloodmeal in 300 g 
distilled water and adjusting to pH 7 by adding 1 mol/L sodium hydroxide 
solution. The slurry was filtered, washed, frozen and freeze dried overnight using 
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a Labconco Freezone 2.5 freeze dryer to 5-8% moisture. They were then ground 
using a bench top grinder and sieved using a 700 m sieve. 
6.2.2.2 Powder Analysis Methods 
Molecular mass, powder colour, smell, and thermal stability analysis was carried 
out as described in Chapter Four and Chapter Five. 
6.2.2.3 X-ray diffraction 
Crystallinity was investigated using X-ray diffraction as described in Chapter 
Five. In addition the data was baseline corrected from 5-60 ° and an amorphous 
halo was fit to this region (Figure 43). Peaks identified at 9.5 and 20° were 
assigned to inter-helical packing and the alpha helical backbone based on values 
found in literature [137]. In addition peaks were also identified at 24 and 40°. 
These were assigned to beta sheets based on calculations for expected structural 
spacing and previous values identified in literature [46, 140]. The percent 
crystallinity was calculated by finding the area between the corrected XRD plot 
and the amorphous halo then dividing by the total area. 
 
Figure 43: Example of a corrected XRD plot showing the amorphous halo and assigned peak locations. 
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6.2.2.4 Dynamic Mechanical Analysis 
The glass transition temperature is where the amorphous regions of a polymer 
transition from a glassy brittle state to a rubbery flexible state. The glass transition 
is affected by the ability of the proteins chains to move past each other. Therefore 
changes in interactions cross-linking and hydrophobic interaction will alter the 
glass transition temperature. Glass transition temperature of PAA treated 
bloodmeal was investigated using dynamic mechanical analysis to investigate 
changes in stabilising interactions such as cross-linking, hydrogen bonding and 
hydrophobic interactions caused by PAA treatment. 
Dynamic mechanical analysis (DMA) of PAA treated powders was carried out 
using a Perkin Elmer DMA8000. Approximately 50 mg of PAA treated powders 
were placed inside a stainless steel powder pocket (Perkin Elmer) and mounted in 
single cantilever mode. The sample was cooled to below -150°C using a cryo gun 
and liquid nitrogen, then heated from -150°C to 250°C at 2°C per minute and 
oscillated at frequencies of 1, 10 and 30 Hz. Glass transition temperatures were 
indicated by a peak in the Tan Delta (measure of mechanical damping) which was 
calculated based on the amount of lost and recovered energy during oscillation 
(Figure 44). 
 
Figure 44: Calculation of Tan Delta from the loss and elastic modulus. 
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6.2.2.5 Solubility 
The solubility of PAA treated bloodmeal was tested in phosphate buffer (pH 7), 
phosphate buffer with 1% SDS, phosphate buffer with 1% sodium sulphite and 
phosphate buffer with combined 1% SDS and 1% sodium sulphite. Solubility in 
phosphate buffer and phosphate buffer with 1% sodium sulphite was used to 
investigate changes in disulphide cross-linking. Solubility in phosphate buffer 
with 1% SDS was used to investigate changes in hydrophobic interactions. 
Solubility in phosphate buffer with 1% SDS and 1% sodium sulphite was used to 
investigate how SDS and sodium sulphite will affect the PAA treated bloodmeal. 
1g of PAA treated bloodmeal was dissolved in 5 mL of buffer and heated to 60, 
80 and 100°C for 80 minutes. The samples were centrifuged at 4000 rpm for 10 
minutes and decanted. The pellets were washed with 20 mL of distilled water, 
centrifuged and decanted again. They were then dried at 110°C overnight and the 
soluble fraction calculated based on change in solids content. 
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6.3 Results and Discussion 
6.3.1 Analysing Peracetic Acid Treated Bloodmeal 
6.3.1.1 Peracetic Acid Treated Bloodmeal Colour 
When bloodmeal was treated with PAA, colour removal occurred almost 
instantaneously. If the decoloured mixture was left for longer periods of time no 
increase in colour removal occurred. Therefore a reaction time of five minutes 
was used. When treating bloodmeal with 1 and 2% PAA the temperature of the 
mixture reached 60-70°C. At 3, 4 and 5% PAA concentration the temperature 
reached a maximum of 100°C. However it was found that this could be reduced 
using ice without slowing the rate of colour removal. Increased swelling of the 
bloodmeal protein was also observed at 5% PAA and it was difficult to filter the 
decoloured slurry. This was probably due to the higher acetic acid content of the 
5% mixture. 
PAA has been shown to remove colour by breaking the double bonds in colour 
compounds [141]. Its action on haem is probably similar. It would first have to 
break the tetrapyrole structure and then remove one of the double bonds which 
results in the yellow colour (Figure 6, Figure 7). Untreated bloodmeal is 19% 
white, treating bloodmeal with 1 and 2% PAA resulted in 47 and 55% white 
powders, but the odour was not removed (Table 30). Odour was removed at 3% 
PAA and at this concentration percent whiteness reached a plateau (Figure 45). 
Even 15 % PAA treatment only increased whiteness by a small amount to 76% as 
shown in Chapter Five. This indicated that above 3% PAA treatment most of the 
haem and odour compounds are degraded and is the lowest possible treatment 
strength able to be used for bioplastic production. 
Table 30: Effect of different peracetic acid treatment strengths on bloodmeal colour and smell. 
Treatment Method L* R G B Whiteness (%) Colour Smell 
Modified? 
Untreated 20 61 45 42 19 
 
No 
PAA (1%) 54 155 124 79 47 
 
No 
PAA (2%) 64 182 149 91 55 
 
No 
PAA (3%) 72 206 172 103 63 
 
Yes 
PAA (4%) 74 208 178 104 64 
 
Yes 
PAA (5%) 77 215 187 111 67 
 
Yes 
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Figure 45: Percent whiteness of bloodmeal treated with 1-5% peracetic acid. 
6.3.1.2 Peracetic Acid Treated Bloodmeal Molecular Mass 
No significant change in peak locations were seen for PAA treated bloodmeal 
indicating molecular mass was not significantly reduced (Figure 46). At 4 and 5% 
PAA a small peak started to appear below 1.13 kDa although this was very small 
in comparison and outside of the column limits. Literature has shown that treating 
other proteins such as casein with PAA also resulted in no aggregation or protein 
back bone fragmentation [109]. This indicated that PAA may have preferred to 
react with other readily available components such as haem and odour compounds 
instead of the protein backbone. 
Treating bloodmeal with PAA increased the number average molecular weight 
from 139 kDa to about 200 kDa depending on treatment strength. No trend was 
identified between PAA treatment strength and number average molecular weight. 
Most importantly PAA treatment did not result in the formation of small 
molecular weight compounds. 23% of untreated bloodmeal was below 30 kDa, 
whereas 22-25% of 1-5% PAA treated bloodmeal was below 30 kDa (Table 31). 
The increased number average molecular weight could be due to disulphide cross-
link formation, however if this happened a decrease in solubility and increase in 
thermal stability would be expected. This was investigated later in this chapter. 
The apparent increase in molecular mass was most likely caused by PAA 
treatment breaking disulphide cross-links and making a higher proportion of the 
longer chains soluble. 
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Figure 46: Elution profile for bloodmeal treated with 1-5% peracetic acid. 
Table 31: Number average molecular weight, weight average molecular weight, polydispersity index and 
molecular mass distribution of PAA treated bloodmeal powders. 
    Molecular Mass Distribution (kDa) 
 MN 
(kDa) 
MW 
(kDa) 
PI 1490-560 560-215 215-80 80-30 30-11 11-4 4-1.6 1.6-0.6 
Bloodmeal 139 455 3.3 0.07 0.11 0.21 0.38 0.09 0.06 0.05 0.03 
1% PAA 190 542 2.8 0.12 0.15 0.20 0.31 0.07 0.06 0.06 0.03 
2% PAA 223 590 2.6 0.15 0.17 0.19 0.29 0.07 0.06 0.05 0.02 
3% PAA 206 549 2.7 0.12 0.18 0.20 0.30 0.07 0.06 0.05 0.02 
4% PAA 210 556 2.7 0.13 0.18 0.19 0.25 0.07 0.07 0.08 0.03 
5% PAA 214 555 2.6 0.13 0.19 0.19 0.26 0.06 0.07 0.06 0.04 
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6.3.1.3 Peracetic Acid Treated Bloodmeal Crystallinity 
XRD results showed that untreated bloodmeal (Figure 47) was 35% crystalline. 
This was reduced to 31-27% when treated with 1-5% PAA (Figure 48 to Figure 
52). These results showed that when PAA treatment concentration increased 
crystallinity decreased (Table 32). This could indicate a reduction in stabilising 
interactions such as hydrogen bonding which are responsible for stabilising 
regular structure. 
Methionine is one of the most common amino acids in alpha helices. [46]. Alpha 
helices are common in bloodmeal and contribute to its crystallinity. Due to its 
structure methionine is highly susceptible to oxidation [125, 126, 129]. Proline is 
usually found on the outside of alpha helices and is responsible for turns [46]. Its 
structure and location mean that it could also be susceptible to PAA oxidation. It 
contributes to the overall alpha helical structure but not to stabilisation because it 
cannot form hydrogen bonds. As treatment concentration increased, crystallinity 
decreased as expected due to the higher concentration probably modifying the 
methionine side groups and removing the alpha helix stabilising hydrogen bonds. 
Oxidation of proline may be contributing a small amount to structure loss due to 
loss of turns or bends. 
As expected 1 and 2% PAA treatment resulted in a small reduction in crystallinity 
due to their weak concentration. 5% reduced the crystallinity the most which was 
also expected. This was probably caused by its higher concentration increasing the 
reactions with amino acid side chains, therefore reducing the amount of structure 
stabilising interactions and leading to destabilised structures and reduced 
crystallinity. 
XRD plots for 1, 2 and 5% PAA treated bloodmeal showed a random spike at 
approximately 45°. These were not detected in repeat experiments and were most 
likely caused by the XRD equipment and should be ignored. 
Table 32: Calculated crystallinity of bloodmeal and PAA (1-5%) treated bloodmeal. 
 Bloodmeal 1% PAA 2% PAA 3% PAA 4% PAA 5% PAA 
Crystallinity (%) 35 31 31 29 28 27 
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Figure 47: Corrected XRD plot for bloodmeal showing peak locations. 
 
 
Figure 48: Corrected XRD plot for 1% PAA treated bloodmeal showing peak locations. 
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Figure 49: Corrected XRD plot for 2% PAA treated bloodmeal showing peak locations. 
 
 
Figure 50: Corrected XRD plot for 3% PAA treated bloodmeal showing peak locations. 
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Figure 51: Corrected XRD plot for 4% PAA treated bloodmeal showing peak locations. 
 
 
Figure 52: Corrected XRD plot for 5% PAA treated bloodmeal showing peak locations. 
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6.3.1.4 Peracetic Acid Treated Bloodmeal Thermal Stability 
TGA results showed 1 and 2% PAA treatment had a similar mass loss profile to 
untreated bloodmeal (Figure 53). Oxidation of disulphide cross-links and amino 
acid side chains has been shown to cause loss of protein stability [107]. Above 3% 
PAA concentration rate of mass loss continued to increase showing loss of 
stabilising interactions probably due to disulphide cross-link and side chain 
modification.  
It was previously shown in Chapter Five that thermal degradation of decoloured 
bloodmeal occurred in three stages. These were 0 to 150°C, 230 to 400°C and 
above 400°C. The first stage was attributed to the loss of bound water and the 
second stage to the breaking of S-S, O-N and O-O linkages. Above 400°C thermal 
decomposition is occurring through peptide bond reduction [7]. 
No significant loss in bloodmeal molecular mass was detected due to PAA 
treatment from TGA. If small molecular mass compounds had been produced, a 
complete loss of thermal stability such as that shown for sodium chlorite treated 
mRBCC (Chapter Five, Figure 34) would have been observed. Also if small 
molecular mass peptides were present an additional region of mass loss would 
have been observed at 150-230°C. This confirmed the results obtained using gel 
chromatography. 
 
Figure 53: Thermal stability of bloodmeal treated with 1-5% peracetic acid. 
 111 
 
Table 33: Percentage mass loss of PAA (1-5%) treated bloodmeal at different regions during thermal 
degradation. 
Region Bloodmeal PAA (1%) PAA (2%) PAA (3%) PAA (4%) PAA (5%)  
0-150 °C 4 7 6 7 6 5 
230-400 °C 40 37 36 39 39 38 
400 °C  Thermal Decomposition 
Another contributing factor to the reduction in thermal stability could be the pH. 
The low pH of PAA could be causing the haem group to dissociate. Removing the 
haem group destabilises the globin as shown in previous studies and earlier 
thermal stability tests in Chapter Five (Figure 34). 
6.3.1.5 Peracetic Acid Treated Bloodmeal Solubility 
Solubility trials were carried out to confirm disulphide cross-link and stabilising 
interaction reduction by PAA treatment of bloodmeal. Previous studies have used 
protein solubility in SDS as an indication of cross-linking [142]. Bloodmeal 
solubility in buffer increased linearly as PAA treatment increased (Figure 54), 
indicating that the amount of cross-links and stabilising interactions that were 
removed by PAA treatment was proportional to PAA concentration. 
 
Figure 54: 1-5% peracetic acid treated bloodmeal solubility in buffer at 60, 80 and 100°C. 
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Sodium sulphite is a reducing agent used to break disulphide crosslinks [143]. 
Sodium sulphite increased solubility by approximately 5% (depending on 
temperature) for untreated bloodmeal, 1, 2 and 3% PAA treated bloodmeal due to 
its breakage of disulphide cross-links contained in these powders (comparing 
Figure 54 and Figure 55). Above 3% PAA a plateau was reached and solubility in 
sodium sulphite (Figure 55) was roughly equal to solubility in buffer (Figure 54). 
This indicated that 3% PAA treatment may have broken the majority of disulphide 
cross-links. Bloodmeal treated with PAA concentrations above 3% did not 
increase in solubility in sodium sulphite because there may have been no 
disulphide cross-links left for it to remove. No improvement in solubility in the 
presence of sodium sulphite for treatment concentrations above 3% PAA may 
show that the use of sodium sulphite is not required when processing these 
powders into bioplastics. 
 
Figure 55: 1-5% peracetic acid treated bloodmeal solubility in sodium sulphite solution at 60, 80 and 100°C. 
Solubility could also be affected by hydrophobic interactions. SDS is an anionic 
surfactant and interacts with hydrophobic regions of proteins making them 
soluble. Untreated bloodmeal and 1-2% PAA treated bloodmeal only showed a 
small increase in solubility in the presence of SDS (comparing Figure 54 and 
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Figure 56) which indicated that they also had other interactions such as disulphide 
cross-links. For untreated bloodmeal and 1% PAA treatment a small percentage 
mass gain was obtained and this was probably due to SDS which was not removed 
during the washing stages.  
 
Figure 56: 1-5% peracetic acid treated bloodmeal solubility in sodium dodecyl sulphate solution at 60, 80 and 
100°C. 
Above 3% PAA treatment concentration, large increases in solubility were seen in 
the presence of SDS. This indicated that the majority of disulphide crosslinks 
were removed when treated with PAA concentrations above 3%. The large 
increase in 3, 4 and 5% PAA treated bloodmeal in the presence of SDS indicated 
that the remaining interactions were most likely hydrophobic interactions which 
could be reduced with SDS. Some of these interactions could have been formed 
by the drying process applied after the decolourising process. 
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By combining the solubility results for water, SDS and sodium sulphite it was 
shown that that the increase in solubility for bloodmeal treated with PAA 
concentrations up to 3% was mainly due to disulphide cross-link breakage. 
Previous studies showed that PAA reacted preferentially with conjugated systems 
and disulphide cross-links [109, 138]. At low concentrations it also appeared to 
react preferentially with the readily available haem porphyrin and odour 
compounds which are also conjugated or ring structures.  Above 3% PAA 
concentration most of the cross-links, haem and odour compounds were removed 
and the increase in solubility in buffer is due to the PAA concentration being high 
enough to increase its reaction with side chains causing it to reduce other 
interactions such as hydrogen bonding or hydrophobic interactions. 
Solubility in the presence of SDS and sodium sulphite showed large increases in 
solubility for untreated bloodmeal and 1-3% PAA treated bloodmeal (Figure 57). 
In these cases the solubility was almost equal to the solubility in SDS and sodium 
sulphite combined suggesting a cooperative effect between SDS and sodium 
sulphite at PAA concentrations up to 3%.  
Above 3% PAA treatment concentration, solubility in SDS and sodium sulphite 
plateaued. Disulphide cross-links are broken by the action of the sulphite ion 
(   
    [144]. If there were no disulphide cross-links for the sulphite ion to react 
with then it would have remained in the solution. As a result it may react 
electrostatically with SDS (both have negative charge) or act as a salting out 
agent. This result indicated that combining both SDS and sodium sulphite may be 
unsuitable for processing the 3-5% PAA treated bloodmeal into a bioplastic. 
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Figure 57: 1-5% peracetic acid treated bloodmeal solubility in sodium dodecyl sulphate/sodium sulphite 
solution at 60, 80 and 100°C. 
During solubility trials, increased swelling of powders was observed for 3-5% 
PAA treated powders. The amount of swelling was also observed to increase 
proportionally as PAA treatment concentration increased. Increased swelling is 
also used as an indication of a reduction in disulphide cross-links and other 
stabilising interaction. This observation was further evidence that PAA treatment 
reduced disulphide cross-links and stabilising interactions. 
PAA treated powders showed the highest solubility in the presence of SDS. It was 
also observed that the pellets and supernatants from SDS solubility trials (above 
3% PAA treatment) formed a consolidated film when dried, whereas pellets from 
sodium sulphite solubility trials remained a powder. This may indicate that 
successfully processing PAA treated bloodmeal into a bioplastic could be more 
dependent on SDS than sodium sulphite because PAA treated bloodmeal will be 
stabilised by more hydrophobic interactions than disulphide cross-links. 
6.3.1.6 Peracetic Acid Treated Bloodmeal Glass Transition Temperature 
DMA analysis showed bloodmeal has one main peak in Tan Delta indicating a 
glass transition at approximately 225°C (peak 1) which is typically seen in most 
proteins (Figure 58). Two smaller peaks were also seen at approximately -100°C 
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(peak 2) and 50°C (peak 3). Peak 3 was attributed to side group motions and peak 
2 to short range interactions. 1 and 2% PAA treated bloodmeal showed a similar 
profile to untreated bloodmeal although peak 2 became larger which indicated that 
the protein was becoming more mobile possibly due to reduction in stabilising 
forces. 
At 3% PAA treatment peak 2 became larger and more distinct indicating another 
lower glass transition temperature. Reduction in glass transition temperature can 
be an indication of reduction in disulphide cross-links and other intermolecular 
interactions. The larger peak 2 of 3% PAA treated bloodmeal could be due to 
regions of low disulphide cross-linking, hydrogen bonding and hydrophobic 
interactions. Some stabilising interactions may still have been present and could 
be responsible for peak 1. 
At 4% PAA treatment peak 1 began to decrease noticeably. This was probably 
because the higher PAA concentration increased the amount of reactions with the 
amino acids which were responsible for stabilising the protein which resulted in 
increased protein mobility and a lower glass transition temperature. At 5% PAA 
treatment peak 1was almost completely gone, indicating that a significant amount 
of the original stabilising interactions in bloodmeal could have been reduced. 
These results indicated that PAA treated bloodmeal contained less stabilising 
interactions than untreated bloodmeal. The most interactions were removed when 
bloodmeal was treated with PAA concentrations above 3% as indicated by a lower 
glass transition temperature. Processing untreated bloodmeal into a bioplastic 
required that disulphide cross-links, hydrogen bonding and hydrophobic 
interactions be reduced using urea, SDS and sodium sulphite. It appeared that 
PAA treatment was completing the role of urea, SDS and sodium sulphite by 
reducing these interactions. The acetic acid in the PAA equilibrium mixture could 
also be acting as a plasticiser because it can penetrate between chains and cause 
swelling. This could also be contributing to the reduction in glass transition 
temperature. These possibilities were investigated later in this chapter by 
comparing PAA treated bloodmeal to untreated bloodmeal mixed with urea, SDS 
and sodium sulphite as well as untreated bloodmeal mixed with acetic acid. 
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Figure 58: DMA plots for bloodmeal treated with 1-5% PAA. 
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6.3.1.7 Overall Effect of Peracetic Acid Treatment on Bloodmeal 
1 and 2% PAA treatment did not completely remove the colour or odour from 
bloodmeal. 3% PAA was the minimum concentration level required for sufficient 
colour and odour removal (Table 30). After this no significant colour 
improvement was obtained as PAA concentration increased (Figure 45), which 
suggested that 3% PAA treatment was sufficient to remove the majority of the 
haem and odour causing compounds.  
No significant changes in molecular weight occurred as PAA treatment 
concentration increased (Figure 46). As the treatment concentration increased 
above 3% PAA, the treated bloodmeal began to show significantly different 
responses when analysed with XRD, TGA and DMA. XRD showed reduced 
crystallinity, TGA reduced thermal stability and DMA reduced glass transition 
temperature. This indicated a reduction in stabilising interactions due to the higher 
concentrations of PAA increasing the reactions with components which were not 
haem or odour compounds. 
Solubility analysis confirmed cross-link reduction from PAA treatment. As PAA 
treatment concentration increased so did the amount of disulphide cross-links and 
other stabilising interactions that were broken as shown by increased solubility in 
buffer (Figure 54). Non-disulphide interactions removed were probably 
hydrophobic interactions and hydrogen bonding due to the modification of 
proline, tryptophan and methionine. Solubility in SDS increased greatly at 4 and 
5% PAA treatment (Figure 56). This showed that the majority of remaining 
interactions at these concentrations were most likely hydrophobic or electrostatic 
interactions which can be reduced by SDS. 
DMA analysis showed bloodmeal had one main peak in Tan Delta at 
approximately 225 °C. 1 and 2% PAA treated bloodmeal showed a similar profile 
to untreated bloodmeal although a second peak became more distinct at 
approximately 50 °C. At 3% PAA both peak 1 and peak 2 were clearly visible.  
At 4% PAA peak 1 was reduced and at 5% PAA it disappeared indicating that a 
high amount of disulphide cross-links, hydrogen bonding and hydrophobic 
interactions were removed at these high treatment concentrations. Peak 2 was 
thought to be caused by regions of low molecular stability. Solubility data 
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suggested that this peak which becomes distinct above 3% PAA treatment was 
mainly due to disulphide cross-link breakage and the remainder of peak 1 was due 
to the remaining interactions such as hydrogen bonds, hydrophobic interactions 
and electrostatic interactions. As PAA concentration increased these interactions 
were also reduced due to the PAA most probably reacting with tryptophan, 
methionine, proline and to a lesser extent tyrosine and histidine. 
XRD plots and calculated crystallinity values showed 1 and 2% PAA treated 
bloodmeal reduced bloodmeal crystallinity from 35 to 31%. Above 3% PAA 
treatment concentration the XRD plots and calculated crystallinity showed a 
significant reduction in crystallinity (reduced from 35 to 27%) most probably 
though reduction in hydrogen bonding by modification of methionine and proline 
side chains. 
By combining the results from gel chromatography, TGA, DMA, XRD and 
solubility analysis it was concluded that at up to 3% PAA treatment 
concentrations, the PAA reacted preferentially with the haem, odour causing 
compounds and disulphide cross-links. Above 3% PAA, the concentration was 
high enough to increase the amount of reactions with the amino acid side chains 
of proline, tryptophan, methionine, tyrosine and histidine, further reducing other 
stabilising interactions such as hydrogen bonding and hydrophobic and 
electrostatic interactions. This resulted in an overall loss of regular structure and 
stability. PAA showed limited reactivity with the protein backbone with even very 
high PAA concentrations (e.g. 15%) having limited effects on molecular mass 
(Figure 38). The effect of different PAA treatment concentrations on bloodmeal 
was summarised in Table 34. 
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Table 34: Effects of different PAA treatment concentrations on bloodmeal properties. 
  Peracetic Acid Treatment Concentration 
  1% 2% 3% 4% 5% 
 
Mainly Reacted 
With 
Haem Haem Haem Haem Haem 
 Odour Compounds Odour Compounds Odour Compounds Odour Compounds Odour Compounds 
   Disulphide Cross-links Disulphide Cross-links Disulphide Cross-links 
    Side Chains Side Chains 
    Peptide Backbone Peptide Backbone 
R
e
d
u
c
ti
o
n
 I
n
 
Colour Low Low High High High 
Odour No No Yes Yes Yes 
Cross-link Low Low High High High 
Crystallinity Low Low Medium High High 
Total 
Stabilising 
Interactions 
Low Low Medium High High 
Molecular Mass Low Low Low Low Low 
 Potential to be 
Processed? 
No No Yes Yes Yes 
3-5% PAA treated bloodmeal could potentially be used for producing a bioplastic. 
However the additives, processing conditions required and material properties for 
each may be different as they had different levels of stabilising interactions. The 
processing of bloodmeal treated with all three concentrations should be 
investigated because each may have different advantages and disadvantages. 
6.3.2 Comparing Peracetic Acid Treated Bloodmeal 
to Pre-extruded Novatein Thermoplastic Protein 
Pre-extruded Novatein Thermoplastic Protein (PNTP) was produced by mixing 
water, TEG, urea, SDS and sodium sulphite with untreated bloodmeal as 
described in section 8.2.2.1. PAA is an equilibrium mixture of PAA, water, 
hydrogen peroxide and acetic acid. It was thought that acetic acid could also be 
acting as a plasticiser by interfering with hydrogen bonding or by acetylating the 
protein and contributing to the change in thermal stability and glass transition 
temperature. Untreated bloodmeal was also mixed with 6% acetic acid (same 
amount present in 4% PAA equilibrium mixture). The bloodmeal was treated with 
the acetic acid for 5 minutes then washed and filtered and neutralised using the 
same method for producing PAA treated bloodmeal. Samples were freeze dried to 
5-8% moisture. These were compared to 4% PAA treated bloodmeal to 
investigate how its processing requirements compared to untreated bloodmeal and 
also to see if acetic acid was contributing to the reduction in thermal stability and 
glass transition temperature. 
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6.3.2.1 Comparing Thermal Stability 
TGA results showed 4% PAA treated bloodmeal and (PNTP) both had reduced 
thermal stability. However in the region between 150-230°C PNTP had greater 
mass loss which was attributed to the degradation of urea from the PNTP mixture. 
In addition the region between 350-400°C for PNTP showed greater mass loss 
than 4% PAA treated bloodmeal. This could be due to the presence of sodium 
sulphite and SDS in PNTP aiding the thermal breaking of peptide bonds.  
The acetic acid treated bloodmeal displayed slightly reduced thermal stability. 
This could be due to the acidic pH causing some of the haem to dissociate from 
the protein which can reduce thermal stability as previously shown. However, the 
reduction in thermal stability is not as great as that seen when haem is removed 
from RBCC (Figure 34), probably because bloodmeal is more aggregated and has 
more stabilising interactions caused by the drying process. This result showed that 
thermal stability of bloodmeal was not significantly affected by the presence of 
acetic acid. 
 
 
Figure 59: Thermogravimetric analysis comparison of bloodmeal, PNTP, 4% peracetic acid treated 
bloodmeal and acetic acid treated bloodmeal 
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6.3.2.2 Comparing Crystallinity 
Crystallinity for PNTP and acetic acid treated bloodmeal was calculated using the 
same method as that for PAA treated bloodmeal. PNTP crystallinity was reduced 
to 33% and also showed a XRD pattern different to bloodmeal (Figure 60). 
Reduction in crystallinity was achieved by urea disrupting hydrogen bonding, 
SDS disrupting hydrophobic interactions and sodium sulphite breaking disulphide 
cross-links which can stabilise regular structure. Treating bloodmeal with 4% 
PAA resulted in a similar XRD profile to PNTP, indicating similar loss in 
crystallinity and stabilising interactions. This suggested that the existing 
combination of urea, SDS and sodium sulphite may not be suitable for processing 
3-5% PAA treated bloodmeal.  
Treating bloodmeal with acetic acid increased crystallinity to 65% and it had a 
similar XRD plot to untreated bloodmeal except the peaks were more intense. 
This suggested that acetic acid has plasticised the protein and weakened forces 
holding it in its heat denatured state allowing some of it to refold into ordered 
structures. Most importantly the result showed that acetic acid did not contribute 
to reduction in crystallinity and that the reduction in crystallinity when bloodmeal 
was treated with PAA was most likely caused by the action of PAA reacting with 
amino acid side chains as suggested previously. 
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Figure 60: XRD comparison of bloodmeal, PNTP, 4% PAA treated bloodmeal and acetic acid treated 
bloodmeal 
6.3.2.3 Comparing Glass Transition Temperature 
Acetic acid treated bloodmeal formed a small peak (peak2) in the Tan Delta at 
approximately 50°C. This could be due to the acetic acid causing the dissociation 
of haem from the protein which causes a slight reduction in the proteins stability. 
However it is most likely due to the plasticisation effect of acetic acid. Acetic acid 
has been shown to cause proteins to swell or increase free volume [139, 145]. This 
result indicated that acetic acid could be acting as a weak plasticiser. 
4% PAA treated bloodmeal had a very similar DMA profile to PNTP. Both had a 
large peak 2 at 50°C and a smaller peak 1 at 225 °C. This result indicated that 
PAA treatment was reducing the disulphide cross-links and other stabilising 
0
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0
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0
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0
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interactions such as hydrophobic interactions and hydrogen bonding to a similar 
amount as urea, sodium sulphite and SDS. Therefore, if bloodmeal were treated 
with a high enough concentration of PAA it may be possible to process it into a 
bioplastic with none or reduced amounts of urea, sodium sulphite and SDS. 
 
 
Figure 61: Dynamic mechanical analysis comparison of bloodmeal, PNTP, 4% PAA treated bloodmeal and 
acetic acid treated bloodmeal. 
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6.4 Conclusion 
Treating bloodmeal with 1, 2, 3, 4 and 5% PAA resulted in 47, 55, 63, 64, 67% 
white powders respectively. 3% PAA was the lowest concentration required to 
sufficiently remove the odour from bloodmeal. PAA has a high affinity for 
conjugated compounds and would have oxidised the haem porphyrin and odour 
compounds resulting in colour and odour removal. However PAA treatment also 
had other effects on the bloodmeal protein. 
PAA treatment reduced crystallinity, cross links, hydrogen bonding and other 
stabilising interactions as shown by XRD plots, reduced thermal stability, reduced 
glass transition temperature and increased solubility. The extent that these were 
reduced by was dependent on the concentration of PAA. Thermal stability, glass 
transition temperature and solubility of 1-2% PAA treated bloodmeal were similar 
to untreated bloodmeal. This indicated that at low concentrations, PAA reacted 
preferentially with haem, odour compounds and disulphide cross-links.  
Above 3% PAA, the concentration was high enough to increase the amount of 
reactions with other components. These were most probably the side chains of 
proline, tryptophan, methionine, tyrosine and histidine as suggested in previous 
studies. This resulted in significantly reduced crystallinity, thermal stability, glass 
transition temperature and increased solubility most probably by reducing the 
amount of disulphide cross-links and other stabilising interactions such as 
hydrogen bonding.  
PAA treatment increased the number average molecular mass from 139 kDa to 
approximately 200 kDa depending on treatment strength. From gel 
chromatography results it appeared that disulphide cross-linking occurred. 
However thermal stability, glass transition temperature were reduced and 
solubility increased which indicated disulphide cross-links did not form. The 
apparent increase in molecular mass was most likely caused by PAA treatment 
breaking disulphide cross-links and making a higher proportion of the longer 
chains soluble. Most importantly PAA treatment did not reduce molecular mass 
significantly even at 3-5% PAA concentration, which means consolidation may 
still be possible and mechanical properties may not be significantly reduced. 
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Solubility results also showed that combining SDS and sodium sulphite caused a 
reduction in solubility when compared to solubility in just SDS. This indicated 
that combining these two additives may have negative effects on processing PAA 
decoloured bloodmeal. 
When bloodmeal treated with PAA at 4% was compared to PNTP using TGA, 
XRD and DMA they had similar results. This indicated that PAA treatment was 
having a similar effect as urea, sodium sulphite and SDS by reducing stabilising 
interactions such as disulphide cross-links and hydrogen bonding. This suggested 
that the processing of PAA treated bloodmeal powders may not require urea, 
sodium sulphite and SDS or may require them at lower amounts depending on the 
concentration of PAA treatment used. Alternatively additives which increase 
interactions between protein chains may be required because PAA treatment may 
have removed too many stabilising interactions which are required for 
consolidation into a bioplastic. 
These results indicated that 3, 4 and 5% PAA could be used to produce a 
bioplastic, although their additives and processing requirements will most 
probably be different as they have different amounts of remaining stabilising 
interactions. All three PAA concentrations should be used to produce powders for 
processing trials as each powder and its bioplastic could have advantages and 
disadvantages. 
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7.1 Introduction 
Bioplastics have been around for many years. A very early example includes 
Henry Ford who incorporated soy based plastics into automobile parts [4]. Casein 
and cellulose have also been used to produce bioplastics. However, synthetic 
plastics became more common because they were cheaper and easier to produce 
and had better properties such as strength, durability and water resistance. Recent 
concern over petroleum levels and plastic waste has caused renewed interest in 
biodegradable plastics produced from renewable biopolymers. These bioplastics 
can be used in applications where their biodegradability would be an advantage 
such as disposable items and packaging.  
This chapter covers brief background information about synthetic polymers and 
common thermoplastic processing methods used to convert them into usable 
items. It then focuses more specifically on the direct conversion of biopolymers 
such as carbohydrates, proteins and polysaccharides into bioplastics using 
additives and thermoplastic processing techniques. 
7.2 Synthetic Polymers and Processing 
Plastics are materials made of high molecular weight molecules known as 
polymers [146, 147]. They are used in many applications because of their 
properties (low density, resistance to corrosion, low conductivities) and ability to 
be processed easily at relatively low temperatures [146, 147]. 
Polymers are long chains made from one or more types of repeating units called 
monomers. A polymer containing one type of monomer is a homopolymer and a 
polymer containing more than one monomer type is a copolymer [4]. Polymers 
can be linear chains, branched chains or cross-linked networks of chains (Figure 
62). 
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Figure 62: Summary of polymer structure [4, 147]. 
Synthetic polymers can be produced by addition or condensation polymerisation. 
During addition polymerisation monomers are added together by breaking double 
bonds that exist between carbon atoms. This allows them to be linked to 
neighbouring carbon atoms forming long chains [146]. An example is the 
polymerisation of polyethylene. Condensation polymerisation involves two units 
with end group components which react and bond with each other producing 
water as a molecule.  
Plastics can be categorised as a thermoplastic, thermoset or rubbery. 
Thermoplastics solidify as they cool, but when heated again can flow as the 
molecules begin to slide past each other. Thermoplastics can be either amorphous 
(disordered, Figure 63) or semi-crystalline (some sections of order, Figure 64) 
[146]. When an amorphous thermoplastic cools below its glass transition 
temperature (Tg is the temperature when material changes from hard glassy state 
to a soft rubbery state), their molecules form a random molecular structure. The 
glass transition temperature can be recognised by a drop in shear modulus or a 
peak in Tan delta during a dynamic mechanical test. Amorphous polymers are 
transparent or clear because their bond lengths are small and absorb light smaller 
than visible wavelengths [146]. 
Monomer
Tetramer
Trimer
Dimer
Oligomers (up to 100 monomers)
Crosslinked Polymer
Linear Polymer Branched Polymer
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Figure 63: Amorphous structure of plastics. 
 
 
Figure 64: Structure of semi crystalline plastics. 
 
 
Semi-crystalline thermoplastics have a melting temperature (Tm) as well as a glass 
transition temperature. Above the glass transition temperature the amorphous 
regions soften and above the melting temperature the crystalline regions melt 
(Figure 63). In semi-crystalline thermoplastics molecular arrangement of 
crystalline regions begin below the melting temperature and some molecules in 
semi-crystalline polymers which are not ordered remain in amorphous regions 
(Figure 64). Below the glass transition temperature the amorphous regions begin 
to solidify. Due to their molecular arrangement semi-crystalline polymers are 
translucent instead of transparent [146]. 
 
Thermosetting polymers solidify by a chemical curing process when the polymer 
chains form covalent crosslinks and become a network. The chains are no longer 
able to slide past each other even when heated. The cross-linked network causes 
thermosets to be brittle and have high glass transition temperatures often above 
their thermal degradation temperature [146]. Elastomers are rubbery materials that 
are slightly cross-linked. This allows them to undergo reversible deformation. 
Common thermoplastics, thermosets and elastomers are summarised in Table 35. 
  
Crystalline Regions
Amorphous Regions
 131 
 
Table 35: Properties and applications of common polymers [4, 146, 148]. 
Polymer Applications Properties 
Thermoplastics 
Amorphous   
Polystyrene Transparent products, 
packaging, insulation 
Brittle, rigid, translucent, low 
cost, easy to process 
Polyvinyl chloride Shoes, hoses, bottles, 
packaging, construction 
materials 
Durable, rigid, good 
insulator, weather proof 
Polycarbonate Helmets, head lights, 
protective equipment 
Transparent, tough, 
thermally stable 
Semi-crystalline   
High density polyethylene 
(less branching-more 
interactions) 
Milk and soap bottles, toys, 
electrical insulation 
Flexible, translucent, low 
cost easy to process 
Low density polyethylene 
(more branching-less 
interactions) 
Household products, plastic 
bags, bottles 
Low cost, tough, 
translucent, weather proof, 
easily processed 
Polypropylene Electrical appliance cases, 
automobile parts, 
containers 
Semi rigid, translucent, 
good chemical resistance 
Thermosets 
Phenolics Heat resistant applications Brittle, opaque, heat and 
chemical resistant 
Melamine Heat resistant surfaces Hard, opaque, scratch 
resistant 
Unsaturated polyester Sinks and automotive body 
parts 
Low weight, corrosion 
resistant, other properties 
are depending on additives 
used 
Elastomers 
Natural rubber Tyres and engine mounts Flexible, undergoes 
reversible deformation 
Polyurethane elastomer Seats and shoe soles Elastic, abrasion, chemical 
resistant 
Silicone rubber Seals, flexible hoses Temperature and chemical 
resistant 
 
The molecular weight distribution of a material is strongly related to its properties 
and most thermoplastic materials have a distribution similar to that shown in 
Figure 65. In general a low molecular weight results in poor strength and stiffness, 
although there are some exceptions. Increasing molecular weight increases 
strength and stiffness until the critical chain length is reached and no further 
increase in strength or stiffness occurs (Figure 66) [146]. 
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Figure 65: Molecular weight distribution of a typical thermoplastic [146]. 
 
Figure 66: Influence of molecular weight on stiffness and viscosity [146]. 
Different additives can be added to plastics to improve the physical properties or 
processing. These include processing additives (lubricants, blowing agents), 
stabilisers (antioxidant, heat and light stabilisers), performance enhancers (fibres, 
pigments, fillers) and plasticisers. Plasticisers can be mixed into a polymer to 
change its processing and mechanical properties. They reduce stiffness and glass 
transition temperature of a material by loosening the molecular structure making it 
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easier for the polymer chains to move. They are used to aid processing because 
they reduce the risk of thermal degradation [4, 146].  
Polymer processing involves converting raw polymer compounds into products of 
a desired shape. The most common methods are extrusion and injection moulding. 
Other processing methods include fibre spinning, film blowing, calendaring, 
rotational moulding and compression moulding. 
7.2.1 Extrusion 
Extruders are the most common and important machines in the plastic industry. 
Most moulding processes (e.g. injection moulding, blow moulding) also use an 
extruder [149]. Extrusion is widely used because it is a continuous process with 
high production rates. Most products are extruded twice, first to make the polymer 
pellets and again to form the final product [147]. During extrusion enough 
pressure is generated to push the molten polymer through the die so that it 
acquires the shape of the die. The main components of an extruder are the screw 
or screws, the barrel and barrel heating and cooling (Figure 67) [149]. Processing 
variables include the feed material composition, screw speed, barrel temperature 
profile, feed rates and die size/shape. These variables can influence specific 
mechanical energy input (SME, energy input into extruder per unit mass), torque, 
pressure and residence time [7]. 
 
Figure 67: Main features of a single screw extruder [146, 149]. 
 
 
Motor
Feed Hopper
Die
Material Flow
Powder ConsolidationMelt
Solids Conveying Zone
(Compacting)
Transition Zone
(Melting)
Metering Zone
(Pumping)
Heaters
Pellets or Powder
Extrudate
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Extruders can have a single screw or twin screw configuration. Twin screw 
extruders can have intermeshing or non-intermeshing screws which can be co-
rotating or counter rotating (Figure 68). 
Single screw extruders contain a screw housed in a heated barrel. The screw is the 
most important feature and performance is directly related to it. The extruder acts 
as a volumetric pump with no positive conveying action of material. The material 
moves forward due to frictional differences between the screw and barrel where 
the screw friction is less than the barrel friction. Frictional differences and 
material movement can be improved by adding grooves to the barrel [146, 147]. 
During extrusion with twin screw extruders the majority of work is done in the 
screw channel and output is proportional to the screw channel volume (volume 
between screws). Unlike single screw extruders, twin screw extruders convey the 
material by positive displacement resulting in better conveying and mixing of the 
material. They also have better melting, faster pressure build up, shorter residence 
time and can be self-cleaning due to the stresses between the two screws. 
However twin screw extruders can be more expensive, have lower head pressures 
and require a metered feeder to prevent over feeding and excessive pressures. 
Single Screw Twin Screw 
 
 
 
Single Screw 
 
Intermeshing 
Co-rotating 
 
Intermeshing 
Counter-rotating 
 
Non-
intermeshing 
Counter-rotating 
Figure 68: Single and twin screw extruder configuration [146, 147] 
7.2.2 Injection Moulding 
Injection moulding is another important and commonly used processing method 
used to manufacture plastic products into complex shapes with precise 
measurements. More than 30% of all thermoplastic materials are injection 
moulded. The main components are the plasticating unit, clamping unit and the 
mould (Figure 69) [146]. The plasticating unit is used to melt and inject the 
polymer. It is similar to a single screw extruder, except the screw is known as a 
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reciprocation screw because it is able to move backwards and forwards to allow 
accumulation and injection of the polymer melt. The clamping unit opens and 
closes the mould tightly to prevent flashing during filling. The mould distributes 
the melt and cools it into various shapes [146]. 
 
Figure 69: Basic layout of injection moulding components. 
During injection moulding the polymer is melted in the plasticating unit, injected 
at high pressure into the mould and held at pressure while cooled. When cooled 
the mould is opened, the part ejected and the process repeated. This process is 
usually automated. 
7.2.3 Compression Moulding 
Compression moulding is often used to produce automotive parts and household 
goods [146]. Compression moulding is used for both thermoplastics and 
thermosets. During compression moulding the material and additives are placed in 
a mould and heated under pressure (Figure 70). This causes the material to melt 
and conform to the mould’s shape. When processing thermoplastics using 
compression moulding they must be cooled under pressure which increases their 
processing time. 
Hydraulics Hydraulics
Check Valve
Plasticating Unit
Clamping Unit
Mould
Feed Hopper
Mould Cavity
Sprue
Nozzle
Reciprocating Screw
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Figure 70: Compression moulding press. 
7.2.4 Plastic Waste 
Producing synthetic plastic feedstocks accounts for 4-5% of oil and gas 
production. Because plastics are durable, water resistant and not susceptible to 
bacterial degradation they can persist in the environment for hundreds of years 
once discarded. Approximately 200 million tonnes of plastic are consumed 
worldwide per year [1]. Approximately 30-45% of the plastic discarded 
worldwide is plastic used for packaging or other short life span products [2-4]. In 
New Zealand 252 thousand tonnes of plastic waste is disposed to landfills each 
year [5]. Another problem is plastic litter accumulating on land and in the sea 
where it is hazardous to animals [4]. 
Incineration and recycling are methods used to reduce plastic accumulation. 
However these methods both have disadvantages. Incineration can potentially 
release toxic pollutants and does not remove dependence on non-renewable 
petrochemical resources [4, 150]. Recycling is difficult because it is labour 
(collecting, sorting) and energy intensive. Composites and laminates can also 
make some types of plastics difficult to recycle, in addition material properties 
also deteriorate after with each cycle of recycling [4]. Sometimes recycling is not 
practical due to contamination or because of the plastic type [1, 2, 4].  
As a result of increasing environmental and raw material supply concerns 
associated with petroleum based plastics, interest has increased in bioplastics 
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made from renewable resources. Bioplastics can potentially be used in a wide 
range of short life span applications such as loose fill packaging, packaging, 
disposable utensils, compost bags, disposable sporting equipment, controlled 
release systems and a variety of agricultural uses [151, 152]. Many countries are 
introducing initiatives and setting goals for future bioplastics use. Some estimates 
suggest that global bioplastics production capacity could reach 1.7 million tonnes 
by 2015, although this is still only a small percentage of all plastic production 
which is estimated to be up to 200-250 million tonnes.  
Biodegradable bioplastics can be produced using two methods. The first is 
bacterial fermentation using energy sources (e.g. glucose) to produce intracellular 
polymers such as polyhydroxyalkanoates or monomers like polylactic acid which 
require further polymerisation [153-155]. Producing plastic using this method can 
be energy intensive and expensive [150, 156, 157]. However as technology 
improves energy use and costs may decrease [4]. The second method is direct 
conversion of naturally occurring biological polymers such as carbohydrates and 
proteins into bioplastics. The following section covers bioplastics produced using 
this method. 
7.3 Bioplastics Produced from Biopolymers 
Biopolymers such as carbohydrates and proteins are widely available, nontoxic, 
biodegradable and are usually sourced from agricultural operations making them 
available in large quantities at relatively low cost [158]. This makes them 
potential feedstocks for bioplastics. However they usually require plasticisers and 
other additives to aid processing [4]. Bioplastics are “biodegradable plastics 
whose components are derived entirely or almost entirely from renewable raw 
materials” [4]. 
Bioplastics have been produced using a range of different biopolymers (Figure 
71). Various animal protein sources including egg whites, feather keratin, casein, 
whey, collagen and bloodmeal have been used [4, 142, 143, 159-161]. Also plant 
sources such as sunflower protein isolate, wheat gluten, soy protein isolate, zein, 
starch, corn gluten meal [8, 137, 142, 162-166]. In addition to this bioplastics 
from human blood plasma plasticised with water and glycerol have been produced 
[167].  
 138 
 
 
Figure 71: Examples of biodegradable polymers produced from renewable sources [4, 8]. 
The acceptance of bioplastic products by consumers is dependent on factors such 
as cost, appearance, colour, feel and smell [168]. Bioplastics can also have poor 
mechanical and permeability properties when compared to synthetic polymers [3, 
4, 169]. However these can be improved by chemical modifications, coatings, 
blends and composite formation. Additives such as reactive amino acids and 
cross-linkers such as sodium silicate, borax, formaldehyde, glutaraldehyde have 
been used to increase molecular interactions [170]. Processing of bioplastics can 
also be difficult due to the large amount of interactions and their softening 
temperatures being higher than their degradation temperatures [171]. Another 
problem associated with bioplastics is that some feedstocks (corn, soy, wheat etc.) 
are also used in food applications and biofuel production. However using by-
products such as bloodmeal could reduce reliance on petrochemical resources, 
while also avoiding competition for food and biofuel resources. 
7.3.1 Bioplastic Processing and Additives 
Solvent casting (wet), compression moulding, extrusion and injection moulding 
(thermoplastic) has been used to process bioplastics. Extrusion and injection 
moulding of bioplastics are most favourable and economically viable because they 
are already commonly used in the plastics industry [144, 172]. They also have 
relatively low processing temperatures and high production rates [168]. Twin 
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screw extruders have better mixing, conveying and shorter residence times so are 
often used for processing bioplastics because they are sometimes difficult to 
compound and have limited heat stability [150]. 
Proteins are heteropolymers made from up to 20 different amino acids in a 
specific sequence and structure of varying lengths. This means that there are a 
large number of different possible interactions between protein chains that can 
make processing difficult with only a small range of operating conditions 
available for successfully processing them into a bioplastic [144]. However, the 
range of amino acids (Table 36) and possible interactions can also be seen as an 
advantage as it means that proteins can be used to produce a range of unique 
materials. 
Table 36: Amino acid profile of some proteins used to produce bioplastics. 
 Egg 
White 
[173] 
Whey 
[173] 
Casein 
[173] 
Gelatine 
[174] 
Soy 
[173] 
Corn 
Gluten 
Meal 
[166] 
Wheat 
Gluten 
[175] 
Bloodmeal 
[55] 
Bloodmeal 
[56] 
Non-polar 
Valine 7.00 6.00 6.60 2.20 5.00 4.60 4.10 9.32 7.08 
Leucine 8.50 9.50 9.00 3.30 8.10 14.50 6.80 12.97 11.42 
Isoleucine 6.00 6.00 5.10 1.50 4.80 3.50 4.00 0.91 3.19 
Phenylalanine 6.00 2.30 5.10 2.40 5.20 4.40 4.90 7.34 6.20 
Methionine 3.60 1.90 2.70 0.70 1.30 2.20 1.80 1.01 1.10 
Tryptophan 1.40 2.20 1.30 - 1.30 0.30 1.00 - 1.22 
Alanine 6.60 5.20 2.90 8.90 4.20 11.50 2.40 7.94 7.69 
Proline 3.80 6.60 10.70 24.30 5.10 9.60 13.70 4.12 4.62 
Cysteine 2.50 2.20 0.30 - 1.30 1.70 2.10 1.08 1.24 
Glycine 3.60 2.20 2.10 21.40 4.10 4.10 3.10 4.06 4.46 
Polar 
Serine 7.30 5.40 5.60 3.60 5.20 5.50 5.20 4.03 4.08 
Threonine 4.40 6.90 4.30 2.10 3.80 3.80 2.50 4.47 3.49 
Tyrosine 2.70 2.70 5.60 0.50 3.80 3.40 3.80 2.80 2.34 
Acidic Residues 
Glutamic acid 13.50 16.80 21.50 10.00 19.00 20.30 37.30 9.08 8.79 
Aspartic acid 8.90 10.90 6.60 6.00 11.50 5.50 2.90 10.42 7.17 
Basic Residues 
Lysine 6.20 8.80 3.80 4.50 6.20 1.40 1.20 10.23 7.85 
Arginine 5.60 2.50 3.70 7.80 7.50 2.20 2.40 4.23 4.18 
Histidine 2.20 2.00 3.00 0.80 2.60 1.50 2.20 6.13 6.53 
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Consolidation of a biopolymer into a bioplastic is the detangling and flow of the 
original biopolymer allowing the reformation of new stabilising interactions 
between the biopolymer chains and the subsequent formation of a new 
homogenous bioplastic material. During thermoplastic processing several steps 
are required to form a consolidated protein network [144]. These are: 
1. Disruption of stabilising intermolecular bonds and intermolecular 
interactions using additives and plasticisers. 
2. Heating above the glass transition temperature allowing increased 
molecular movement. 
3. Applying mechanical stress to aid molecular rearrangement and form a 
homogenous blend. 
4. Formation of consolidated network where new stabilising bonds and 
interactions are formed. 
In general processing requires the formation of a melt where the material flows 
and is able to be shaped. Large amounts of interactions between protein chains 
often mean the temperature where this occurs is above the proteins degradation 
temperature. Processing at high temperatures can also lead to excessive cross-link 
formation and poor quality extrudates [142, 176]. Disruption of bonds and 
interactions are usually achieved by using additives and plasticisers (Figure 72) 
[144]. This lowers the glass transition temperature and allows the proteins to be 
processed. 
 
Figure 72: Protein interactions and action of additives. 
Reducing agents
e.g. Sodium Sulphite
Surfactants 
e.g. Sodium Dodecyl
Sulphate Denaturants e.g. Urea
Plasticisers e.g. Water, Glycerol
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Plasticisers act as lubricants by increasing chain mobility and lowering the glass 
transition temperature (Figure 73) [144]. Their hydrophilic parts interact with the 
polymer and reduce polymer-polymer interactions [177]. Plasticisers can also 
affect the mechanical properties of the material usually causing a decrease in 
resistance and stiffness but an increase in flexibility and maximum elongation 
[152]. They are usually used at concentration ranging from 10-50 % (w/w) [152]. 
Common plasticisers for bioplastics include water, glycerol, sorbitol, polyethylene 
glycol, sucrose, glucose, fructose, diethylene glycol and triethylene glycol. More 
effective plasticisers will cause a greater reduction in the glass transition 
temperature [152, 178]. A summary of common plasticisers used for bioplastics 
and their properties are given in Table 37. 
 
Figure 73: Schematic representation of the thermoplastic process applied to processing biopolymers in 
relation to glass transition and plasticiser content [179]. 
Plasticisers work by inserting between the polymer chains, acting as a molecular 
lubricant and increasing free volume [166]. Small molecules such as water and 
glycerol are more effective as plasticisers and often used in different processing 
techniques such as film blowing, extrusion, compression moulding and casting. 
Lower molecular mass molecules such as water and glycerol will be more 
effective when compared on a mass basis because each plasticiser molecule can 
interact with a protein chain. If a plasticiser has a lower molecular mass then there 
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will be more plasticiser molecules increasing plasticisation efficiency. 
Hydrophilic plasticisers will interact with polar amino acids while amphiphilic 
plasticisers will interact with hydrophobic amino acids [180]. 
Table 37: Characteristics of some commonly used plasticisers [142, 166] 
Plasticiser Molecular Mass Hydrogen Bonds Hydrophilic Groups 
(%) 
Water 18 4 100 
Sorbitol 182 18 56 
Lactic Acid 90 8 55.6 
Glycerol 92 9 55.4 
Ethylene Glycol 62 6 54.8 
Diethylene Glycol 106 8 47.2 
Propylene Glycol 76 6 44.7 
Triethylene Glycol 150 10 44.0 
1,4-butanediol 90 6 31.80 
Dibutyl Tartate 262 14 37.4 
Dibutyl Phthalate 278 4 23.5 
Octanic Acid 144 5 22.9 
Palmitic Acid 256 5 12.9 
The presence of hydrophobic interactions and cross-links prohibits processing due 
to reduced chain mobility. Sodium sulphite is a reducing agent used to break 
disulphide bonds when processing various biopolymers [9, 17, 143]. Surfactants 
such as sodium dodecyl sulphate have been used to denature and dissociate 
proteins and aid processing [178, 181]. Sodium dodecyl sulphate contains a 
hydrophobic tail and a negatively charged head. The tail interacts with a protein’s 
hydrophobic regions and the head with water. This causes the protein to become 
detangled and increases its solubility. Urea has also been used to denature and 
process proteins as it prevents protein interactions by forming hydrogen bonds 
with amino acids [182]. Urea can be used as a plasticiser but it is not as effective 
as polyol plasticisers [7]. Urea can also migrate out of the bioplastic when the 
bioplastic is stored for long periods of time. The processing of biopolymers is 
summarised in Figure 74. 
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Figure 74: Summary of processing methods for direct conversion of biopolymers into film, sheet and complex 
shaped bioplastics. 
7.3.2 Previous Studies on Processing of Biopolymers 
Many studies have investigated processing biopolymers from agricultural sources 
into bioplastics [8]. Corn, wheat, sunflower protein isolate, soy protein isolate, 
casein, agar, feathers, egg white and bloodmeal are example biopolymers which 
have been studied [8, 9, 143, 159, 163, 183-185]. In addition one study was 
identified where human blood plasma was used to produce a bioplastic [167]. 
Selections of previous studies are outlined in this section and the mechanical 
properties of bioplastics produced from different biopolymer sources summarised 
in Table 38. 
Jerez et al (2007) compression moulded egg white protein which was plasticised 
with glycerol at 60, 90 and 120°C under 0-12 kpsi of pressure. They compared 
this to wheat gluten plasticised with glycerol and concluded that egg white protein 
was easier to process and required less severe thermo-processing conditions. In 
addition they saw that at high pressures larger aggregates were formed, indicating 
that pressure can cause an increase in intermolecular cross-linking. They also 
suggested that compression moulding results could be used to help optimise other 
thermo-processing techniques such as extrusion [159]. 
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Gonzalez-Gutierrez et al (2010) produced bioplastics from albumen blended with 
wheat gluten, potato starch and corn starch (0-30% w/w) with glycerol as the 
plasticiser (37.5% w/w). The material was compression moulded at 120°C, with 
10 MPa pressure for 10 minutes. When compared to linear low density 
polyethylene the produced bioplastics had much lower tensile strengths and 
elongations. They also found that starch addition reduced mechanical properties 
of the protein bioplastics [160]. 
Lagrain et al (2010) reviewed the use of wheat gluten in bioplastics. They found 
that aggregation during thermo-processing occurs through inter and intra protein 
chain covalent cross-linking. They suggested that in addition to temperature, 
pressure and mechanical shear was important because they increased the 
molecular mobility of the protein chains and increased the amount of reactive sites 
available for cross-linking. Due to the large number of possible cross-linking 
reactions which will increase viscosity and restrict processing, they suggested that 
successfully extruding wheat gluten was only possible in a small window of 
processing conditions and at relatively low temperatures (80-130°C). 
Plasticisation with water, glycerol, polyols, oligosaccharides or lactic acid was 
recommended [6]. 
Redl et al (1999) extruded wheat gluten plasticised with glycerol using a co-
rotating twin screw extruder with three heating zones which were varied between 
60-140°C and screw speed between 50-200 rpm. The extruder was fitted with a 
converging die with diameters 19, 8 and 5 mm. They found that when the severity 
of the processing conditions were kept low (low rpm and temperature), extrudate 
surfaces were smooth. Increasing the severity of the processing conditions caused 
increased network formation due to covalent cross-linking. This resulted in 
reduced chain mobility and disrupted or poor quality extrudates [186]. 
Mo and Sun (2000) compression moulded (140°C, 20 MPa, 5 minutes) soy 
protein isolate which had been modified using SDS (0-10% w/w). They found that 
at up to 1% SDS, strength increased and suggested that the partially unfolded soy 
protein increased the amount of surface area for interactions between side groups 
as well as increased the amount of chain entanglements formed during thermo-
processing which lead to improved strength. At high SDS levels (e.g. 10%) the 
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strength decreased and it was suggested that the high SDS levels disrupted the 
protein matrix and also reduced the interactions between the protein chains. They 
also found that Young’s modulus decreased with increasing SDS concentration, 
therefore indicating that SDS was acting as a plasticiser. The plasticising effect of 
SDS was also observed in other studies [178]. 
Biopolymers sourced from agricultural rendering operations are attractive 
feedstocks for producing bioplastics because they are cheap, readily available in 
large quantities and do not compete with the human food and biofuel industries. 
Feathermeal and feather keratin are readily available low cost rendering products 
which are used as animal feed [143, 185]. Feathermeal is insoluble and stabilised 
by disulphide cross-links; therefore it must be processed under higher 
temperatures and pressures or with additives such as sodium sulphite to remove 
the cross-links. Sharma et al (2008) compression moulded hexane defatted 
feathermeal (150°C, 20 MPa, 5 minutes). They found that after processing, 
irreversible rearrangement of the protein occurred and suggested that heat and 
pressure could contribute to the formation of new structures during plastic 
processing [185]. 
The main problem with compression moulding is that it is not a continuous 
process and will have lower productivities when compared to extrusion. Barone et 
al (2006) extruded feather keratin (50-60% w/w) blended with water (8-18% 
w/w), sodium sulphite (2-6% w/w) and glycerol (10-30% w/w). Extrusion was 
carried out using a single screw extruder heated to between 100-140°C. The 
extruder was fitted with a 0.5 mm slit die. They found that increasing sodium 
sulphite concentration increased the amount of disulphide cross-links broken. 
They also found that processing with higher sodium sulphite concentrations 
resulted in increased crystallinity of the bioplastic and suggested this was due to 
breaking of the disulphide cross-links freeing the keratin chains and allowing 
them to rearrange during processing [143]. 
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Bloodmeal is another rendering product which has been used to produce a 
bioplastic [7, 9, 17]. Verbeek and van den Berg (2011) extruded bloodmeal which 
had been blended with water, sodium sulphite, SDS and urea. Extrusion was 
carried out using a twin screw extruder with screw speed 150 rpm, 4 heating 
zones at 70, 100, 100, 100°C and a 10 mm die heated to 120°C. They found that 
extrusion was only possible when sodium sulphite was used to break disulphide 
cross-links. In addition, extrusion and consolidation was also dependent on SDS, 
but excessive amounts would restrict reformation of new stabilising interactions. 
Excessive amounts of urea also reduced mechanical properties as was expected 
for plasticisers. They found that a material could be produced with good 
consolidation and mechanical properties when 60 pphBM water, 1 pphBM sodium 
sulphite, 1 pphBM SDS and 20 pphBM urea were used. Subsequent studies revealed 
that mechanical properties could be modified by varying the levels of each 
additive. Addition of triethylene glycol (TEG) as a plasticiser also increased its 
flexibility. The optimum formulation was chosen to be 60 pphBM water, 3 pphBM 
sodium sulphite, 3 pphBM SDS, 10 pphBM urea and 10 pphBM TEG [19]. 
In another example where blood proteins where used to produce bioplastics, 
Burgess et al (2008) produced bioplastic sheets from human blood plasma 
plasticised with water and glycerol by compression moulding at 9-25 kpsi and 55-
150 °C. These sheets could be used for drug delivery, barrier membranes and 
scaffolds for tissue repair. The feed material is not available in large quantities 
and had a high value which makes it not applicable to lower value and high 
volume use applications such as single use packaging [167]. 
Treating bloodmeal with PAA reduced the amount of intermolecular interactions 
of bloodmeal (Chapter Six). Successfully extruding biopolymers requires 
equilibrium between removing these forces and reforming them to stabilise the 
new bioplastic structure. Therefore the amount of interactions between bloodmeal 
protein chains may need to be increased to aid processing. Cross-linkers and 
agents which increase intermolecular forces such as hydrogen bonding have been 
used to improve the mechanical properties of bioplastics and other products from 
biopolymers. Borax contains hydroxyl groups and can increase hydrogen bonding 
of polymers [187]. Coviello et al (2009) used borax, aluminium and iron to 
increase the molecular interactions of scleroglucan hydrogels and tablets. They 
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found that borax was able to increase hydrogen bonding and increased strength, 
whereas aluminium and iron decreased strength [187].  
Sodium silicate can increase electrostatic interactions and hydrogen bonding 
between biopolymers [188, 189]. Lin and Gunasekaran (2010) produced an 
adhesive using cow blood and sodium silicate (0.5-2% v/v). They found that the 
adhesive had similar bonding strengths to conventionally used phenol 
formaldehyde in dry conditions. The presence of sodium silicate above 2% (v/v) 
improved water resistance but bonding in wet conditions was still weaker than 
when phenol formaldehyde was used [189]. Coradin et al (2003) studied the 
interactions between bovine serum albumin and sodium silicate. They found that 
at pH 4.7, the negatively charged sodium silicate caused aggregation of positively 
charged bovine serum albumin. They suggested that protein unfolding due to pH 
combined with the electrostatic effect of sodium silicate contributed to the 
aggregation of bovine serum albumin [190]. 
These studies showed that processing conditions such as temperature, pressure 
and additives varied greatly depending on what biopolymer was being processed 
into a bioplastic. Most studies showed water was required as a plasticiser, and it 
was often used in combination with another plasticiser such as glycerol. It was 
also found that extrusion was the most desirable process because it is continuous 
and will have higher productivity. However it was found to be a difficult 
processing method and extrudate quality varied greatly depending on specific 
mechanical energy input and additives used. It was suggested that compression 
moulding be used as a scouting method first then applying the best conditions to 
extrusion. No studies were found which attempted to process decoloured or 
chemically treated bloodmeal into a bioplastic. 
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Table 38: Examples of bioplastics made with various proteins, additives, processing methods and their properties [17, 19, 137, 143, 160, 162-165, 169, 181, 183, 191-196] 
Protein Plasticiser/Additives (wt %) Processing Method Tensile Strength (MPa) Young’s Modulus (MPa) Elongation (%) 
Agar [197] Water (96), Glycerol (1.3) Solvent Casting 29.7 - 45.3 
Casein [198] Glycerol (30), Aldehyde Cross-linkers (2) Solvent Casting 49-52 1107-1391 - 
Casein and Maillard Modified 
Casein [199] 
Glycerol (20) Solvent Casting - - 13.4-42.5 
Whey Protein Isolate [200] Glycerol (30) Solvent Casting 8 275 20 
Starch [165] Glycerol (0-20) Extrusion, Compression 
Moulding 
- 710-1380  
Wheat Gluten [160] Glycerol (37.5) Compression Moulding 0.52 - 235 
Wheat Gluten [172] Glycerol (25) Extrusion 2-5.1 4-26 85-165 
Wheat Gluten + Corn Starch 
(20 wt %) [160] 
Glycerol (37.5) Compression Moulding 0.13 - 70.8 
Wheat Gluten + Potato Starch 
(20 wt %) [160] 
Glycerol (37.5) Compression Moulding 0.32 - 163.5 
Soy Protein Isolate + Corn 
Starch (50 wt %) [194] 
Water, Glycerol (11.5 total) Extrusion, Injection 
Moulding 
2.9-3.9 28-46 69.4-94.7 
Soy Protein Isolate + 
Polyester Amide (33 wt %) 
[196] 
Glycerol (0-20), Sorbitol (0-20) Extrusion, Injection 
Moulding 
9-13 200-800 - 
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Protein Plasticiser/Additives (wt %) Processing Method Tensile Strength (MPa) Young’s Modulus (MPa) Elongation (%) 
Soy Protein Isolate [181] Sodium Dodecyl Sulphate (0,0.5, 1, 5, 
10) 
Compression Moulding 5.38-26.5 758-1667 1.4-2.4 
Soy Protein Isolate [163] Sodium Dodecyl Sulphate, 
Polycaprolacton-triol (various) 
Solvent Casting 3-23 436-1718 1-6.9 
Soy Protein Isolate [169] Glycerol (0-30), Stearic Acid (0-30) Solvent Casting 6.2-18.1 120.2-1121.7 3.6-168.4 
Sunflower Protein Isolate 
[162] 
Water (18), Glycerol (4-22) Extrusion, Injection 
Moulding 
10.6-16.1 500-2000 0.58-1.8 
Sunflower Protein Isolate 
[193] 
Water (10.5), Glycerol (37) Film Extrusion 3.2 18 73 
Corn Gluten Meal and Starch 
(25, 50, 75, 100 wt %) [184] 
Glycerol (20) Compression Moulding 2.5-3 100-250 20 
Zein [192] Sodium Dodecyl Sulphate (0-10) Extrusion, Compression 
Moulding 
17.3-22.4 186-299 11-13 
Zein (various sources) [162] Polyethylene glycol (25) Compression Moulding - 4.1-383 42-270 
Zein [164] Oleic Acid (30-50), Linoleic Acid (37.5-
44.4) 
Hot Press 2-9.4 136-557 5.9-46.9 
Starch-Zein (0-100 wt %) 
[183] 
Glycerol (22, 30, 40) Compression Moulding 1.5-12 10-1150 2-66 
Bloodmeal [17] Water (32), Urea (11), Sodium Sulphite 
(1.6), Sodium Dodecyl Sulphite (1.6) 
Extrusion, Injection 
Moulding 
9.6 534.9 12.1 
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Protein Plasticiser/Additives (wt %) Processing Method Tensile Strength (MPa) Young’s Modulus (MPa) Elongation (%) 
Bloodmeal Water (33), Urea (11), Sodium Sulphite 
(0.5), Sodium Dodecyl Sulphite (0.5) 
Extrusion, Injection 
Moulding 
8 320 - 
Bloodmeal [19] Water (22.7), Urea (5.7), Sodium 
Sulphite (1.7), Sodium Dodecyl Sulphite 
(1.7), Triethylene Glycol (11.36) 
Extrusion, Injection 
Moulding 
5.7 49.4 81 
Feather Keratin [143] Glycerol (30), Water (8), Sodium 
Sulphite (2) 
Extrusion - 25 8-50 
Feathermeal + Whey or 
Albumen (50 wt %) [185] 
Water (25) Compression Moulding 9-13 2000-3500 1.4-1.8 
Gelatine [195] Glycerol (30) Compression Moulding 3.9 3.7 96.9 
Human Blood Plasma [167] Glycerol, Water Extrusion, Compression 
Moulding 
0.8 9 - 
Egg White [159] Glycerol (37.5) Compression Moulding 7.1 - 130 
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7.4 Conclusion 
Renewed attention in bioplastics emerged because of concerns with petroleum 
levels and pollution caused by synthetic polymers. Different methods for 
producing biodegradable bioplastics include biotechnology/fermentation and 
direct conversion of biopolymers into products. Direct conversion involves 
solvent casting and thermoplastic processing.  
Due to the complex nature of biopolymers and their many different stabilising 
interactions, thermoplastic processing is only possible within a small window of 
processing conditions. Another problem is that the glass transition temperature is 
usually higher than the degradation temperature. To reduce the glass transition 
temperature and enable processing required the use of surfactants, reducing 
agents, surfactants and plasticisers to reduce interactions and increase chain 
mobility enabling the formation of a melt. The type and amount of additives 
required for processing is dependent on the type of biopolymer, its structure and 
amino acid content. After or during the end of processing new interactions are 
formed which stabilise the final structure. 
For bioplastics to become economically viable they must be processed using 
common plastics processing methods such as extrusion. Successfully extruding 
bioplastics requires equilibrium between the loss of molecular interactions 
(enabling melt and flow) and the reformation of molecular interactions which 
stabilise the extrudate. High temperatures can lead to excessive stabilising 
interactions (e.g. cross-links) forming during extrusion causing the extruder to 
fail, poor quality extrudate or degradation. Whereas insufficient temperatures 
prevent melt formation. 
When processing biopolymers using extrusion, there are a wide range of variables 
such as biopolymer-biopolymer interactions, biopolymer-additive interactions, 
temperature and shear. A balance between reducing interactions allowing 
melt/flow and the formation of new interactions which stabilise the product must 
also be achieved. Therefore successful extrusion is influenced by many factors 
and it is difficult to achieve and only possible within a small window of 
conditions. 
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Chapter 8 Processing Decoloured Bloodmeal Powders 
Chapter 8  
Processing Decoloured Bloodmeal Powders 
 
Twin screw extruder at Waikato University. 
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8.1 Chapter Overview 
Peracetic acid has been used to decolour and deodorise bloodmeal. This chapter 
investigated the use of decoloured bloodmeal powders for bioplastic production. 
The aim of this section was to identify the additives and processing conditions 
required to produce a consolidated bioplastic from PAA decoloured bloodmeal 
powders. This was achieved by investigating many combinations of water, 
plasticisers (TEG, glycerol), SDS, sodium sulphite, urea and additives which aid 
the formation of stabilising interactions (sodium chloride, sodium silicate and 
borax). 
Initial extrusion trials using PAA, hydrogen peroxide and sodium chlorite treated 
bloodmeal were carried out using the standard formula (10 pphBM urea, 3 pphBM 
sodium sulphite, 3 pphBM SDS, 60 pphBM water, 10 pphBM TEG) for processing 
untreated bloodmeal into Novatein Thermoplastic Protein (NTP). Hydrogen 
peroxide and sodium chlorite treated bloodmeal extrusions were unsuccessful and 
resulted in the extruder blocking, as well as the return of the bloodmeal smell. 
This result further justified the decision not to use these methods. PAA treated 
bloodmeal extrusion had limited success, the extruder did not block but instead 
the extrudate was small sections of compressed powder. 
Subsequent extrusions revealed that if acetic acid was not neutralised the 
extrudate would darken possibly due to the acetic acid degrading the protein 
through deamidation. PAA treatment reduced stabilising interactions of 
bloodmeal and because successful extrusion required equilibrium between the 
removal of forces in the extruder barrel and the formation of new stabilising 
forces as the material exits the die it was initially thought that additives were 
required to help reform the stabilising interactions. However, when these were 
used extrudates were sections of compressed powders, indicating increased 
aggregation but no melt formation. 
It was found that extrudate quality improved when only water, TEG and SDS was 
used. However the extrudates were still not completely consolidated and still 
contained sections of compressed powder. Extrusion was a difficult technique to 
use as a scoping method due to the wide range of variables (feed rate, barrel 
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temperatures, die size, screw speed) and a switch to compression moulding was 
made. Compression moulding achieved complete consolidation of PAA treated 
bloodmeal using 25 pphBM water, 3 pphBM SDS and 20 pphBM TEG. This showed 
that it was possible to produce a consolidated bioplastic using PAA treated 
bloodmeal but high pressure was required.  
A return to extrusion was made using 3, 4 and 5% PAA treated bloodmeal. In 
addition the extrudate was granulated and injection moulded to obtain the high 
pressures required. After injection moulding, consolidated and flexible samples 
were obtained and their colours were brown (3% PAA treated bloodmeal), 
yellow/orange (4% PAA treated bloodmeal) and yellow (5% PAA treated 
bloodmeal). Bioplastics produced using 3% PAA treated bloodmeal were not 
chosen to be investigated further because of its dark brown colour and bioplastics 
produced from 5% PAA treated bloodmeal were not investigated further because 
they broke apart easily when stretched. 4 % PAA treated bloodmeal was chosen to 
be optimised because it produced the best extruded and injection moulded 
samples. 
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8.2 Experimental 
8.2.1 Aim 
The aim of this section was to investigate the processing of decoloured and 
deodorised bloodmeal powders into a bioplastic using extrusion, compression 
moulding and injection moulding. 
8.2.2 Methods and Materials 
8.2.2.1 Standard Method for Producing Novatein ThermoPlastic 
Protein 
Processing bloodmeal into Novatein ThermoPlastic Protein (NTP) requires water, 
urea, sodium sulphite and sodium dodecyl sulphate. Sodium sulphite is required to 
break covalent crosslinks. While urea and sodium dodecyl sulphate act as 
processing aids by denaturing the protein. After processing water content was 
reduced allowing new intermolecular interactions to form. The materials 
properties vary depending on the amount of additives used [9, 17, 19]. 
The standard method for producing NTP involves dissolving urea (10 pphBM), 
sodium sulphite (3 pphBM, sodium dodecyl sulphite (3 pphBM) in water (60 
pphBM) and heating the solution to 60 °C while stirring. The hot solution is added 
to the bloodmeal in a high speed mixer and blended for 5 minutes. Triethylene 
glycol (10 pphBM) is then added and the mixture blended for a further 5 minutes. 
The pre-extrusion mixture (PNTP) is left for at least one hour to equilibrate. 
Extrusion is carried out using a twin screw extruder with temperature profile 70, 
100, 100, 100, 120°C from the feed zone to the die. The extrudate is granulated 
and injection moulded with temperature profile 100, 100, 100, 115, 120°C from 
feed to exit. The mould was heated to 65 °C [7, 18]. The final material is black 
and has an offensive odour. 
8.2.2.2 Producing Decoloured Bloodmeal Powders 
Several decoloured bloodmeal powders were produced for processing trials by 
treating 100 g bloodmeal with 300 g of sodium chlorite, hydrogen peroxide or 
PAA solution (Table 39). After 5 minutes of continuous mixing, 300 g distilled 
water was then added to create a slurry which was then filtered. The treated 
bloodmeal was washed again with 200 g distilled water. It was frozen and freeze 
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dried overnight using a Labconco Freezone 2.5 freeze dryer to 5-8% moisture. 
They were then ground with a bench top grinder and sieved using a 700 m sieve. 
In some cases when using PAA, acetic acid was neutralised by submerging the 
filtered and treated bloodmeal in 300 g distilled water and adjusting to pH 7 by 
adding 1 mol/L sodium hydroxide solution. The slurry was then filtered, washed, 
dried, ground and sieved as normal. 
Table 39: Decoloured bloodmeal powders used for extrusion, injection moulding and compression moulding. 
Type of Treated Bloodmeal Powder 
Sodium Chlorite (5%) treated bloodmeal 
Hydrogen Peroxide (30%) treated bloodmeal 
Peracetic Acid (3%) treated bloodmeal 
Peracetic Acid (4%) treated bloodmeal 
Peracetic Acid (5%) treated bloodmeal 
Peracetic Acid (3%) treated bloodmeal (Acetic Acid Neutralised) 
Peracetic Acid (4%) treated bloodmeal (Acetic Acid Neutralised) 
Peracetic Acid (5%) treated bloodmeal (Acetic Acid Neutralised)  
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8.2.2.3 Extrusion 
Decoloured bloodmeal powder was processed into pre-extrusion mixtures by 
dissolving various pre-weighed amounts of additives in different volumes of 
distilled water heated to 60°C while stirring (Table 40). The hot mixture was 
added to the decoloured bloodmeal powder and mixed in a high speed mixer for 
five minutes. Plasticiser (TEG or glycerol) was then added and the pre-extrusion 
mixture mixed for a further 5 minutes. The mixture was transferred to an air tight 
bag and left in the fridge at 2°C overnight to equilibrate.  
Table 40: Additives used for processing. 
Material Supplier Grade Purpose Amount 
(pphBM) 
Sodium Dodecyl 
Sulphate (SDS) 
Biolab Technical Surfactant 0-6 
Sodium Sulphite BDH Lab Supplies Analytical Remove cross-links 0-6 
Urea Agrinutrients-Balance Agricultural Denaturant 0-10 
Distilled Water - - Plasticiser, Dissolve 
Additives 
0-60 
Triethylene Glycol BDH Lab Supplies Analytical Plasticiser 0-40 
Glycerol BDH Lab Supplies Analytical Plasticiser 0-45 
Sodium Chloride Ajax Finechem Analytical Increase Aggregation 0-10 
Sodium Silicate Ajax Finechem Analytical Increase Electrostatic 
Interactions 
0-15 
Borax Ajax Finechem Analytical Increase Hydrogen 
Bonding 
0-15 
Extrusion was carried out using a ThermoPrism TSE-16-TC twin screw extruder 
fed with a rotating auger. The feed rate was adjusted to 30-35 g/min. Feed zone 
temperature was varied between 70-100°C and barrel temperature (zones 2, 3 
and4) between 100-140°C. The exit die temperature was varied between 120-
155°C. The screws were operated between 100-150 RPM and die size was either 5 
mm or 10 mm in diameter (Figure 75). 
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Figure 75: Extrusion screw configuration and heating zones. 
8.2.2.4 Compression Moulding 
3pphBM SDS was dissolved in 25 pphBM distilled water. The solution was heated 
and stirred to 60°C. The hot solution was added to 1-5% PAA decoloured 
bloodmeal (acetic acid neutralised) and mixed in a high speed mixer for 5 
minutes. 20 pphBM TEG was added and mixed for further 5 minutes. These 
conditions were chosen after several initial compression moulding trials. 
50 g of the mixture was compression moulded using a hydraulic press with top 
and bottom heated plates. The mixture was placed in the preheated mould (size 
150 x 220 x 2 mm) and compression moulded at 110°C (top and bottom plate) 
under 2.2 MPa of pressure for 5 minutes. Heating was turned off after 5 minutes 
and the mould was left under pressure for a further 5 minutes. The pressure was 
released, the sheet removed and left to cool. 
Compression moulded sheet colour was measured at multiple randomly selected 
locations using a Chroma Meter set in L*a*b* (CIE 1976) mode using D (6504K) 
illuminant conditions. L*a*b* values were converted to RGB and average percent 
whiteness calculated. 
Motor
Feed Auger
Die
Material Flow
Powder ConsolidationMelt
Mixing 
Zone 1
Mixing 
Zone 2
Mixing 
Zone 3
Feed Zone/Zone 1 Zone 2 Zone 3 Zone 4
ThermoPrism
TSE-16-TC
 159 
 
 
Figure 76: Compression moulding conditions. 
8.2.2.5 Injection Moulding 
After extrusion, some samples were granulated using a tri-blade granulator from 
Castin Machinery Manufacturer Ltd and injection moulded into tensile test 
specimens using a Boy 35A injection moulder. Injection pressure was 160 bar and 
back pressure 10 bar. The mould was water heated to 70°C and the barrel 
temperature profile from feed to exit was 100, 100, 100, 115, 120°C. The clamp 
pressure was 270 kN and the total cycle time was 45 seconds. 
 
Figure 77: Injection moulder configuration and temperature settings. 
  
270 kN
Hydraulics Hydraulics
Feed Hopper
70 ˚ C
120 ˚ C
Boy 35A
Heaters
115 ˚ C 100 ˚ C 100 ˚ C 100 ˚ C
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8.3 Results and Discussion 
8.3.1 Extrusions with Sodium Chlorite, Hydrogen Treated Bloodmeal 
Sodium chlorite, hydrogen peroxide and PAA treated bloodmeal were extruded 
using the existing NTP (10 pphBM urea, 3 pphBM SDS, 3 pphBM sodium sulphite, 
60 pphBM water, 10 pphBM TEG) formulation. Initial attempts to extrude sodium 
chlorite and hydrogen peroxide decoloured bloodmeal resulted in excessive 
pressure and torque readings and the extruder blocking. This could have been 
caused by aggregates and disulphide cross-links formed during the decolouring 
treatment. These would not have been detected during gel chromatography 
because the sodium sulphite in the dissolving buffer would have removed them. 
No consolidation or melt formation was observed when the extruder was opened 
for cleaning (Figure 78). In future studies, problems with the extruder blocking 
could be avoided by using a mixing chamber to investigate processing prior to 
extrusion. However this piece of equipment was not available during this study. 
When the pre-extrusion mixture for sodium chlorite and hydrogen peroxide 
treated bloodmeal was prepared the original bloodmeal odour returned when the 
denaturants were added. In addition a chlorine smell was also observed for 
sodium chlorite treated bloodmeal and a burnt hair smell for hydrogen peroxide 
treated bloodmeal. This justified the previous decision made in Chapter Five of 
not utilising these two treatment methods. 
 
Figure 78: Failed attempt at extruding sodium chlorite treated BM. 
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8.3.2 Extrusions with Peracetic Acid Treated Bloodmeal 
Initial attempts to extrude 3% PAA treated bloodmeal using the existing 
formulation for producing NTP were also unsuccessful. However the extruder did 
not block as was the case for sodium chlorite and hydrogen peroxide treated 
bloodmeal. Instead extrusions resulted in the extrudate exiting the extruder as 
either a powder or small sections of compressed powder. When pre-extrusion 
mixtures where being produced a strong acetic acid smell was observed but the 
characteristic bloodmeal smell did not return. 
3% PAA treated bloodmeal was used because this was the lowest treatment 
strength which removed the smell from bloodmeal. Below this strength smell and 
colour removal was not sufficient. Choosing the lowest possible PAA treatment 
strength also meant that the processing behaviour of the decoloured powder could 
be as close as possible to the untreated bloodmeal making results easier to 
understand.  
Extrusion trials with PAA treated bloodmeal resulted in the formation of four 
general types of extrudate as shown in Table 41. Additives, processing 
combinations and the resultant extrudate type are summarised in Table 42 and a 
full photo summary can be found in Appendix 1.  
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Table 41: Types of extrudate formed when extruding three percent PAA treated bloodmeal with different 
additives under various processing conditions. 
Type 1. Powder/Compressed Powder 
  
There was no melt formation and extrudate exited the extruder as powder or small sections of compressed 
powder. The sections of compressed powder had high amounts of surface defects and broke apart easily if bent 
or compressed. 
Type 2. Dark Poorly Consolidated/Compressed Powder Extrudate 
  
No melt formation and extrudate flowed poorly out of the extruder causing high pressures and torque. Extrudate 
was not flexible or rubbery and broke when bent. Surface defects such as voids, cracks and shark skinning 
were also present. 
Type 3. Semi-Consolidated with Rough Surface and Powdery Sections 
  
Extrudate flowed well out of the extruder with moderate pressures and torque. Extrudate was flexible and 
rubbery but had large sections with defects such as voids, cracks, compressed powder sections and shark 
skinning. They also broke easily when bent or compressed. 
Type 4. Semi-Consolidated with Semi Smooth Surface 
  
Extrudate flowed well out of extruder with moderate pressures and torque. Extrudate was flexible and rubbery 
and its surface was reasonably smooth. Some surface defects such as small cracks, powder and shark skinning 
were present. 
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Table 42: Summary of extrudates produced using various additive and processing combinations. Red=Poor, Yellow=Average, Green=Good. 
 Additives (pphBM)     
 Additives to Decrease 
Interactions 
Additives to Increase 
Interactions 
Plasticisers Processing Conditions  
Treatment Type Urea SDS Sodium 
Sulphite 
Salt Borax Sodium 
Silicate 
Water TEG Glycerol Screw 
Speed 
(RPM) 
Temperature Profile 
(feed to die °C) 
Die 
Diameter 
(mm) 
Extrudate 
Type 
Initial Trials 
Sodium Chlorite (5%) 10 3 3 - - - 60 10 - 150 70,100, 100, 100, 120 10 Blocked 
Hydrogen Peroxide (30%) 10 3 3 - - - 60 10 - 150 70,100, 100, 100, 120 10 Blocked 
PAA (3%) AA not 
Neutralised 
10 3 3 - - - 60 10 - 150 70,100, 100, 100, 120 10 1 
Extrusion Trials with Peracetic Acid Treated Bloodmeal (Acetic Acid Not Neutralised) 
PAA (3%) 10 3 3 - - - 60 10 - 150 80,110, 110, 110, 130 10 1 
PAA (3%) 10 3 3 - - - 60 10 - 150 70,100, 100, 100, 120 5 1 
PAA (3%) 10 3 3 - - - 60 10 - 150 80, 110, 110, 110, 130 5 1 
PAA (3%) 10 3 3 - - - 60 10 - 150 90, 110, 110, 110, 120 5 1 
PAA (3%) 10 3 3 - - - 60 10 - 150 90, 110, 115, 120, 120 5 2 
PAA (3%) 10 6 3 - - - 60 10 - 150 70, 105, 110, 110, 120 5 1 
PAA (3%) 10 6 3 - - - 60 10 - 150 70, 110, 110, 110, 130 5 2 
PAA (3%) 10 6 3 - - - 60 10 - 125 70, 110, 110, 110, 130 5 2 
Extrusion Trials with Peracetic Acid Treated Bloodmeal (Acetic Acid Neutralised) 
Standard Additives 
PAA (3%) 10 3 3 - - - 60 10 - 150 70, 100, 100, 100, 120 10 1 
PAA (3%) - - - - - - 60 - - 150 70, 100, 100, 100,120 5 1 
PAA (3%) 10 - - - - - 60 - - 150 70, 100, 100, 100, 120 5 1 
Additives to Increase Aggregation, Electrostatic Interactions and Hydrogen Bonding  
PAA (3%) 10 - - 10 - - 60 - - 150 70, 100, 100, 100, 120 5 1 
PAA (3%) 10 - - 10 - - 60 - - 150 95, 105, 105, 105, 120 5 1 
PAA (3%) 10 - - - - 20 60 - - 150 80, 100, 100, 100, 120 10 2 
PAA (3%) - - - - 5 - 60 10 - 150 70, 100, 105, 110, 130 10 2 
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Treatment Type Urea SDS Sodium 
Sulphite 
Salt Borax Sodium 
Silicate 
Water TEG Glycerol Screw 
Speed 
(RPM) 
Temperature Profile 
(feed to die °C) 
Die 
Diameter 
(mm) 
Extrudate 
Type 
Extrusion Trials with Peracetic Acid Treated Bloodmeal (Acetic Acid Neutralised) Continued 
Additives to Increase Aggregation, Electrostatic Interactions and Hydrogen Bonding Continued 
PAA (3%) 10 - - - - 20 60 10 - 140 75, 100, 100, 100, 120 10 2 
PAA (3%) - - - - - 5 60 - - 140 70, 100, 100, 100, 120 10 2 
PAA (3%) - - - - - 10 60 - - 140 70, 100, 100, 100, 120 10 2 
PAA (3%) - - - - - 15 60 - - 140 70, 100, 100, 100, 120 10 2 
PAA (3%) 10 1.5 - - - 10 60 10 - 150 70, 100, 100, 100, 120 10 2 
PAA (3%) - - - - - 15 60 5 - 150 70, 100, 100, 100, 120 10 2 
PAA (3%) - - - - - 15 60 10 - 150 70, 100, 100, 100, 120 10 2 
PAA (3%) - - - - - 15 60 15 - 150 70, 100, 100, 100, 120 10 2 
PAA (3%) 10 - - - 5 - 60 10 - 150 70, 105, 110, 110, 125 10 2 
PAA (3%) - - - - 10 - 60 - - 150 70, 100, 100, 100, 120 5 2 
PAA (3%) - - - - 10 - 60 10 - 150 70, 105, 110, 110, 130 5 2 
PAA (3%) - 3 - - 5 - 60 10 - 150 70, 105, 110, 110, 130 5 2 
PAA (3%) - 3 - - 5 5 60 10 - 150 70, 100, 100, 100, 120 10 2 
PAA (3%) - - - - 5 - 60 10 - 150 70, 100, 100, 100, 120 10 2 
PAA (3%) - - - - 5 - 60 10 - 150 70, 100, 105, 110, 125 5 2 
PAA (3%) - - - - 5 - - - 45 80 70, 100, 105, 110, 125 5 2 
PAA (3%) - - - - 5 - - - 45 150 70, 100, 105, 110, 125 5 2 
PAA (3%) - - - - 5 10 60 15 - 150 70, 100, 100, 100, 120 5 2 
PAA (3%) - - - - 5 10 60 15 - 150 70, 100, 110, 115, 125 5 2 
PAA (3%) - - - - 5 10 60 15 - 150 70, 100, 110, 120, 130 5 2 
PAA (3%) - - - - 5 - 60 15 - 150 70, 100, 110, 120, 140 10 2 
PAA (3%) - - - - 10 - 60 15 - 150 70, 100, 110, 130, 140 10 2 
PAA (3%) - - - - 5 2.5 60 15 - 150 70, 100, 110, 130, 140 10 2 
PAA (3%) - - - - 5 5 60 15 - 150 70, 100, 110, 130, 140 10 2 
PAA (3%) - - - - 10 2.5 60 15 - 150 70, 100, 110, 130, 140 10 2 
PAA (3%) - - - - 10 5 60 15 - 150 70, 100, 110, 130, 140 10 2 
PAA (3%) 5 - - - 10 - 60 15 - 150 70, 100, 110, 130, 140 10 2 
PAA (3%) - - - - 15 - 60 15 - 150 70, 100, 110, 130, 140 10 2 
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Treatment Type Urea SDS Sodium 
Sulphite 
Salt Borax Sodium 
Silicate 
Water TEG Glycerol Screw 
Speed 
(RPM) 
Temperature Profile 
(feed to die °C) 
Die 
Diameter 
(mm) 
Extrudate 
Type 
Extrusion Trials with Peracetic Acid Treated Bloodmeal (Acetic Acid Neutralised) Continued 
Urea and SDS 
PAA (3%) 10 3 - - - - 30 30 - 150 80, 100, 100, 105, 125 10 3 
PAA (3%) 10 3 - - - - 40 30 - 150 70, 110, 115, 130, 140 10 2 
PAA (3%) 10 3 - - - - 30 30 - 150 80, 100, 120, 140, 155 5 2 
SDS 
PAA (3%) - 6 - - - -- 25 30 - 100 80, 100, 100, 105, 130 10 3 
PAA (3%) - 6 - - - - 25 - - 150 80, 100, 100, 105, 125 10 3 
PAA (3%) - 6 - - - - 25 - - 100 80, 100, 100, 105, 125 10 3 
PAA (3%) - 6 - - - - 25 15 - 150 80, 100, 100, 105, 125 10 3 
PAA (3%) - 6 - - - - 40 30 - 150 70, 100, 100, 100, 120 10 3 
PAA (3%) - 4.5 - - - - 20 30 - 150 80, 100, 100, 105, 125 10 3 
PAA (3%) - 3 - - - - 30 30 - 150 80, 100, 100, 105, 125 5 3 
PAA (3%) - 6 - - - - 20 30 - 150 80, 100, 100, 105, 125 10 3 
PAA (3%) - 6 - - - - 30 25 - 100 80, 100, 100, 105, 125 5 3 
PAA (3%) - 6 - - - - 30 25 - 75 80, 100, 100, 105, 125 5 3 
PAA (3%) - 6 - - - - 25 30 - 120 80, 100, 100, 110, 125 5 4 
PAA (3%) - 6 - - - - 25 30 - 150 80, 100, 100, 100, 120 10 4 
PAA (3%) - 6 - - - - 50 40 - 125 80, 100, 100, 110, 120 10 4 
PAA (4%) - 3 - - - - 50 30 - 150 80, 100, 100, 110, 125 10 4 
PAA (4%) - 6 - - - - 25 30 - 150 80, 100, 100, 110, 125 10 4 
PAA (4%) - 6 - - - - 50 40 - 150 80, 100, 100, 110, 125 10 4 
PAA (5%) - 6 - - - - 50 20 - 150 80, 100, 100, 115, 135 5 3 
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8.3.3 Extruding Peracetic Acid Treated Bloodmeal 
8.3.3.1 Extrusions without Neutralising Acetic Acid 
PAA treated bloodmeal (acetic acid not neutralised) was extruded using the NTP 
formulation. These extrusions resulted in compressed powders and no melt 
formation (type one). A strong acetic acid smell was also observed during mixing 
and extrusion. It appeared that a higher temperature was required to form a melt, 
but when this was done the extrudate darkened and material clumped in the feed 
zone, most probably due to water evaporating in the barrel because of the high 
temperatures and accumulating there. Previous studies have shown that successful 
extrusion requires equilibrium between the loss of stabilising interactions which 
allows the material to flow and entangle during extrusion and the reformation of 
stabilising interactions as the extrudate exits the extruder which leads to 
consolidation. Literature has shown that acetic acid can denature and degrade 
proteins through deamidation [139, 201]. This could explain why no consolidation 
occurs and the extrudate darkens when PAA treated bloodmeal is extruded 
without neutralising the acetic acid. If it was not neutralised it could have caused 
excessive denaturation and prevented the formation of the stabilising forces 
required for consolidation. It could have also caused degradation which resulted in 
the dark coloured extrudate.  
The presence of urea, sodium sulphite and SDS may not be necessary because 
PAA treatment has already reduced some of the interactions. The reduction of 
interactions by PAA treatment combined with the presence of acetic acid and the 
other denaturants may also be preventing the reformation of chain interactions 
during extrusion. When acetic acid was neutralised and the temperature increased 
no darkening occurred which confirmed that acetic acid was responsible for the 
dark extrudate. It was decided that acetic acid should be neutralised before 
extrusion to prevent excessive denaturation and degradation. It was also decided 
to carry out extrusion trials with additives which increase interactions as well as 
less/different combinations of urea, sodium sulphite, SDS, water and TEG. 
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8.3.3.2 Extrusions with Additives to Increase Interactions 
It appeared that PAA treated bloodmeal required more interactions to stabilise the 
extrudate and help aid consolidation. This could be achieved by removing 
denaturants or adding additives which increased interactions. Extrusion with just 
water and no denaturants resulted in compressed powder extrudates (type one). 
Sodium chloride, sodium silicate and borax have been used to increase 
aggregation, cross-linking and hydrogen bonds in proteins [187-190, 202, 203]. 
These were added to try and improve consolidation.  
Sodium chloride has been used to increase protein aggregation. When it was 
added to extrusion mixtures it produced type one extrudates which showed 
increased aggregation when exiting the extruder but no melt formation. Sodium 
silicate and borax have been used to increase electrostatic interactions and 
hydrogen bonding between biopolymers. When these were used in extrusion, type 
two and three extrudates were produced. Interactions were increased as shown by 
increased extrudate length, aggregation and semi-consolidation, but melt 
formation was poor and extrudate surfaces were rough. These extrusions often had 
high pressures and torque due to the increased interactions. They were also often 
dark which could be due to the high pressures and torques which have been shown 
to cause protein degradation [142, 176]. It was decided that denaturants were still 
required to reduce interactions but not at the levels or combinations that were 
required for untreated bloodmeal. 
8.3.3.3 Extrusions with Urea, SDS, SS, TEG and Water 
Using various combinations of water, urea, sodium sulphite, SDS and TEG 
resulted in type three extrudates (Table 42). The presence of sodium sulphite and 
urea resulted in non-continuous extrudates which showed some consolidation but 
had a lot of defects and broke apart easily. When sodium sulphite was excluded it 
was still possible to process the PAA decoloured powder and extrudate quality 
was reasonable (type four). Processing without urea was also possible and 
extrudate quality was reasonable (type four). Processing without SDS resulted in 
poor extrudates (type three). Insufficient water and TEG (below 40 pphBM total) 
produced poor flow, high pressures and torques, as well as brittle extrudates with 
various surface defects (type three and type four). This suggested that successful 
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processing may be possible with just water, SDS and TEG if their concentrations 
and processing conditions could be optimised. 
Extrusion had limited success and this was caused by the wide range of variables 
such as the die size, screw speed, feed rate and five temperature zones making it 
difficult to understand the processing requirements of the decoloured bloodmeal 
powders. A simpler method such as compression moulding with fewer variables 
could help to identify what conditions and additives were required for 
consolidation of PAA treated bloodmeal powders. These conditions and additives 
could then be applied to extrusion. Compression moulding was used with the aim 
of investigating what processing conditions and additives were required for 
consolidation of PAA decoloured bloodmeal powders. After these were found, 
they could then be applied to extrusion. 
8.3.4 Compression Moulding Peracetic Acid Treated 
Bloodmeal 
Compression moulding is a simpler technique with fewer variables and has been 
used previously to process bioplastics into sheets as previously described in 
Chapter Seven. 
1-5% PAA treated bloodmeal was compression moulded using only water (25 
pphBM), SDS (3 pphBM) and TEG (20 pphBM). These additives were used for 
compression moulding as they gave the most promising results from extrusions. 
Using a smaller number of additives also reduced the amount of variables making 
the processing easier to understand. 
Initial trials involved varying temperature and pressure until a temperature of 
110°C (top and bottom plate) and 2.2 MPa pressure was selected. It was found 
that at temperatures above this the sheets would be brittle due to the evaporation 
of water and below this the material would not form a melt. Excessive pressures 
(above 3 MPa) would cause the material to flow out the sides of the mould. This 
was not good for compression moulding but was a good sign that melting and 
consolidation was possible during extrusion if high pressures could be achieved. 
Compression moulding results showed that consolidation was possible for 3-5% 
PAA treated bloodmeal. Compression moulded sheets of 1 and 2% PAA treated 
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bloodmeal were slightly granular and brittle. This could possibly be caused by the 
remaining disulphide cross-links as the treatment strength may not have been high 
enough to break a significant number of them. These sheets were also dark brown 
to black in colour (Table 43, Figure 79-Figure 81). 
The incomplete consolidation of sheets made from 1 and 2% PAA treated 
bloodmeal could also be caused by the absence of urea and sodium sulphite. 
Results from analysis carried out in Chapter Six showed that 1 and 2% PAA 
treated bloodmeal showed similar thermal stability, glass transition temperatures 
and solubility to untreated bloodmeal. This means that its processing requirements 
(i.e. additives) would also be similar to untreated bloodmeal. Therefore 1 and 2% 
PAA treated bloodmeal may also require some urea and sodium sulphite to aid 
processing and consolidation. However because colour and smell was not 
completely removed at these treatment concentrations, their processing was not 
investigated further. 
Table 43: Colour of 1-5% PAA treated bloodmeal compression moulded sheets. 
 
L* R G B Whiteness (%) Colour 
Untreated BM (standard formula) 23 59 60 61 24   
1% PAA BM 26 62 62 62 24   
2% PAA BM 28 86 59 58 27   
3% PAA BM 57 182 123 43 45   
4% PAA BM 71 199 171 72 58   
5% PAA BM 72 203 173 99 62   
Compression moulded sheets from 3-5% PAA treated bloodmeal produced 
flexible, consolidated and translucent sheets (Figure 79, Figure 80). Results from 
Chapter Six showed that treatment above 3% PAA concentration caused the 
decoloured powder to begin to act similarly to PNTP. This could explain why it is 
possible to compression mould these powders without the use of urea and sodium 
sulphite. 
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Figure 79: Compression moulded sheet produced using 4% PAA treated bloodmeal. 
 
Figure 80: Compression moulded 3 % PAA treated bloodmeal cut into dog bone tensile bar samples. 
One of the problems identified with compression moulding was the presence of 
bubbles in some of the sheets and samples (Figure 80). This could have been 
caused the water evaporating (due to insufficient cooling) when the pressure was 
released. If compression moulding were to be used to produce these sheets for use 
or applications then the method should be adjusted to allow sufficient time for the 
moulds to cool below 100°C while still under pressure to prevent the evaporation 
of water. 
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Figure 81: Compression moulded 1 % PAA treated bloodmeal cut into dog bone tensile bar samples. 
Compression moulding showed that processing PAA decoloured bloodmeal into a 
bioplastic was possible using water (25 pphBM), SDS (3 pphBM) and TEG (20 
pphBM). Observations from compression moulding showed that at 110°C and high 
pressures the decoloured powders formed a melt and squirted out the edges of the 
mould as consolidated ribbons. This showed that processing temperatures around 
110-120°C were sufficient but high pressures were required. From these results it 
was decided to return to extrusion but follow with injection moulding to achieve 
the high pressures required. The water and TEG levels were increased to improve 
material flow and help prevent degradation due to the increased shear rates of 
these processing methods. 
8.3.5 Extruding and Injection Moulding Peracetic 
Acid Treated Bloodmeal 
Extruding 3 and 4% PAA treated bloodmeal with water (40-50 pphBM), SDS 
(3pphBM) and TEG (20-40 pphBM) produced type four extrudates. Extrudates 
flowed well out of the extruder and excessive pressures, torques or blocking did 
not occur. Insufficient TEG resulted in shark skinning on the extrudate surface. 
Extruding 5% PAA treated bloodmeal with the same additives resulted in a semi-
consolidated extrudate with a rough and powdery surface. The extrudate was 
rubbery and could be stretched but broke apart easily. This could possibly be due 
to very little remaining interactions available to stabilise the extrudate (Table 44). 
The extrudates were then granulated and injection moulded. 
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Table 44: Summary of extruding and injection moulding 3-5 % PAA treated bloodmeal. 
Extrusion and Injection Moulding of Peracetic Acid Treated Bloodemal 
3% PAA Treated BM Extrusion and Injection Moulding 
Type 4 
 
 
 Formulation (pphbm) 40 water, 30 TEG, 6 SDS,  
Type 4 
 
 
 Formulation (pphbm) 50 water, 40 TEG, 6 sds 
 4 % PAA Treated BM Extrusion and Injection Moulding 
Type 4 
 
 
 Formulation (pphbm) 50 water, 40 TEG, 6 sds 
Type 3 
 
 
 Formulation (pphbm) 50 water, 20 TEG, 6 sds 
 5 % PAA Treated BM Extrusion and Injection Moulding 
Type 3 
 
 
 Formulation (pphbm) 50 water, 20 TEG, 6 sds 
Note: Extrusion conditions were, temperature profile (feed to exit °C): 70, 100, 100, 100, 120, 
screw speed: 150rpm. 
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Injection moulding 3% PAA treated bloodmeal required sufficient levels of water 
and TEG (above 60 pphBM total) to prevent blocking the injection moulder 
components and protein degradation (see full results in Appendix 1). When these 
conditions were met a brown, flexible and consolidated sample was produced. 
Injection moulding 5% PAA treated bloodmeal produced a consolidated 
translucent sample. However this sample was very flexible and easy to break, 
possibly due to very little stabilising interactions. 4% PAA treated bloodmeal 
injection moulded well and produced an orange, translucent sample which 
appeared to have acceptable mechanical properties. 
Because 4% PAA treated bloodmeal performed the best when extruded and 
injection moulded it was chosen to be investigated further. Additive levels and 
processing should be optimised using this material. The mechanical properties of 
the material should also be investigated. 
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8.4 Conclusion 
Successful extrusion without neutralising acetic acid could not be achieved 
because of its denaturing and degradation effects on bloodmeal protein. Additives 
to increase chain interactions were unsuccessful and some caused the extrudate to 
darken, possibly due to increased interactions causing an increase in shear stresses 
which caused the protein to degrade. Excluding urea and sodium sulphite 
produced better quality extrudates, although these still showed poor consolidation 
and a rough surface. Successful extrusion required equilibrium between removing 
interactions and reforming them to stabilise the structure. Peracetic acid treatment 
reduced interactions as shown in Chapter Six. Therefore including urea and 
sodium sulphite further reduced interactions and prevented the reformation of 
enough stabilising interactions during extrusion. 
Extrusion was a difficult scouting technique to use due to its wide range of 
parameters and limited success was achieved. As a result, compression moulding 
was utilised to investigate if consolidation was possible using decoloured 
bloodmeal powders. Compression moulding with water, SDS and TEG showed 
consolidation was possible using all PAA treatment strengths without urea and 
sodium sulphite. This showed that a higher pressure was required during 
processing. Therefore it was decided to extrude 3, 4, and 5% PAA treated 
bloodmeal, granulate the extrudate and injection mould them. 
After returning to extrusion with water, SDS and TEG, better quality extrudates 
were obtained for 3 and 4% PAA treated bloodmeal. 5% PAA treated bloodmeal 
produced a poor extrudate with a powdery surface, possibly because of 
insufficient chain interactions caused by the strong decolouring treatment. 
Successfully injection moulding 3% PAA treated bloodmeal required at least 60 
pphBM total of water and TEG to enable chain mobility, otherwise the injection 
moulder die would block and protein degradation would occur. When injection 
moulded, 3% PAA treated bloodmeal produced a brown sample, whereas 4 and 
5% PAA treatment produced orange/yellow translucent samples. The 5% PAA 
treated bloodmeal sample was very flexible and broke easily when stretched. 
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4% PAA treated bloodmeal was chosen to be optimised because it produced the 
best extruded and injection moulded samples. The work done in this chapter is 
summarised in Figure 82. 
 
Figure 82: Summary of extruding, compression moulding and injection moulding decoloured bloodmeal 
powders done in Chapter Eight. 
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Chapter 9 Extrusion, Injection Moulding and Mechanical Properties of 
Decoloured Bloodmeal Bioplastics 
Chapter 9  
Extrusion, Injection Moulding and Mechanical 
Properties of Decoloured Bloodmeal Bioplastics 
 
 
Injection moulded samples produced using peracetic acid treated bloodmeal. 
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9.1 Chapter Overview 
In Chapter Eight, 4% PAA treated bloodmeal was chosen to be optimised for 
extrusion and injection moulding. Water, TEG and SDS were identified as the 
main additives required for processing. This section aimed to find the optimum 
levels of water, TEG and SDS and to investigate how these additives affected 
extrusion, injection moulding and material properties. 
It was found that the optimum combination of water, TEG and SDS differed for 
extrusion and injection moulding. SDS was the most important factor for 
whiteness, consolidation and specific mechanical energy (SME) input during 
extrusion. The best extruded sample based on consolidation and whiteness 
contained 40 pphBM water, 10 TEG pphBM and 6 pphBM SDS. This produced a 
sample which was 98% consolidated and 49% white. 
TEG and SDS were the most important factors for injection moulded sample 
colour, processing and material mechanical properties. Water also contributed to 
colour of injection moulded samples and mechanical properties but its 
contribution was reduced due to its evaporation during processing and 
conditioning. Increasing TEG resulted in decreased Young’s modulus and UTS, 
but higher strain at break and toughness. The best injection moulded sample based 
on colour and mechanical properties was obtained using 3 pphBM SDS, 50 pphBM 
water and 20 pphBM TEG. This produced a material with tensile strength 4.62 
MPa, Young’s modulus 85.48 MPa, toughness 1.75 MPa and 82.62% strain at 
break. These mechanical properties were comparable to Novatein Thermoplastic 
Protein produced from untreated bloodmeal. 
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9.2 Experimental 
9.2.1 Aim 
The aim of this section was to find the optimum levels of water, TEG and SDS for 
processing 4% PAA decoloured bloodmeal and investigate how these additives 
affected extrusion, injection moulding and mechanical properties. 
9.2.2 Methods and Materials 
9.2.2.1 Extrusion and Injection Moulding 
Large quantities of bloodmeal were decoloured with 4% PAA and the acetic acid 
was neutralised as previously described in Chapter Eight. The decoloured 
bloodmeal powder was processed into different pre-extrusion mixtures at 
compositions shown in Table 45. SDS was dissolved in distilled water heated to 
60°C while stirring. The hot mixture was added to the decoloured bloodmeal 
powder and mixed in a high speed mixer for 5 minutes. TEG was added and the 
pre-extrusion mixture mixed for a further 5 minutes. The mixture was transferred 
to an air tight bag and left in the fridge at 2°C overnight to equilibrate. 
Table 45: Different combinations of water, SDS and TEG used to extrude four percent PAA treated 
bloodmeal. 
  SDS (pphBM) 
  6 3 0 
  Water (pphBM) 
  30 40 50 30 40 50 30 40 50 
T
E
G
 
(p
p
h
B
M
) 
10 S1 S2 S3 S10 S11 S12 S19 S20 S21 
20 S4 S5 S6 S13 S14 S15 S22 S23 S24 
30 S7 S8 S9 S16 S17 S18 S25 S26 S27 
Extrusion was carried out using a ThermoPrism TSE-16-TC twin screw extruder 
fed with a rotating auger. The feed rate was adjusted to approximately 35 g/min. 
The extruder temperature profile was 80, 100, 100, 110, 125°C from the feed zone 
to the die. The screws were operated at 150 rpm and the die was 10 mm in 
diameter (Figure 83). Pressure, torque and mass flow rates were recorded during 
extrusion and used to calculate specific mechanical energy input using equation 
10 [7].  
    (
  
  
)  
                  
              
 (10) 
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Multiple cross sections were cut for consolidation analysis. Injection moulding 
into tensile bar specimens was then carried out using a Boy 35A injection moulder 
with injection pressure 160 bar and back pressure 10 bar. The mould was water 
heated to 70°C and the barrel temperature profile from feed to exit was 100, 100, 
100, 115, 120°C. The clamp force was 270 kN and the total cycle time was 45 
seconds (Figure 77). 
The colour of extruded and injection moulded samples were analysed using the 
same method as described for measuring the colour of compression moulded 
samples in Chapter Eight. 
 
Figure 83: Extuder conditions used to process 4% PAA treated bloodmeal. 
9.2.2.2 Measuring Consolidation 
Extrudate cross sections were examined using a Heerbrugg Wild 38 microscope 
and photographed with a Nikon DS 5MC digital sight camera attached to the 
microscope. The images were converted into black and white using ImageJ image 
processing software. Consolidated regions appeared black and unconsolidated 
regions appeared white. Percent consolidation was calculated by dividing the 
black area by the total area. Example conversions are shown in Table 46. 
  
Motor
Feed Auger
125 °C
Material Flow
Powder ConsolidationMelt
Mixing 
Zone 1
Mixing 
Zone 2
Mixing 
Zone 3
80 °C 100 °C 100 °C 110 °C
ThermoPrism
TSE-16-TC
Approximately 35 g/min
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Table 46: Example black and white cross sections showing complete, high, average and poorly consolidated 
samples. 
Cross Sections Converted into Black and White Images 
Complete Consolidation (NTP 100%) High Consolidation (Above 95%) 
    
Average Consolidation (80-95%) Poor Consolidation (Less than 80%) 
    
 
9.2.2.3 Mechanical Testing 
Injection moulded samples were conditioned to approximately 10% moisture at  
23°C and 50% relative humidity for 7 days. The tensile strength, strain at break, 
Young’s modulus and toughness of injection moulded samples were analysed 
according to ASTM D638-86 method using an Instron model 4204 fitted with a 5 
kN load cell, extensometer with a gauge length 50 mm and with a cross head 
speed of 5 mm/min. Five samples were analysed for each additive combination 
and the results presented as averages. The standard error was calculated by 
dividing the standard deviation by the square root of the number of samples. The 
mechanical properties of unconditioned samples were also analysed and the 
results can be found in Appendix 2. 
9.2.2.4 Percentage Contribution of Additives to Product Properties 
The contribution of SDS, water and TEG to the average of SME, extrudate 
whiteness, consolidation, injection moulded sample whiteness, tensile strength, 
elongation at break, Young’s modulus and toughness was quantified by carrying 
out analysis of variance using Minitab statistical processing software.  
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9.3 Results and Discussion 
9.3.1 General Observations 
During extrusion several general observations were made. Samples with SDS 
showed better consolidation than samples without SDS. At high water and TEG 
content consolidation was reduced. In addition these samples also had difficulty 
feeding and water was also seen in the feed zone. The powders would clump and 
block in the feed zone leading to build up in the feed hopper. Water in the feed 
zone was probably due to water being evaporated in the extruder barrel. 
Water and TEG was observed to be the most important factors for injection 
moulding processing. Samples with low water and TEG content could not be 
injection moulded. The material became stuck in the mould and sprue or formed 
incomplete tensile test samples. Low water and TEG also resulted in darkening of 
the material once injection moulded which could indicate thermal degradation of 
the protein. These results are summarised and pictures of extruded and injection 
moulded samples presented in Table 47. 
These observations suggested that SDS was the most important component for 
consolidation during extrusion, whereas injection moulding is more dependent on 
water and TEG. The primary role of SDS is to detangle the bloodmeal protein. 
During injection moulding the bloodmeal protein would have experience greater 
pressure than it would during extrusion. The high pressures of injection moulding 
could also have detangled the bloodmeal protein which could be why 
formulations without SDS were able to be consolidated with injection moulding 
but showed poor consolidation after extrusion. The higher shear stresses and 
mechanical energy input during injection moulding could be what makes the role 
of plasticisers more important as these have been shown to reduce thermal and 
mechanical degradation [8]. 
The majority of extruded samples were a transparent yellow/orange colour. 
Injection moulding produced transparent yellow/orange or brown tensile test 
samples depending on plasticiser content. The lighter coloured samples could be 
modified with the use of pigments if desired. 
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Table 47: Extrusion and injection moulding of 4% PAA treated bloodmeal with different amounts of water, SDS and TEG. 
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r 
Extrusion Cross Section Injection Moulded Test Piece 
1 6 30 10 Yes Yes Smooth Good  No 
   
2 6 40 10 Yes Yes Smooth Good  Yes 
   
3 6 50 10 Yes Yes 
Small 
Cracks 
Good 
Extrudate 
broke easily. 
Yes 
   
4 6 30 20 Yes Yes Smooth Good 
Extrudate 
broke easily. 
No 
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Formulation (pphBM) Observations Pictures 
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Extrusion Cross Section Injection Moulded Test Piece 
5 6 40 20 Yes Yes Smooth Good 
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broke easily. 
Yes 
   
6 6 50 20 Yes Yes 
Cracks 
Powder 
Good 
Extrudate 
broke easily. 
Yes 
   
7 6 30 30 Yes No 
Cracks 
Powder 
Reasonable 
Extrudate 
broke easily. 
Yes 
   
8 6 40 30 Yes No 
Cracks 
Powder 
Reasonable 
Extrudate 
broke easily. 
Yes 
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Formulation (pphBM) Observations Pictures 
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Powder 
Poor 
Powder 
clumped in 
extruder 
feedzone. 
Yes 
   
10 3 30 10 Yes Yes Smooth Good  No 
   
11 3 40 10 Yes Yes Smooth Good  No 
   
12 3 50 10 Yes Yes Smooth Good  Yes 
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Formulation (pphBM) Observations Pictures 
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Extrusion Cross Section Injection Moulded Test Piece 
13 3 30 20 Yes Yes Smooth Good  Yes 
   
14 3 40 20 Yes Yes Smooth Good 
Extrudate 
broke easily. 
Yes 
   
15 3 50 20 No No Cracks Reasonable 
Extrudate 
broke easily. 
Yes 
   
16 3 30 30 Yes Yes 
Small 
Cracks 
Good 
Extrudate 
broke easily. 
Yes 
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Formulation (pphBM) Observations Pictures 
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Extrusion Cross Section Injection Moulded Test Piece 
17 3 40 30 No No Cracks Reasonable 
Powder 
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feed and 
extrudate 
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Yes 
   
18 3 50 30 No No 
Cracks 
Powder 
Poor 
Powder 
c;umped in 
feed and 
extrudate 
broke easily. 
Yes 
   
19 0 30 10 No No 
Cracks 
Powder 
Reasonable  No 
   
20 0 40 10 No No 
Cracks 
Powder 
Reasonable 
Extrudate 
broke easily. 
Yes 
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Formulation (pphBM) Observations Pictures 
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Extrusion Cross Section Injection Moulded Test Piece 
21 0 50 10 No No 
Cracks 
Powder 
Poor 
Extrudate 
broke easily. 
Yes 
   
22 0 30 20 No No 
Cracks 
Powder 
Reasonable 
Extrudate 
broke easily. 
No 
   
23 0 40 20 No No 
Cracks 
Powder 
Poor 
Extrudate 
broke easily. 
Yes 
   
24 0 50 20 No No 
Cracks 
Powder 
Poor 
Extrudate 
broke easily. 
Yes 
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Formulation (pphBM) Observations Pictures 
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Extrusion Cross Section Injection Moulded Test Piece 
25 0 30 30 No No 
Cracks 
Powder 
Poor 
Extrudate 
broke easily. 
Yes 
   
26 0 40 30 No No 
Cracks 
Powder 
Poor 
Powder 
clumped in 
feed and 
extrudate 
broke easily. 
Yes 
   
27 0 50 30 No No 
Cracks 
Powder 
Poor 
Powder 
clumped in 
feed and 
extrudate 
broke easily. 
Yes 
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9.3.2 Effect of SDS, Water and TEG on Consolidation, 
Colour and Mechanical Properties 
9.3.2.1 Extrusion Properties 
The best consolidation results were achieved using 6 pphBM combined with 40 
pphBM water and 10 pphBM TEG or 30 pphBM water and 20 pphBM TEG. These 
samples were 98% consolidated. 97% was also achieved using 3 pphBM SDS with 
40 pphBM water and 10 pphBM TEG or 30 pphBM water and 20 pphBM TEG. The 
highest consolidation at 0 pphBM SDS (86%) was also achieved using this 
combination of water and TEG. This suggested that 50 pphBM total plasticiser is 
the optimum level for consolidation during extrusion. These extrusion trials were 
summarised in Table 48. 
Table 48: Percent consolidation and whiteness after extrusion for different combinations of SDS, water and 
TEG. 
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%
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1 6 30 10 30.39 0.87 96 0.5 43 
2 6 40 10 23.68 0.09 98 0.6 49 
3 6 50 10 23.37 0.12 96 0.2 48 
4 6 30 20 20.97 0.15 98 0.4 44 
5 6 40 20 18.36 0.02 96 1.4 49 
6 6 50 20 17.63 0.34 96 0.6 52 
7 6 30 30 17.02 0.17 93 0.3 51 
8 6 40 30 16.16 0.26 93 0.4 52 
9 6 50 30 16.88 0.56 92 0.0 53 
10 3 30 10 29.30 0.26 95 0.2 43 
11 3 40 10 26.12 0.72 97 1.1 38 
12 3 50 10 20.52 0.23 94 1.7 37 
13 3 30 20 19.22 0.05 97 0.3 37 
14 3 40 20 18.36 0.37 95 1.2 42 
15 3 50 20 18.81 0.85 87 2.3 50 
16 3 30 30 18.31 0.58 95 1.2 42 
17 3 40 30 22.27 1.50 90 1.1 53 
18 3 50 30 23.32 2.11 83 1.5 58 
19 0 30 10 11.81 0.18 83 5.6 52 
20 0 40 10 10.07 0.10 86 2.1 49 
21 0 50 10 10.29 0.05 62 6.7 63 
22 0 30 20 8.74 0.12 74 6.9 58 
23 0 40 20 10.63 1.67 68 3.5 63 
24 0 50 20 9.40 0.15 63 5.8 65 
25 0 30 30 11.09 0.92 62 9.3 62 
26 0 40 30 10.19 2.29 38 8.3 67 
27 0 50 30 8.39 0.49 54 11.0 64 
Main effects graphs (Figure 84 to Figure 86) and observations suggested SDS had 
the greatest impact on consolidation, extrudate colour and SME. This was 
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confirmed using analysis of variance (Table 49). Analysis of variance revealed 
that SDS contributed 71.2% to SME input, 71.9% to whiteness and 58.5% to 
consolidation. This confirmed the observations made during extrusion where 
extruding formulations with no SDS resulted in poorly consolidated samples, 
which were powdery, had many surface defects and were easy to break. In some 
cases consolidation reached a plateau at 3 pphBM SDS which suggested that this 
amount of SDS was sufficient to reduce hydrophobic interactions allowing the 
protein chains to interact and reform new stabilising interactions so the plastic 
could consolidate. 
 
Figure 84: Main effects of SDS, water and TEG on extrudate whiteness. 
 
Figure 85: Main effects of SDS, water and TEG on extrusion consolidation. 
 
Figure 86: Main effects plot of SDS, water and TEG on SME input during extrusion. 
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Table 49: Contribution of each additive to the average extruded properties, as determined using analysis of 
variance. 
 
SME (%) Extrudate Whiteness (%) Consolidation (%) 
SDS 71.2 71.9 58.5 
Water 1.8 3.5 9.1 
TEG 12.9 9.6 17.4 
SDS*Water 1.1 2.0 0.6 
SDS*TEG 6.4 6.1 2.8 
Water*TEG 3.4 2.2 2.5 
SDS*Water*TEG 3.2 4.6 9.2 
SDS was required to detangle the protein chains in the bloodmeal aggregates by 
reducing the hydrophobic interactions. The detangled proteins were then able to 
re-entangle and form new stabilising interactions during extrusion resulting in 
consolidation. Previous studies have suggested that when proteins are detangled 
or unwound the amount of surface area for new stabilising interactions and 
entanglements increases during processing [181]. If this was true then at 0 pphBM 
SDS the bloodmeal protein would not be detangled sufficiently resulting in low 
amounts of entanglement and few molecular interactions due to the low contact 
area between protein chains. This could explain the poor consolidation at 0 pphBM 
SDS. At 3 and 6 pphBM the protein was unwound enough to allow sufficient 
entanglements and the formation of new stabilising interactions during extrusion 
resulting in good consolidation. 
When biopolymers entangle and form new stabilising interactions during 
extrusion, their viscosity increases and cause an increase in required SME input. 
At 0 pphBM SDS, low SME input was required during extrusion. This was 
probably due to low chain entanglements and chain interactions as the protein was 
not detangled sufficiently enough to allow a high amount of these to new 
entanglements and stabilising interactions to form. 
At 3 pphBM SDS, the protein was detangled sufficiently and the chains were able 
to entangle and interact during extrusion resulting in a high SME input. No 
increase in SME occurred at 6 pphBM SDS and in some cases SME decreased 
slightly. This suggested that 3 pphBM SDS was sufficient to detangle enough of 
the protein chains and as SDS content increased the excess SDS could have been 
acting as a plasticiser as has been shown previously in other studies where SDS 
was used at high concentrations [181]. 
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9.3.2.2 Injection Moulded Sample Properties 
Injection moulded mechanical properties and sample colour varied greatly 
depending on what combinations of water, TEG and SDS were used. SDS and 
water appeared to have a small effect on colour whereas TEG appeared to have a 
significant effect. Water was evaporated during extrusion, injection moulding and 
conditioning as shown in Table 50, which may be why its effect on injection 
moulded sample whiteness and mechanical properties was not as great as TEG 
and SDS. 
Table 50: Moisture contents of samples produced using different combinations of SDS, water and TEG after 
extrusion, injection moulding and conditioning. 
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1 6 30 10 25 20 18 N/A 
2 6 40 10 30 25 21 11 
3 6 50 10 34 23 22 11 
4 6 30 20 24 20 17 N/A 
5 6 40 20 28 24 20 12 
6 6 50 20 32 27 23 11 
7 6 30 30  22 22 18 13 
8 6 40 30 27 24 19 12 
9 6 50 30 31 30 23 13 
10 3 30 10 26 21 18 N/A 
11 3 40 10 31 22 19 N/A 
12 3 50 10 35 27 23 9 
13 3 30 20 24 18 16 10 
14 3 40 20 29 22 18 10 
15 3 50 20 33 28 24 11 
16 3 30 30 23 19 16 12 
17 3 40 30 27 23 19 13 
18 3 50 30 31 28 23 13 
19 0 30 10 26 20 16 N/A 
20 0 40 10 31 25 19 8 
21 0 50 10 36 29 22 8 
22 0 30 20 25 20 16 N/A 
23 0 40 20 29 26 19 9 
24 0 50 20 34 30 22 9 
25 0 30 30 23 24 16 10 
26 0 40 30 28 28 19 10 
27 0 50 30 32 32 22 10 
Note: dried 4% PAA treated bloodmeal contained 7% moisture. 
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Table 51: Mechanical properties of conditioned injection moulded samples produced from four percent PAA 
treated bloodmeal with different water, TEG and SDS combinations. 
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1 6 30 10 Not Injection Mouldable  
2 6 40 10 795.66 27.57 4.60 0.17 1.78 0.05 0.02 0.00 23 
3 6 50 10 687.17 27.65 4.51 0.27 1.82 0.06 0.02 0.00 31 
4 6 30 20 Not Injection Mouldable  
5 6 40 20 223.36 15.21 2.99 0.33 5.06 0.73 0.05 0.02 37 
6 6 50 20 252.81 7.95 3.32 0.08 4.20 0.11 0.04 0.00 38 
7 6 30 30 51.26 1.34 3.50 0.06 71.44 1.01 1.13 0.05 41 
8 6 40 30 51.33 1.72 3.43 0.03 80.34 2.02 1.18 0.08 39 
9 6 50 30 46.11 1.75 3.27 0.06 88.10 1.81 1.29 0.08 40 
10 3 30 10 Not Injection Mouldable  
11 3 40 10 Not Injection Mouldable  
12 3 50 10 848.11 26.11 5.50 0.44 2.28 0.13 0.03 0.01 29 
13 3 30 20 90.85 1.90 4.65 0.10 59.12 2.10 1.21 0.10 28 
14 3 40 20 88.98 1.49 4.89 0.10 75.78 1.70 1.70 0.08 29 
15 3 50 20 85.48 2.40 4.62 0.10 82.62 1.33 1.75 0.09 37 
16 3 30 30 37.82 1.16 3.05 0.07 76.50 2.72 0.92 0.13 33 
17 3 40 30 32.23 1.62 2.81 0.05 81.84 2.60 0.91 0.12 38 
18 3 50 30 40.58 4.99 2.63 0.12 84.86 3.46 0.75 0.15 36 
19 0 30 10 Not Injection Mouldable  
20 0 40 10 1217.17 48.45 8.78 0.76 2.44 0.12 0.04 0.01 26 
21 0 50 10 1133.66 85.92 8.42 0.63 2.42 0.09 0.04 0.01 26 
22 0 30 20 Not Injection Mouldable  
23 0 40 20 352.60 17.46 6.31 0.11 14.44 1.01 0.37 0.08 36 
24 0 50 20 418.26 17.13 6.45 0.38 7.06 0.36 0.14 0.03 33 
25 0 30 30 125.67 11.16 4.47 0.15 49.70 4.31 0.81 0.18 35 
26 0 40 30 95.73 3.12 4.43 0.06 58.14 1.72 0.12 0.07 37 
27 0 50 30 89.36 5.26 4.13 0.03 52.30 0.99 0.96 0.04 37 
Main effects graphs (Figure 87 to Figure 91) and observations made during 
processing and testing suggested TEG to be most important for both colour and 
mechanical properties overall. High TEG produced injection moulded samples 
with whiteness values between 35-41% whereas low TEG resulted in 23-31% 
white samples. Analysis of variance showed that TEG contributed the 38.1% to 
colour of injection moulded samples while water contributed 29.9% and SDS 
contributed 0.5% (Table 52). 
  
Figure 87: Main effects of SDS, water and TEG on whiteness of injection moulded sample. 
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Figure 88: Main effects of SDS, water and TEG on strain at break. 
 
Figure 89: Main effects of SDS, water and TEG on UTS. 
 
Figure 90: Main effects of SDS, water and TEG on toughness. 
 
Figure 91: Main effects of SDS, water and TEG on Young's modulus. 
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Table 52: Contribution of each additive to the average mechanical properties of injection moulded samples, 
as determined using analysis of variance. 
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SDS 8.1 12.5 13.7 15.2 0.5 
Initial Water 19.7 30 1.0 0.6 29.9 
TEG 30.5 0.1 66.9 39.7 38.1 
SDS*Water 6.8 12.8 0.2 0.7 6.3 
SDS*TEG 4.6 12.5 17.6 37.4 4.2 
Water*TEG 21.1 21.9 0.3 2.5 14.1 
SDS*Water*TEG 9.2 10.3 0.4 3.9 6.9 
Polymers can form carbonyl compounds when exposed to high temperatures 
during processing resulting in a brown discolouration of the product [146]. This 
combined with high pressures and shear could be what caused darkening during 
injection moulding. Plasticisers have been shown to prevent thermal and 
mechanical degradation by increasing workability through molecular lubrication 
[164]. Thermal degradation is more likely to occur at low plasticiser contents [8]. 
The higher TEG content could reduce thermal and mechanical degradation by 
improving lubrication and heat dissipation between the chains resulting in a 
lighter colour. Oxidation could also be a cause of discolouration during 
processing. Using antioxidants to prevent this should be investigated in future 
studies. 
The whiteness of injection moulded samples was slightly higher at 6 pphBM SDS 
than 0 and 3 pphBM. At 6 pphBM SDS the excess SDS could be acting as a 
plasticiser and help prevent darkening of the injection moulded sample. 
It is interesting that SDS contributed 71.9% and TEG contributed 9.6% to 
extrudate colour. Whereas SDS only contributed 0.5% and TEG 38.1% to 
injection moulded sample colour. This was probably because after extrusion a 
consolidated sample darkens slightly and there was a clear relationship between 
consolidation and whiteness as shown in Figure 92. This could be why SDS had a 
high contribution to the colour of extrudates. After extrusion consolidation has 
most probably reached a maximum for most cases so any change in colour during 
injection moulding was most probably due to degradation. TEG had an increased 
contribution to injection moulded sample colour, because it can help prevent 
thermal and mechanical degradation of proteins during thermoplastic processing. 
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Figure 92: Relationship between extruded colour and consolidation. 
A similar result was found for mechanical properties. SDS and water appeared to 
have a small effect while TEG had a strong effect. In general it appeared that as 
TEG content increased Young’s modulus and UTS decreased whereas extension 
and toughness increased. Analysis of variance (Table 52) confirmed that TEG had 
a 30.5% contribution to Young’s modulus, 66.9% contribution to extension and 
39.7% contribution to toughness. TEG on its own only contributed 0.1% to UTS 
which was not expected, however its combined effect with water contributed 
21.9% to UTS. Plasticisers can greatly affect mechanical properties due to their 
lubricating effects [164]. High TEG content would have reduced bloodmeal 
protein-protein interactions and increased free volume between molecules making 
movement easier which resulted in the low Young’s modulus and UTS. However 
the increased free volume increased the material’s ability to be stretched without 
breaking which led to greater percentage strain at break and increased toughness. 
Initial water content had a greater effect on unconditioned sample properties than 
conditioned samples (Appendix 2). In general as water content increased Young’s 
modulus and UTS decreased whereas extension and toughness increased as 
expected. Unconditioned samples had lower mechanical properties overall than 
conditioned samples because of the high water content. 
Initial water had a 30% contribution to UTS and 19.7% contribution to Young’s 
modulus of conditioned samples. However it had only a minor effect on strain at 
break and toughness. These results suggest that even though water was removed 
during conditioning, initial water content was still relatively important to the 
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formation of stabilising interactions. This has also been found in other studies [7]. 
The initial water content may aid the action of SDS during processing which may 
explain why it still made a contribution to mechanical properties after 
conditioning. 
Initial water was the second highest single contributor injection moulded sample 
whiteness. Its lower contribution effect is probably because plasticisation with 
water can be affected by evaporation [164]. Its effect on mechanical properties 
could be reduced when compared to unconditioned samples because after 
conditioning, water levels have been equilibrated to approximately 10% and new 
interactions were formed which override the initial contribution of water. 
SDS can increase mechanical properties because detangled proteins are able to 
entangle and their side groups able to interact. However SDS can also reduce 
mechanical properties by removing too many hydrophobic interactions between 
protein chains or by disrupting the protein matrix [181]. SDS had a slight effect 
on UTS (12.5%) and Young’s modulus (8.1%). Generally as SDS increased, UTS 
and Young’s modulus decreased indicating SDS also acted as a plasticiser. 
TEG was found to have the greatest effect on mechanical properties because of its 
plasticising effect. As TEG increased, Young’s modulus and UTS decreased This 
is typical behaviour observed with plasticisers, due to the plasticiser increasing 
free volume between chains and making molecular movements easier which 
causes a reduction in Young’s modulus and UTS. 
The combination of SDS and TEG contributed 17.6% to strain at break and 37.4% 
to toughness. Strain at break and toughness were closely related and showed 
similar trends. This was because toughness is the amount of energy absorbed 
before break which is proportional to the amount of strain. 
In general low SDS and TEG caused low strain at break and toughness due to 
poor entanglement and protein chain interactions from a lack of aggregate 
unwinding. Low plasticisation resulting in restricted molecular movement was 
probably another contributing factor. As SDS and TEG increased so did strain at 
break and toughness because of greater entanglement and plasticisation. When 
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data was analysed it was found that 0 and 6 pphBM SDS showed similar trends for 
strain at break and toughness, although this was due to different reasons. 
When 0 pphBM SDS and low TEG was used there was low strain at break, 
probably due to the combination of low amounts of entanglement and 
plasticisation. Although there was no SDS, pressure and heat could also be acting 
to detangle the aggregated protein and this would have resulted in some 
entanglement. When TEG was increased so did extension due to the increased 
plasticiser making the entangled proteins able to move past each other more 
easily. When 6 pphBM SDS was used, very low strain at break was obtained at 10 
and 20 pphBM TEG. Strain at break was lower than when 0 pphBM SDS was used. 
However when TEG was increased to 30 pphBM, strain at break increased greatly. 
High SDS content can put an overall negative charge on the protein which could 
lead to repulsion effects. This could explain the low strain at break and toughness 
at 10 and 20 pphBM TEG when 6 pphBM SDS was used. At 30 pphBM TEG the free 
volume between chains could be increased sufficiently to overcome these 
repulsion effects leading to improved strain at break and toughness. 
When 3 pphBM SDS was used a different trend was observed for percentage strain 
at break and toughness. Low percentage strain at break occurred when 10 pphBM 
TEG was used which was similar for the other SDS contents. However at 20 
pphBM TEG the percentage strain at break increased greatly and reached a plateau. 
When increased to 30 pphBM TEG very little increase in percentage strain at break 
occurred and toughness was reduced. This is the usual trend observed with 
plasticiser use, where above a critical plasticiser content intermolecular 
interactions become too weak resulting in reduced percentage strain at break and 
toughness [177]. These results suggested that the optimum combination was 3 
pphBM SDS and 20 pphBM TEG. This combination provided the optimum level of 
entanglement, stabilising forces and plasticisation as shown by the best 
mechanical properties. Plasticiser content was at the right level so to allow 
sufficient chain movement for flexibility without causing too much loss in 
strength. If plasticiser was increased above this level then excessive plasticisation 
caused a loss in Young’s modulus and UTS without significant increases in 
percentage strain at break and caused reduced toughness. 
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9.3.3 Ranking Formulations Based on Extruded Sample Properties 
Formulations were ranked for extrusion by adding the normalised values for 
consolidation and colour multiplied by an importance factor. Consolidation was 
decided to be most important; therefore its normalised value was multiplied by 
2.5. When formulations were ranked based the best formulations were, 
formulation 2 and 6 (Table 53). These produced samples which were 98% 
consolidated and 49% white using 6 pphBM SDS combined with 40 pphBM water 
and 10 pphBM TEG. The worst formulation was formulation 26 which achieved 
38% consolidation and 67% whiteness using 0 pphBM SDS, 40 pphBM water and 
30 pphBM TEG. If producing an extruded product formulation 2 and 6 would be 
the preferred formulations to use. However reasonable results could still be 
obtained when 3-6 pphBM SDS were combined with a total plasticiser content 
between 50 and 60 pphBM. 
Table 53: Ranking samples produced from 4% PAA treated bloodmeal with different water, TEG and SDS 
combinations based on consolidation and whiteness after extrusion. 
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1 equal 2 6 40 10 2.49 0.73 3.22 
1 equal 6 6 50 20 2.44 0.78 3.22 
2 5 6 40 20 2.45 0.74 3.19 
3 3 6 50 10 2.44 0.72 3.16 
4 4 6 30 20 2.50 0.66 3.16 
5 9 6 50 30 2.35 0.80 3.15 
6 8 6 40 30 2.37 0.77 3.15 
7 7 6 30 30 2.36 0.76 3.12 
8 1 6 30 10 2.44 0.65 3.09 
9 17 3 40 30 2.27 0.80 3.07 
10 10 3 30 10 2.41 0.65 3.06 
11 16 3 30 30 2.41 0.63 3.05 
12 14 3 40 20 2.41 0.63 3.04 
13 11 3 40 10 2.47 0.56 3.04 
14 13 3 30 20 2.47 0.55 3.02 
15 18 3 50 30 2.11 0.87 2.98 
16 15 3 50 20 2.22 0.75 2.97 
17 12 3 50 10 2.39 0.56 2.95 
17 20 0 40 10 2.17 0.74 2.91 
19 19 0 30 10 2.10 0.78 2.89 
20 22 0 30 20 1.89 0.87 2.75 
21 23 0 40 20 1.72 0.94 2.66 
22 24 0 50 20 1.60 0.97 2.58 
23 25 0 30 30 1.58 0.94 2.51 
24 21 0 50 10 1.56 0.94 2.51 
25 27 0 50 30 1.38 0.96 2.34 
26 26 0 40 30 0.97 1.00 1.97 
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When samples were ranked based on extrusion the most obvious trend was that as 
SDS increased so did the quality of the extrudate. This was also clearly observed 
during extrusion trials as previously described. However SDS along with water 
and TEG can affect injection moulded sample mechanical properties. Therefore 
samples were ranked based on injection moulded sample properties as well to find 
the optimum levels of SDS, water and TEG which produced a light coloured 
sample with acceptable mechanical properties. 
9.3.4 Ranking Formulations Based on Injection 
Moulded Sample Properties 
Formulations were ranked based on colour and mechanical properties of injection 
moulded samples by summing the normalised colour and mechanical property 
responses for each formulation (Table 54). Formulation 15 was found to be the 
best combination of water (50 pphBM), TEG (20 pphBM) and SDS (3pphBM). This 
produced a sample with tensile strength 4.62 MPa, young’s modulus 85.48 MPa, 
toughness 1.75 MPa and 82.62% strain at break. However the combination of 
these can be altered depending on the desired properties of the final material. For 
example, more water or TEG could be used to produce a lighter more flexible and 
flexible sample or less water and TEG could be used to produce a darker sample 
with higher stiffness and strength. 
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Table 54: Ranking samples produced from 4% PAA treated bloodmeal with different water, TEG and SDS 
combinations based on whiteness and mechanical properties after injection moulding. 
Ranking Formulations Based on Injection Moulding 
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1 15 3 50 20 0.90 0.07 0.53 0.94 1.00 3.44 
2 14 3 40 20 0.71 0.07 0.56 0.86 0.97 3.17 
3 9 6 50 30 0.98 0.04 0.37 1.00 0.73 3.13 
4 8 6 40 30 0.95 0.04 0.39 0.91 0.67 2.97 
5 7 6 30 30 1.00 0.04 0.40 0.81 0.65 2.90 
6 17 3 40 30 0.92 0.03 0.32 0.93 0.52 2.71 
7 20 0 40 10 0.64 1.00 1.00 0.03 0.02 2.69 
8 13 3 30 20 0.69 0.07 0.53 0.67 0.69 2.66 
9 27 0 50 30 0.92 0.07 0.47 0.59 0.55 2.60 
10 18 3 50 30 0.88 0.03 0.30 0.96 0.43 2.60 
11 16 3 30 30 0.82 0.03 0.35 0.87 0.52 2.59 
12 21 0 50 10 0.64 0.93 0.96 0.03 0.02 2.58 
13 25 0 30 30 0.86 0.10 0.51 0.56 0.46 2.49 
14 23 0 40 20 0.88 0.29 0.72 0.16 0.21 2.26 
15 26 0 40 30 0.90 0.08 0.50 0.66 0.07 2.22 
16 12 3 50 10 0.71 0.70 0.63 0.03 0.02 2.07 
17 24 0 50 20 0.82 0.34 0.73 0.08 0.08 2.06 
18 3 6 50 10 0.77 0.56 0.51 0.02 0.01 1.88 
19 2 6 40 10 0.57 0.65 0.52 0.02 0.01 1.78 
20 6 6 50 20 0.94 0.21 0.38 0.05 0.02 1.60 
21 5 6 40 20 0.90 0.18 0.34 0.06 0.03 1.51 
22 10* 3 30 10 0.83 0.00 0.00 0.00 0.00 0.83 
23 19* 0 30 10 0.81 0.00 0.00 0.00 0.00 0.81 
24 22* 0 30 20 0.77 0.00 0.00 0.00 0.00 0.77 
25 1* 6 30 10 0.68 0.00 0.00 0.00 0.00 0.68 
26 11* 3 40 10 0.68 0.00 0.00 0.00 0.00 0.68 
27 4* 6 30 20 0.67 0.00 0.00 0.00 0.00 0.67 
* Samples not injection mouldable. 
9.3.5 Ranking Formulations Based on Extruded and 
Injection Moulded Sample Properties 
When formulations were ranked based on extruded and injection moulded sample 
properties using the previously described method, formulation 15 was also found 
to be the optimum combination of water, TEG and SDS. However during 
extrusion this sample only produced an 87.4% consolidated sample with many 
surface defects which broke easily and when assessed based solely on extrusion 
properties, formulation 15 was ranked 16
th
. Other combinations of water, TEG 
and SDS could be used to produce better quality extrudates. This showed that 
different combinations of water, TEG and SDS must be chosen to obtain the best 
quality sample depending if extrusion or injection moulding will be the final 
processing step. If extruding is the final processing technique used to produce the 
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product then 3-6 pphBM combined with 50-60 pphBM total plasticiser content will 
produce a good quality sample. Whereas if injection moulding is the final 
processing technique used then a good quality sample can be obtained using 3-6 
pphBM with 70-80 pphBM total plasticiser where at least 20 pphBM is TEG. 
Table 55: Ranking formulations produced from 4% PAA treated bloodmeal with different water, TEG and 
SDS combinations based on consolidation, whiteness after extrusion and injection moulding and mechanical 
properties after injection moulding. 
Ranking Formulations Based on Extrusion and Injection Moulding 
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1 15 3 50 20 2.97 3.44 6.40 
2 9 6 50 30 3.15 3.13 6.28 
3 14 3 40 20 3.04 3.17 6.20 
4 8 6 40 30 3.15 2.97 6.12 
5 7 6 30 30 3.12 2.90 6.01 
6 17 3 40 30 3.07 2.71 5.78 
7 13 3 30 20 3.02 2.66 5.68 
8 16 3 30 30 3.05 2.59 5.64 
9 20 0 40 10 2.91 2.69 5.60 
10 18 3 50 30 2.98 2.60 5.58 
11 21 0 50 10 2.51 2.58 5.09 
12 3 6 50 10 3.16 1.88 5.04 
13 12 3 50 10 2.95 2.07 5.02 
14 25 0 30 30 2.51 2.49 5.01 
15 2 6 40 10 3.22 1.78 5.00 
16 27 0 50 30 2.34 2.60 4.94 
17 23 0 40 20 2.66 2.26 4.92 
18 6 6 50 20 3.22 1.60 4.81 
19 5 6 40 20 3.19 1.51 4.69 
20 24 0 50 20 2.58 2.06 4.63 
21 26 0 40 30 1.97 2.22 4.19 
22 10* 3 30 10 3.06 0.83 3.89 
23 4* 6 30 20 3.16 0.67 3.83 
24 1* 6 30 10 3.09 0.68 3.77 
25 11* 3 40 10 3.04 0.68 3.72 
26 19* 0 30 10 2.89 0.81 3.70 
27 22* 0 30 20 2.75 0.77 3.52 
* Samples not injection mouldable. 
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9.4 Conclusion 
It was found that the optimum combination of water, TEG and SDS differed for 
extrusion and injection moulding. SDS was found to be the most important factor 
for consolidation during extrusion and SME due to it unwinding the aggregated 
protein and allowing new protein entanglements and new protein interactions to 
form. The best extruded sample based on consolidation and whiteness contained 
40 pphBM water, 10 TEG pphBM and 6 pphBM SDS. This produced a extrudate 
which was 98% consolidated and 49% white. 
TEG was most important for injection moulded sample whiteness with a 38.1% 
contribution. TEG reduced thermal and mechanical stresses which contributed to 
degradation and darkening of the sample. Water contributed 29.9% and SDS also 
had a small 0.5% contribution. Main effects plots and experimental observations 
revealed that high SDS helped prevent darkening which suggested it acted as a 
plasticiser at high concentrations. 
TEG also had the greatest impact on injection moulded sample mechanical 
properties with 30.5% contribution to Young’s modulus, 66.9% contribution to 
extension and 39.1% contribution to toughness. It only contributed 0.1% to UTS 
which was much lower than expected, but its combined effect with water 
contributed 21.9% to UTS. Increasing TEG resulted in increased free volume and 
easier molecular movements which led to decreased Young’s modulus and UTS 
but higher percentage strain at break and toughness.  
SDS was the second highest single contributor to mechanical properties. It 
contributed 8.1% to Young’s modulus, 12.5% to UTS, 13.7% to extension and 
15.2% to toughness. 0 pphBM SDS had low extension and toughness which was 
probably caused by a lack of entanglement from low protein aggregate unwinding. 
6 pphBM SDS had poor mechanical properties at 10-20 pphBM TEG because of 
electrostatic repulsion. When TEG reached 30 pphBM free volume was increased 
sufficiently to overcome the repulsion effect.  
At 3 pphBM SDS, 50 pphBM water and 20 pphBM TEG an optimum level of 
entanglement, stabilising interactions and plasticisation occurred which resulted in 
an injection moulded sample with tensile strength 4.62 MPa, Young’s modulus 
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85.48 MPa, toughness 1.75 MPa and 82.62% strain at break. These mechanical 
properties were comparable to Novatein Thermoplastic Protein produced from 
untreated bloodmeal and bioplastics produced from other agricultural biopolymer 
sources. 
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Chapter 10 Conclusions and Recommendations 
Chapter 10  
Conclusions and Recommendations 
 
 
Bioplastic components produced from peracetic acid treated bloodmeal 
incorporated into remote controlled boat. 
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10.1 Conclusions 
It was shown that a yellow/orange and odourless thermoplastic material could be 
made from peracetic acid (PAA) treated bloodmeal. The most significant findings 
were that bloodmeal’s molecular weight could be presevered by using PAA as an 
oxidant and odour causing compounds were effectively oxidised while degrading 
the iron containing haem group in haemoglobin to reduce the material’s colour. 
This will lead to bloodmeal being used more widely in bioplastics as it can be 
pigmented and converted into a thermoplastic by extrusion and injection 
moulding. This could potentially add value to what was traditionally a low value 
meat processing industry by-product.  The overall research programme is 
summarised in Figure 93 for easy reference. 
Haem consists of a highly conjugated structure while the odorous compounds also 
contain double bonds and ring structures.  In both cases, these can be readily 
removed by oxidation.  The haem group can be dissociated from haemoglobin by 
dilution and reducing solution pH to 2. In this study hydrogen peroxide, PAA, 
sodium hypochlorite, sodium chlorite, sodium chlorate, and chlorine dioxide were 
used to reduce colour and smell in red blood cell concentrate (RBCC), modified 
RBCC (mRBCC), and bloodmeal. 
Treatment of RBCC and mRBCC with peroxides resulted in extensive foaming of 
soluble proteins by oxygen released during peroxide degradation by catalase 
present in blood. Dilution reduced foaming but increased processing volume.  
Hydrogen peroxide treatment of mRBCC resulted in a powder which was 55% 
white, whereas hydrogen peroxide treatment of RBCC produced a powder which 
was 71% white. Treating mRBCC and RBCC with PAA produced powders which 
were 87 and 91% white respectively. Both treatments for RBCC were rapid and 
were completed within 5 minutes.  Treatment time and extent of decolouring were 
dependent on protein and oxidant concentration as was shown when treating 
mRBCC with hydrogen peroxide.  Sodium chlorite was the most successful 
oxidant, producing a powder which was 61% white from RBCC and a powder 
which was 93% white from mRBCC within 30 minutes.  In most cases, where 
decolouring was successful, protein average molecular weight was reduced from 
87-94 kDa to 13-44 kDa.  The exception was sodium chlorite treated RBCC 
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where average molecular weight increased to 143 kDa. This method produced 
small molecular weight peptides but also caused aggregation which was 
responsible for the increase in average molecular weight.  
Treating bloodmeal with hydrogen peroxide, PAA and sodium chlorite produced 
powders which were 59%, 67% and 31% white respectively.  The molecular 
weight for hydrogen peroxide and PAA treated bloodmeal was unaffected, but 
sodium chlorite treated powder was unable to be dissolved in SDS and sodium 
sulphite solutions for molecular weight analysis. Significant foaming occurred 
during hydrogen peroxide treatment, but not for PAA treatment of bloodmeal. 
Bloodmeal was selected as the best feedstock for decolouring as it had a high 
solids content of 95%, it did not need to be diluted for successful treatment and 
protein molecular weight was not reduced.  In addition, using bloodmeal avoided 
handling large processing volumes associated with RBCC and mRBCC and 
prevented microbial degradation because bloodmeal is a dried, stable feedstock. 
PAA preferentially reacted with the haem group, odour compounds and 
disulphide bonds.  At higher concentrations it also reacted with amino acid side 
groups reducing hydrophobic interactions and hydrogen bonding between protein 
chains.  This reduced protein crystallinity, thermal stability, and glass transition 
temperature, while increasing protein solubility in phosphate buffer, SDS and 
sodium sulphite solutions heated to 100°C.  Powder X-ray diffraction showed 
bloodmeal crystallinity decreased from 35% to 31-27% when treated with 1-5% 
PAA accompanied by a decrease in glass transition temperature from 225°C to 
50°C.  The protein solubility increased from 1% to 25% in phosphate buffer, 11% 
to 85% in 1% SDS and 3% to 26% in 1% sodium sulphite.  
Protein chains have a wide range of interactions such as electrostatic and 
hydrophobic interactions, hydrogen bonding and disulphide bonding that are 
responsible for stabilising their structure.  For successful extrusion, these 
interactions must be controlled using a combination of denaturants, surfactants, 
reducing agents and plasticisers. It was shown that PAA treated bloodmeal could 
not be extruded using the same operating conditions and additives as those 
required for untreated bloodmeal.   
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Initial attempts at extruding PAA treated bloodmeal using water (60 pphBM), urea 
(10 pphBM), TEG (10 pphBM), sodium sulphite (3 pphBM) and SDS (3 pphBM) were 
unsuccessful and resulted in an unconsolidated powder.  In further trials, 3-5% 
PAA treated bloodmeal powder was extruded using different combinations of 
water (0-60 pphBM), TEG (0-40 pphBM), glycerol (0-45 pphBM), SDS (0-6pphBM), 
sodium sulphite (0-6 pphBM), urea (0-10 pphBM), borax (0-15 pphBM), salt (0-10 
pphBM) and sodium silicate (0-15 pphBM).  
Urea and sodium sulphite which were required to produce NTP were found to be 
unnecessary for PAA treated bloodmeal as the disulphide cross-links and 
hydrogen bonds had been reduced by PAA treatment. Using sodium silicate, 
borax, and salt were also unsuccessful and gave dark poorly consolidated 
extrudates. The most important additives for successful extrusion and injection 
moulding were water, TEG and SDS.   
3% PAA treated bloodmeal produced dark brown injection moulded samples 
while 5% PAA treated bloodmeal resulted in yellow but easily broken test 
specimens. 4% PAA treated bloodmeal produced the best extruded and injection 
moulded samples and was chosen for investigating the effects of water, TEG and 
SDS concentration on consolidation, specific mechanical energy input, extrudate 
and injection moulded colour as well as mechanical properties.  
ANOVA showed that SDS was the most important variable for extrusion. The 
best extruded sample which was 98% consolidated and 49% white contained 40 
pphBM water, 10 pphBM TEG and 6 pphBM SDS. 
TEG had the greatest effect on colour after injection moulding and mechanical 
properties because of its plasticisation effect. ANOVA showed that TEG 
contributed 30.5% to Young’s modulus, 66.9% to strain, 39.7% to toughness, 
0.1% to UTS and 38.1% to colour, while SDS contributed 8.1% to Young’s 
modulus, 13.7% to strain, 15.2% to toughness, 12.5% to UTS, 0.5% to colour. 
Initial water contributed 19.7% to Young’s modulus, 1% to strain, 0.6% to 
toughness, 30% to UTS and 29.9% to colour.  
The best injection moulded sample was produced using 50 pphBM water, 20 pphBM 
TEG and 3 pphBM SDS. This produced an injection moulded sample which was 
39% white, had an almost transparent yellow/orange colour with a tensile strength 
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of 4.62 MPa, Young’s modulus 85.48 MPa, toughness 1.75 MPa and 82.62% 
strain. These mechanical properties were comparable to NTP and the resulting 
product can be easily pigmented. 
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Figure 93: Flow diagram summarising work carried out and conclusions made during the production of decoloured bioplastic from bloodmeal 
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10.2 Recommendations for Future Work 
Recommendations for further research cover three areas: The first is fully 
characterising the reaction kinetics of PAA treatment, secondly processing 
decoloured bloodmeal and thirdly biodegradation. 
Further research could be carried out on the PAA bleaching process. This should 
focus on developing the decolouring processing and looking at recycling 
unreacted PAA. This could reduce treatment costs and also reduce waste. Work 
could also be done to investigate the time required for any PAA, acetic acid and 
hydrogen peroxide to decompose when it is discarded. The effect of PAA 
treatment on the amino acid composition of bloodmeal should also be investigated 
as these may help to understand protein-protein interactions. 
The effect of processing on the molecular structure and protein chain interactions 
should be explored further, including processing using alternative plasticisers. 
Mechanical properties of PAA decoloured bloodmeal were highly dependent on 
TEG content. Using a different plasticiser could produce a material with different 
advantages. Attempts could also be made to improve the mechanical properties 
and water resistance of PAA decoloured bioplastics by incorporating fibres, clays 
and additives. Initial trials using compression moulding suggested that this may be 
feasible (Appendix 3). However, this needs to be confirmed with extrusion, 
injection moulding and more accurate tensile testing.  Low strength, stiffness and 
water resistance are the main disadvantages associated with bioplastics when 
compared to synthetic plastics. If these could be improved then bioplastics could 
be used in a wider range of applications where synthetic plastics are 
conventionally used. 
Life cycle assessment studies on NTP have been completed [204, 205]. However 
these should be updated to include treating bloodmeal with peracetic acid. Finally 
investigations into how PAA treatment affects the bioplastics compostability 
should be investigated. NTP degrades within twelve weeks when composted and 
it would be interesting to see if the sanitising effect of PAA treatment had any 
impact on degradation time.   
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Appendix 1: Summary of Extrusion and Injection 
Moulding Trials 
Table 56: Full extrusion and injection moulding summary. 
Additives 
(pphbm)
 
Conditions 
(extruder 
temperature 
profile °C, screw 
speed RPM) 
Observations 
Comments 
Photo 
(scale: cm) 
60 water, 10 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water, 10 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 130, 110, 
110, 110, 80 
Screw speed: 
150 
 
10mm 
diameter die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water, 10 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water, 10 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 130, 110, 
110, 110, 80 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
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60 water, 10 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 120, 110, 
110, 110, 90 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water, 10 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 120, 120, 
115, 110, 90 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water, 10 
TEG, 10 urea, 6 
sds, 3ss 
Temp: 120, 110, 
110, 105, 70 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water, 10 
TEG, 10 urea, 6 
sds, 3ss 
Temp: 130, 110, 
110, 110, 70 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water, 10 
TEG, 10 urea, 6 
sds, 3ss 
Temp: 130, 110, 
110, 110, 70 
Screw speed: 
125 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid not 
neutralised 
 
60 water Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
Acetic acid 
neutralised for 
all samples 
from here 
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60 water, 10 
urea 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 10 
urea, 10 salt 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 10 
urea, 10 salt 
Temp: 120, 105, 
105, 105, 95 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 10 
urea, 20 sodium 
silicate 
Temp: 120, 100, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 5 borax 
Temp: 130, 110, 
105, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
urea, 15 sds, 20 
sodium silicate, 
20 polyethylene 
glycol, blue 
pigment 
Temp: 120, 100, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 10 urea, 
20 sodium 
silicate 
Temp: 120, 100, 
100, 100, 75 
Screw speed: 
100 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 10 urea, 
20 sodium 
silicate 
Temp: 120, 100, 
100, 100, 75 
Screw speed: 
140 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 5 
sodium silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
140 
10mm 
diameter die 
3% PAA 
treated BM  
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60 water, 10 
sodium silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
140 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
sodium silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
140 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 10 urea, 
1.5 sds, 10 
sodium silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 5 
TEG, 15 
sodium silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 15 
sodium silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 15 
sodium silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 10 urea, 5 
borax 
Temp: 125, 110, 
110, 105, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 10 urea, 5 
borax 
Temp: 125, 110, 
110, 105, 70 
Screw speed: 
150 
 
10mm 
diameter die 
3% PAA 
treated BM 
extruded, 
granulated and 
re-extruded 
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60 water, 10 
borax 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
5 mm diameter 
die 
3% PAA 
treated BM  
60 water, 10 
TEG, 10 borax 
Temp: 130, 110, 
110, 105, 70 
Screw speed: 
150 
5 mm diameter 
die 
3% PAA 
treated BM  
60 water, 10 
TEG, 3 sds, 5 
borax 
Temp: 130, 110, 
110, 105, 70 
Screw speed: 
150 
5 mm diameter 
die 
3% PAA 
treated BM  
60 water, 10 
TEG, 5 borax, 5 
silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 5 borax 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 5 borax 
Temp: 125, 110, 
105, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
45 glycerol, 5 
borax 
Temp: 125, 110, 
105, 100, 70 
Screw speed: 80 
5mm diameter 
die 
3% PAA 
treated BM  
45 glycerol, 5 
borax 
Temp: 125, 110, 
105, 100, 70 
Screw speed: 
150 
 
5mm diameter 
die 
3% PAA 
treated BM 
 
 
60 water, 15 
TEG, 5 borax, 
20 guar gum 
Temp: 125, 110, 
105, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
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60 water, 15 
TEG, 5 borax, 
20 guar gum 
Temp: 125, 120, 
110, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 
10 silicate 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 
10 silicate 
Temp: 125, 115, 
110, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 
10 silicate 
Temp: 130, 120, 
110, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 
silicate, 3 
centrimonium 
chloride 
Temp: 130, 120, 
110, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 
10 silicate, 20 
guar gum 
Temp: 130, 120, 
110, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 
20 guar gum 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 
20 guar gum 
Temp: 140, 120, 
110, 100, 70 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax 
Temp: 140, 120, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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60 water, 15 
TEG, 10 borax 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 
2.5 silicate 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 borax, 5 
silicate 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 borax, 
2.5 silicate 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 borax, 
5 guar gum 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 borax, 
5 sodium 
silicate 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 5 urea, 10 
borax 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 15 borax 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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60 water, 15 
TEG, 15 borax 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
 
10mm 
diameter die 
3% PAA 
treated BM 
 
extruded, 
granulated and 
re-extruded 
 
30 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
 
10mm 
diameter die 
3% PAA 
treated BM 
Extruded, 
granulated and 
injection 
moulded 
Injection temp: 
125, 105, 100, 
100, 80 
 
25 water, 30 
TEG, 6 sds 
Temp: 130, 105, 
100, 100, 80 
Screw speed: 
100 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 6 sds Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 6 sds Temp: 125, 105, 
100, 100, 80 
Screw speed: 
100 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 15 
TEG, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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40 water, 10 
TEG, 10 borax, 
1.5 silicate 
Temp: 140, 135, 
115, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
triacetine, 3ss, 
10 borax 
Temp: 125, 120, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
50 water, 10 
TEG, 5 borax, 1 
sodium silicate 
Temp: 125, 120, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
10 water, 10 
TEG, 3 sodium 
sulphite, 10 
borax 
Temp: 125, 120, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
50 water, 10 
TEG, 5 borax 
Temp: 125, 125, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
40 water, 10 
TEG, 10 borax, 
1.5 sodium 
silicate 
Temp: 135, 130, 
115, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
40 water, 10 
TEG, 10 borax, 
1.5 sodium 
silicate 
Temp: 130, 125, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 5 borax 
Temp: 130, 125, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
TEG, 10 borax 
Temp: 130, 120, 
105, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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60 water, 10 
triacetine, 10 
borax, 3 sodium 
sulphite 
Temp: 130, 125, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
50 water, 5 
borax, 1 sodium 
silicate 
Temp: 125, 125, 
115, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
triacetine, 10 
borax, 3 sodium 
sulphite 
Temp: 135, 125, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 10 
triacetine, 10 
borax, 3 sodium 
sulphite 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 borax, 
2.5 sodium 
silicate 
Temp: 145, 140, 
135, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 borax, 
2.5 sodium 
silicate 
Temp: 140, 140, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 borax, 
2.5 sodium 
silicate 
Temp: 145, 140, 
120, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 15 
TEG, 10 borax, 
2.5 sodium 
silicate 
Temp: 145, 140, 
130, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
60 water, 5 
TEG, 5 borax 
Temp: 140, 130, 
110, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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25 water, 30 
TEG, 6 sds, 5 
borax 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
40 water, 30 
TEG, 6 sds 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 120, 100, 
100, 100, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea, 3 
sds, 3 sodium 
sulphite 
Temp: 130, 110, 
105, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 3 sds, 3 
sodium 
sulphite, 3 
borax 
Temp: 130, 115, 
105, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 3 sds, 3 
sodium 
sulphite, 3 
borax 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
triacetine, 10 
urea, 3 sds, 3 
sodium sulphite 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
40 water, 30 
TEG, 5 borax 
Temp: 140, 130, 
115, 110, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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40 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 140, 130, 
115, 110, 70 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 10 
TEG, 10 urea, 3 
sds 
Temp: 140, 130, 
115, 110, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 155, 140, 
120, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
40 TEG, 10 
urea, 3 sds 
Temp: 155, 140, 
120, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
30 TEG, 10 
urea, 3 sds 
Temp: 155, 140, 
120, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
20 water, 30 
TEG, 5 borax 
Temp: 130, 110, 
105, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
20 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea, 
4.5 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
120 
5mm diameter 
die 
3% PAA 
treated BM  
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30 water, 30 
TEG, 4.5 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
20 water, 30 
TEG, 4.5 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 140, 130, 
115, 110, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
40 TEG, 5 
borax 
Temp: 155, 140, 
120, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
30 water, 30 
TEG, 3 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
20 water, 30 
TEG, 5 borax 
Temp: 145, 130, 
110, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
30 water, 30 
TEG, 10 urea 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
3% PAA 
treated BM  
20 water, 30 
TEG, 4.5 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
20 water, 30 
TEG, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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20 water, 30 
TEG, 4.5 sds, 5 
stearic acid 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 4.5 sds, 5 
stearic acid 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
30 water, 30 
TEG, 4.5 sds, 5 
stearic acid 
Temp: 140, 115, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds, 5 
borax 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
100 
5mm diameter 
die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 75 
5mm diameter 
die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 80 
5mm diameter 
die 
3% PAA 
treated BM  
25 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
100 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 30 
TEG, 10 urea, 3 
sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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25 water, 5 
urea, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
100 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 5 
urea, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 15 
TEG, 6 sds 
Temp: 125, 105, 
100, 100, 80 
Screw speed: 
100 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 125, 110, 
100, 100, 80 
Screw speed: 
120 
10mm 
diameter die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 125, 110, 
100, 100, 80 
Screw speed: 
120 
 
10mm 
diameter die 
3% PAA 
treated BM 
extruded, 
granulated and 
re-extruded 
 
25 water, 30 
TEG, 6 sds 
Temp: 125, 110, 
100, 100, 80 
Screw speed: 
120 
5mm diameter 
die 
3% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 120, 100, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
3% PAA 
treated BM  
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40 water, 30 
TEG, 6 sds 
Temp: 120, 100, 
100, 100, 80 
Screw speed: 
150 
 
10mm 
diameter die 
3% PAA 
treated BM 
Extruded, 
granulated and 
injection 
moulded 
Injection temp: 
120, 100, 100, 
100, 70 
 
50 water, 30 
TEG, 3 sds 
Temp: 125, 110, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
4% PAA 
treated BM  
25 water, 30 
TEG, 6 sds 
Temp: 125, 110, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
4% PAA 
treated BM  
50 water, 40 
TEG, 6 sds 
Temp: 125, 110, 
100, 100, 80 
Screw speed: 
150 
10mm 
diameter die 
4% PAA 
treated BM  
50 water, 40 
TEG, 6 sds 
Temp: 125, 110, 
100, 100, 80 
Screw speed: 
150 
 
10mm 
diameter die 
4% PAA 
treated BM 
Extrude, 
granulate and 
injection mould 
Injection temp: 
120, 115, 100, 
100, 100 
 
50 water, 40 
TEG, 6 sds 
Temp: 120, 110, 
100, 100, 80 
Screw speed: 
125 
10mm 
diameter die 
3% PAA 
treated BM  
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50 water, 40 
TEG, 6 sds 
Temp: 120, 110, 
100, 100, 80 
Screw speed: 
125 
 
10mm 
diameter die 
3% PAA 
treated BM 
Extrude, 
granulate and 
injection mould 
Injection temp: 
120, 115, 100, 
100, 100 
 
50 water, 40 
TEG, 6 sds 
Temp: 120, 110, 
100, 100, 80 
Screw speed: 
125 
 
10mm 
diameter die 
3% PAA 
treated BM 
Extrude, 
granulate and 
injection mould 
(straight from 
nozzle) 
Injection temp: 
120, 115, 100, 
100, 100 
 
50 water, 20 
TEG, 6 sds 
Temp: 135, 115, 
100, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
4% PAA 
treated BM  
50 water, 20 
TEG, 6 sds 
Temp: 135, 115, 
100, 100, 80 
Screw speed: 
150 
Capillary tube 
(approx. 3mm 
diameter) 
4% PAA 
treated BM 
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50 water, 20 
TEG, 6 sds 
Temp: 135, 115, 
100, 100, 80 
Screw speed: 
150 
 
5mm diameter 
die 
4% PAA 
treated BM 
Extrude, 
granulate and 
injection mould 
Injection temp: 
120, 115, 100, 
100, 10 
 
50 water, 20 
TEG, 6 sds 
Temp: 135, 115, 
100, 100, 80 
Screw speed: 
150 
5mm diameter 
die 
5% PAA 
treated BM  
50 water, 20 
TEG, 6 sds 
Temp: 135, 115, 
100, 100, 80 
Screw speed: 
150 
 
5mm diameter 
die 
5% PAA 
treated BM 
Extrude, 
granulate and 
injection mould 
Injection temp: 
120, 115, 100, 
100, 100 
 
50 water, 20 
TEG, 6 sds 
Temp: 135, 115, 
100, 100, 80 
Screw speed: 
150 
 
5mm diameter 
die 
5% PAA 
treated BM 
Extrude, 
granulate and 
injection mould 
(straight from 
nozzle) 
Injection temp: 
120, 115, 100, 
100, 100 
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Appendix 2: Properties of Unconditioned Samples Produced from 
4% PAA Treated Bloodmeal 
Table 57: Mechanical properties of unconditioned injection moulded samples produced from four percent 
PAA treated bloodmeal with different water, TEG and SDS combinations. 
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1 6 30 10 #N/A 
2 6 40 10 20.77 0.29 2.12 0.03 61.44 1.85 0.45 0.04 
3 6 50 10 20.72 0.60 2.10 0.05 76.70 1.30 0.60 0.02 
4 6 30 20 #N/A 
5 6 40 20 13.74 0.52 1.69 0.03 80.82 2.77 0.49 0.05 
6 6 50 20 9.74 0.16 1.25 0.05 66.78 2.29 0.26 0.03 
7 6 30 30 12.89 0.27 1.47 0.05 55.54 1.72 0.30 0.03 
8 6 40 30 9.49 0.07 1.26 0.02 60.90 1.24 0.25 0.02 
9 6 50 30 7.91 0.10 0.94 0.02 48.38 0.75 0.13 0.01 
10 3 30 10 #N/A 
11 3 40 10 #N/A 
12 3 50 10 39.08 4.34 2.41 0.05 58.90 2.67 0.54 0.09 
13 3 30 20 27.89 1.85 2.33 0.10 56.12 1.90 0.46 0.05 
14 3 40 20 24.16 0.57 2.30 0.02 73.68 0.62 0.61 0.02 
15 3 50 20 17.84 0.75 1.70 0.02 69.80 2.61 0.38 0.04 
16 3 30 30 20.20 0.73 2.09 0.03 67.38 1.43 0.49 0.03 
17 3 40 30 15.19 0.59 1.50 0.05 60.76 2.99 0.31 0.05 
18 3 50 30 11.24 0.47 1.25 0.04 61.34 1.22 0.24 0.01 
19 0 30 10 #N/A 
20 0 40 10 70.56 4.71 3.02 0.11 43.14 2.51 0.56 0.10 
21 0 50 10 48.52 3.94 2.29 0.06 46.46 2.06 0.43 0.06 
22 0 30 20 #N/A 
23 0 40 20 26.98 1.44 1.75 0.13 46.06 3.44 0.30 0.06 
24 0 50 20 20.09 0.88 1.64 0.06 61.70 2.15 0.37 0.05 
25 0 30 30 21.54 1.39 1.45 0.08 38.50 2.01 0.16 0.04 
26 0 40 30 16.55 0.37 1.30 0.04 43.62 2.56 0.20 0.03 
27 0 50 30 14.08 0.40 1.09 0.03 35.42 0.57 0.14 0.01 
 
 
Figure 94: Main effects of SDS, water and TEG on Young’s modulus of unconditioned injection moulded 
samples. 
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Figure 95: Main effects of SDS, water and TEG on UTS of unconditioned injection moulded samples. 
 
Figure 96: Main effects of SDS, water and TEG on toughness of unconditioned injection moulded samples. 
 
Figure 97: Main effects of SDS, water and TEG on strain at break of unconditioned injection moulded 
samples. 
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Appendix 3: Mechanical Properties of 4% PAA Treated 
Bloodmeal with Clay, Borax and Sodium Silicate 
Method 
Sodium dodecyl sulphate (SDS) and clay were premixed with water before adding to 4% 
PAA treated bloodmeal. Reagents were mixed in the following proportions: 3 g SDS and 
1, 3 or 5 g additive (borax, sodium silicate, sodium bentonite or octodecylamine 
bentonite) was mixed with 15 g distilled water, heated to 60°C, and added to 100 g 
treated bloodmeal.  This was mixed using a high speed mixer for 5 minutes, before 20 g 
of triethylene glycol (TEG) was added and mixed for a further five minutes.  The mixture 
was transferred to a sealable plastic bag and stored overnight. 
Compression molding 
Bioplastic sheets were formed by compression moulding 50 g of the mixture at 110°C 
(top and bottom plate). 10 tonnes of pressure was applied for five minutes. Heating was 
turned off after five minutes and the mould was left under 10 tonnes of pressure for a 
further five minutes. The pressure was released, the sheet removed and left to cool. 
Tensile test 
Compression moulded sheets were laser cut into type 1 dog bone tensile test specimens. 
The tensile test specimens were conditioned for seven days in a conditioning chamber at 
50% humidity. The mechanical properties were analysed using a Lloyd Tensile Tester LR 
30K with a 500 N load cell at 5 mm/min. 
X-ray diffraction 
Sections of compression moulded sheets were powderised using an IKA MF10 basic 
Microfine grinder and clay-protein or additive-protein interactions analysed using a 
Phillip’s X-ray diffractometer at low angle configuration of 2θ = 2o to 12o, a scanning rate 
of 2θ = 2omin-1, operating at a current of 40 mA and a voltage of 40 kV using CuKα1 
radiation. 
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Results 
 
Figure 98: UTS at different clay/additive levels. 
 
Figure 99: Young’s modulus at different clay/additive levels. 
 
Figure 100: Extension at break at different clay/additive levels. 
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Figure 101: x-ray diffraction pattern for bentonite clay and 4% PAA treated bloodmeal composite. 
 
Figure 102: x-ray diffraction pattern for amine modified clay and 4% PAA treated bloodmeal composite. 
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Figure 103: x-ray diffraction pattern for sodium silicate and 4% PAA treated bloodmeal bioplastic. 
 
Figure 104: x-ray diffraction pattern for borax and 4% PAA treated bloodmeal bioplastic. 
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